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ABSTRACT 
 
A broadly based approach has been undertaken to the development and use of camphor 
derivatives as chiral auxiliaries in asymmetric synthesis – an approach which has embraced 
synthetic, mechanistic and computational studies. 
 
The unambiguous characterization of mono- and dihydroxy-derivatives, obtained by reduction 
of chiral camphor ether dimers, has been achieved through detailed one- and two-dimensional 
NMR spectroscopic analysis. The resulting data has been used to establish both the regio- and 
stereochemistry of the hydroxyl groups. 
 
A camphor-derived cyclic iminolactone has been shown to provide a convenient platform for 
the synthesis of chiral α-amino acids, stereoselective monoalkylation of the iminolactone 
affording a range of products in yields of 52 - 65 % with up to 85 % d.e. 
 
The attempted development of chiral bifunctional Morita-Baylis-Hillman substrates has 
revealed an unexpected equilibration between isomeric bornane 2,3-diol monoacrylates via 
acid-catalysed intramolecular transesterification. A detailed 1H NMR-based kinetic study of 
the rearrangement in various media and at various temperatures has permitted the 
determination of the kinetic and thermodynamic parameters. A computational study at the 
DFT level has been used to explore the potential energy surfaces of the acid-catalysed and 
uncatalysed transesterification of the monoacrylate esters. The theoretical data supports the 
involvement of cyclic intermediates and has provided a rational basis for predicting the 
favoured reaction pathways. 
 
Novel camphor-derived phenyl sulfonate esters and N-adamantylsulfonamides have been 
synthesised for use as chiral auxiliaries in the Morita-Baylis-Hillman reaction. Modeling at 
the Molecular Mechanics level has provided useful insights into possible conformational 
constraints and an adamantyl sulfonate auxiliary has been successfully used in the 
stereoselective synthesis of a range of products, generally in excellent yield and with up to 95 
% d.e. 
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1. INTRODUCTION 
 
The necessity of asymmetric synthesis cannot be overstated; perhaps its importance is best 
exemplified by the regular, exclusive occurrence of single enantiomeric compounds in the 
grandest synthetic process of them all, nature itself. 
 
1.1 ASYMMETRIC SYNTHESIS 
 
1.1.1 Importance of Asymmetric Synthesis 
 
The fundamental basis of asymmetric synthesis is the creation of asymmetric centres such that 
the resulting enantiomers or diastereomers are formed in unequal proportions. This is 
achieved by the creation of new asymmetric centres either in achiral molecules, through the 
use of asymmetric reagents or catalysts, or in molecules already possessing asymmetric 
centres, which generally influence the formation of new diastereomers in unequal amounts. It 
should be mentioned that the formation of chiral carbon compounds is by far the most widely 
investigated of asymmetric syntheses. However, similar approaches have been employed for 
the synthesis of chiral centres at sulfur, phosphorus and other elements.1 
 
Biological activity is most often associated with the interactions of a particular stereoisomer 
with a biological receptor. This distinction between stereoisomers occurs due to the 
asymmetric nature of the environment around typical receptors. The vast majority of drugs 
produced commercially contain one or more stereocentres, but only one of the stereoisomers 
may exhibit beneficial properties whilst the other(s) may be ineffective or even hazardous. 
The widely known and tragic introduction of racemic thalidomide as a sedative hypnotic drug 
resulted in teratogenic effects, which were attributed to one enantiomer while the other was 
effective in the role that it was intended.2 The need for single enantiomer or diastereomer 
drugs is thus of vital importance and the stereoselective synthesis of these drugs is a great and 
fundamental challenge for organic chemists.3 
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1.1.2 Methods of Achieving Asymmetric Synthesis 
 
At the forefront of asymmetric research are synthetic methods that involve the use of chiral 
auxiliaries, reagents or catalysts, which function as an external source that induces chirality in 
a reaction.4 While chiral auxiliaries are often without equal as exceedingly effective tools, 
chiral reagents and catalysts have increasingly found favour.4 The evolution of synthetic 
methodology in this area may be viewed in terms of four generations. 
 
First generation: Substrate-controlled methods 
 
Chiral starting materials are selected from a range of chiral molecules available from natural 
sources, viz., the “chiral pool”,5 and include amino acids, carbohydrates and alkaloids. The 
molecules are then modified by suitable means to obtain products whose overall 
stereochemistry is directly influenced by the existing chiral centre(s) in the starting material.6  
 
Second generation: Auxiliary-controlled methods 
 
The chiral auxiliary is a chiral moiety that is attached to a prochiral substrate molecule, thus 
creating an asymmetric environment around the substrate. This molecule is then able to 
undergo a reaction where the very nature of the auxiliary induces some measure of 
stereocontrol in the formation of products. Removal, and recycling, of the auxiliary then 
affords a chiral product. Requirements for a chiral auxiliary include: - i) ready availability as a 
homochiral moiety that can be easily attached to the prochiral substrate; ii) capacity to induce 
a high degree of stereoselectivity; iii) easy removal from the product and recoverability in 
high yield. 
 
Third generation: Reagent-controlled methods 
 
In this approach, stereocontrol is achieved through the use of stoichiometric quantities of 
chiral reagent which directly influence the stereochemical outcome of the reaction of the 
prochiral substrate. This method characteristically involves fewer steps than with a chiral 
auxiliary, as there is no need to introduce or remove the auxiliary. The majority of chiral 
reagents are organometallic, and the most common metals involved are titanium, 7 lithium, 
magnesium, aluminum8 and iron.9 
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Fourth generation: Catalyst-controlled methods 
 
Chiral catalysts are typically composed of asymmetric ligands that are co-ordinated to a 
metal. They may be covalently attached to the substrate, forming an intermediate in the 
catalytic cycle, or they may act in an intermolecular manner, inducing asymmetry in a single 
step. Catalytic methods are often favoured due to the potential for recycling the catalyst and 
the small amounts of chiral material required. Furthermore, catalysts which are able to 
participate in a secondary interaction with substrates, in a substrate-catalyst complex, are 
highly valued as they have been observed to promote efficient asymmetric induction.10 Such 
interaction may involve the co-ordination of the catalyst not only with the functional groups 
undergoing chemical transformation, but also with other functional groups in the substrate. 
 
The success of asymmetric reactions is directly related to the asymmetric environment that is 
achieved as a result of the chiral nature of the reactive species that surround the reactive or 
catalytic core. The asymmetric grouping is the ultimate source of enantioselectivity because, 
in order to introduce a new chiral centre into a prochiral molecule or manipulate an existing 
chiral centre, it is necessary to spatially direct the reaction. The chirality surrounding the 
reactive centre will facilitate the generation of one enantiomer, while hindering generation of 
the other. Computational methods have recently become powerful enough to predict, with 
varying degrees of success, the nature of the interactions at the reactive centre and 
consequently aid in the rational design of ligands for asymmetric synthesis. 
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1.2 CAMPHOR IN ASYMMETRIC SYNTHESIS 
 
Camphor has been used for hundreds of years as a rubefacient, mild analgesic, lip-balm, 
chilblain ointment, cold-sore ointment and in liniments against rheumatic pain, fibrositis and 
muscle stiffness.11 Natural production of camphor has been largely replaced by the synthesis 
of a racemate from pinene, which is obtained from turpentine oil.11 
 
1.2.1 Occurrence and Biosynthesis of Camphor 
 
Cinnamomum camphora (L.) J. Presl. (Lauraceae) is a tree in the coastal regions of South-
East Asia growing up to 40m high and having coriaceous leaves and an aromatic smell. Steam 
distillation of the wood affords a volatile oil whose main constituent is camphor, which on 
cooling separates as a white crystalline solid from the mother liquor. Natural camphor is a 
dextrorotatory ketone with a specific rotation of [α]D +42º.11 
 
Camphor is a terpenoid, which is biosynthetically produced by way of the intermediates, 
mevalonic acid (MVA) 4 or 1-deoxy-D-xylulose 5-phosphate (DXP) 6 (Scheme 1.1).  The 
first steps of the mevalonate pathway have traditionally been believed to be common to the 
whole range of natural terpenoid derivatives, but it has subsequently been established that an 
alternative pathway exists, viz., the mevalonate-independent pathway (also known as 
methylerythritol phosphate or DXP pathway) which provides an alternative pathway to the 
intermediates, isopentenyl diphosphate (IPP) 8 and dimethylallyl diphosphate (DMAPP) 9. 
The mevalonate-independent pathway is still incompletely characterised although it 
undoubtedly exists and is considered the most likely pathway for the biosynthesis of IPP and 
DMAPP in plants.12 The isopentenyl diphosphate pathway to (1R)-(+)-camphor 16 (Scheme 
1.2) uses DMAPP produced by either the mevalonate or deoxyxylulose phosphate pathways 
and results in numerous compounds, including several monoterpenes. However, only the 
routes that specifically generate camphor 16 and α-pinene 13 are illustrated.12 
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Scheme 1.1: The mevalonic acid and deoxyxylulose phosphate pathways for the 
biosynthesis of isopentenyl diphosphate (IPP) 8 and dimethylallyl diphosphate 
(DMAPP) 9.12 
2 × 1 2 5
 
 
 
3 
6
4
7 
9 
8
Introduction 
- 6 - 
OPP
DMAPP
OPP
α-terpenyl cation
OH
O
H2O
[O]
α-pinene (1R)-(+)-Camphor
ARD 208
ARD 214 ARD 215
ARD 216
ARD 217
ARD 1ARD 219
ARD 218
 
 
Scheme 1.2: The biosynthesis of camphor 16 and α-pinene 13 from dimethylallyl 
diphosphate via the isopentenyl diphosphate pathway.12 
 
Cyclization of the α-terpenyl cation 11 occurs through enzymatic catalysis, in which the 
cationic side chain is folded towards the double bond, and results in the bornyl 14 and pinyl 
12 cations, depending on which end of the double bond is involved in the formation of the 
new bond (Scheme 1.2). Addition of water to the bornyl cation 14 results in borneol 15, 
oxidation of which leads to the ketone, (1R)-(+)-camphor 16. Alternatively, loss of a proton 
from the pinyl cation 12 generates the alkene, α-pinene 13. 
 
 
 
9
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1.2.2. Structure and Reactivity of Camphor 
 
The use of camphor 16 as a starting material in asymmetric synthesis has enjoyed widespread 
attention, due primarily to its availability in both (+)- and (-)-enantiomeric forms and its 
versatility in the generation of specific derivatives, often consisting of a single stereoisomer. 
Functionality may be introduced at the C-3, C-5, C-8, C-9 or C-10 positions of the camphor 
scaffold either directly or indirectly through chemospecific, regiospecific and enantiospecific 
synthesis.13 Furthermore, a large number of intriguing rearrangements, observed since early 
the last century by Meerwein and van Emster,14 and cleavage of C(1)-C(2), C(2)-C(3) and 
C(1)-C(7) bonds in camphor and its derivatives are readily achieved resulting in valuable 
synthetic intermediates.15  
 
 
 
 
 
Asymmetric induction in the reactions of various camphor derivatives is primarily due to the 
steric constraints resulting from the rigidity of the structure and the bulk of the 8-, 9- and 10-
methyl groups.16 Initial attack on the camphor skeleton occurs, in most instances, from the 
less hindered endo-face to generate enantiomeric products. The resulting derivatives may, in 
turn, play crucial roles in stereodirecting further synthetic steps through blocking or 
encouraging attack from one or other face due to their steric bulk or polarity effects, which are 
known, collectively, as secondary interactions and which are vital for effective 
stereocontrol.17,18 Various modifications at individual positions of the camphor skeleton will 
be described in the following sections and illustrated by relevant examples. Specific attention 
will be paid to the stereodirecting characteristics of the camphor derivatives. 
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1.2.2.1 C(2)-Modification 
 
The carbonyl moiety at C-2 in camphor is already a highly reactive group that undergoes 
characteristic reactions to form a wide variety of synthetic intermediates. Hung et al.19 
synthesised the hydroxythiol 17a, which they used to achieve high stereoselective induction 
in Solladie-type reductions. Furthermore, the sense of induction could be reversed by 
changing the catalyst. Yang et al.20 examined the use of a range of auxiliaries 17a-d differing 
only at the C-2 position (Scheme 1.3). These thiols were used to produce the sulfenimines 
18a-d, which were oxidized to the sulfinimines 20a-d, with moderate to excellent 
stereoinduction (40 – 98 % d.e.). The high diastereoselectivity was attributed to chelation in 
the intermediates 19a-d. It was suggested that si-face attack occurs preferentially in the final 
step due to chelation to the sulfinimine oxygen and/or shielding of the re-face by the bornane 
skeleton.  
 
OR
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H
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R
O Ph
O
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O
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N
R
O
H Ph
O
S
HN
R
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Scheme 1.3: Diastereoselective modification of C-2/ C-3 modified camphor derivatives.19,20 
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1.2.2.2 C(3)-Modification 
 
A considerable number of C-3 substituted camphor derivatives have been reported as the 
reactivity of this position is extremely high, perhaps even as high as would be expected for 
reactive methylene groups.13 Oxidation of camphor is regularly performed to obtain 
camphorquinone 22,21,22 which has been monoallylated at the less sterically congested 3-
carbonyl from the endo π-surface to produce 23 (Scheme 1.4).23 The high degree of steric 
shielding of the C-2 carbonyl in 23 necessitated harsh reaction conditions to effect further 
modification at this position, which was finally achieved through an alkyllithium reaction. 
The resulting diol 24 was subsequently cyclized to 25. 
 
O
O
O
OH OH
OH
O
O
O
8 8
In,
THF-H2O
Br
Li,
THF, 0 oC
Br
8
pyr, CH2Cl2
Cl Cl
O
90 %
60 % 80 %  
Scheme 1.4: Oxidation and stereoselective allylation at C-3, followed by stereoselective  
 C-2 alkylation and subsequent cyclization.23 
 
The synthesis of the chiral auxiliary 3-exo-amino-2-exo-hydroxy camphor 26 was achieved by 
Chitenden et al.24 This was subsequently used in the preparation of oxazoline intermediates 
27. Alkylation of these intermediates was achieved with a high level of diastereoselectivity 
(~88 % d.e.) which was relatively independent of the substrate used, suggesting that the 
stereochemistry of the anionic intermediate 27 is responsible for the observed stereocontrol. 
The auxiliary 26 has also found use in the synthesis of optically active heterohelicines25 and 
oxazolines, such as 28,26 which was subsequently alkylated with moderate success using 
Grignard reagents. 
 
 22 
 
23 
24 25 
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Monobromination of camphor 16 at C-3 to afford 3-endo-bromocamphor 29 has been 
achieved in excellent yield (~92 %) and high diastereoselectivity (84 % d.e.) through various 
methods.27-29 Furthermore, Josephy et al.27 were amongst the first to report monomethylation 
at C-3 to afford 3-endo-methylcamphor 30 with low stereoselectivity (50 % d.e.), 
subsequently improved by Hutchinson et al.13 to 80 % d.e. The diethylaluminum enol 
derivative 31 has been proposed as an intermediate in the conversion of 3-endo-
bromocamphor 29 into the aldol derivative 32.30 The reaction, however, proceeds with little or 
no stereoinduction.  
 
O
ARD 261
H
Br
O
ARD 262
Me
OAlEt2 O
OH
ARD 263 ARD 264
H
  
 
1.2.2.3 C(5)- and C(6)-Modification 
 
A limited number of transformations have been accomplished that achieve functionalization at 
the C-5 or C-6 positions of (+)-camphor and very few give single products or acceptable 
yields. Bredt et al.31 achieved C-5 and C-6 functionalization of camphor through remote 
oxidation with CrO3 and Ac2O (Scheme 1.5). Although the low yield (6 %) of a mixture of 
bornane-2,5-dione 33 and the 2,6-isomer 34 effectively makes the reaction synthetically 
useless, it did provide bornanediones which assisted in the identification of the products 
obtained from the remote oxidation of (-)-bornyl acetate 35 and (+)-isobornyl acetate 40 
(Scheme 1.6).13,32 
 
 26   27 28 
 29  30 31 32 
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Scheme 1.5: C-5 and C-6 modification of camphor 16.31 
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Scheme 1.6: The oxidation of (-)-bornyl acetate 35 and (+)-isobornyl acetate 40. 
 
 
1.2.2.4 C(8)-Modification  
 
The stereospecific conversion of 3,3-dibromocamphor 43 into 8-bromocamphor 45 by Eck et 
al.33 has permitted the synthesis of numerous other derivatives of camphor (Scheme 1.7). 
Komarov et al.,18 for example, made use of 8-bromocamphor 45 in the synthesis of several 
compounds, including the thioether 46, the phosphines 48 and 54, the tricyclic cyano 
compound 53, the tricyclic phosphine oxide 55, diphenylphosphanylcamphor 50 and the 
hydroxyphosphine oxide 52. 
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Scheme 1.7: The synthesis of 8-bromocamphor 45 and derivatives.18,33 
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1.2.2.5 C(9)-Modification  
 
Kipping et al.34 achieved regiospecific sulfonation of camphor with chlorosulfonic acid or 
fuming sulfuric acid to afford a mixture of (+)- and (-)-camphor-9-sulfonic acid 58 and 59, 
respectively (Scheme 1.8). The procedure was improved by several other researchers to a 
point where sulfonation can now be accomplished via 3-endo-bromocamphor 56 to afford (+)-
camphor-9-sulfonic acid 58 exclusively.28,29,35 Similarly, regiospecific bromination has been 
achieved by reacting (1R)-(+)-camphor with bromine and chlorosulfonic acid to afford a 
mixture of (+)- and (-)-9-bromocamphor 62 and 63, respectively (Scheme 1.9).35,36 Treatment 
of 3-endo-bromocamphor 56, however, affords (+)-3-endo-9-dibromocamphor 60 and a small 
quantity of (+)-3-endo-9,9-tribromocamphor 61. Selective debromination of 61 with zinc and 
acetic acid affords (+)-9-bromocamphor exclusively. 
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Scheme 1.8: Regiospecific sulfonation of camphor 16 at C-9. 
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Scheme 1.9: Regiospecific bromination of camphor 16 at C-9. 
 
Further modification of camphor derivatives, such as 62, has led to useful intermediates, such 
as the hydroxydiphosphine 6617 and the hydroxyphosphine 7018 (Scheme 1.10). Both hydroxy 
derivatives 66 and 70 possess no symmetry elements. In the case of 66 the hydroxy group and 
the cis-diphenylphosphine moiety are able to form eight-membered chelates upon 
coordination with a transition metal. 
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Scheme 1.10: Regiospecific synthesis of hydroxyphosphines 66 and 70. 
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1.2.2.6 C(10)-Modification 
 
C-10 functionalization of camphor is most often achieved through the use of camphor-10-
sulfonic acid 71. This is obtained through the sulfonation of camphor via a Wagner-Meerwein 
rearrangement.13 Kaye et al.37 reported the diastereoselective (>99 % d.e.) cyclopropanation 
of α,β-unsaturated acetals resulting in the cyclopropyl derivatives 73a-c. This was achieved 
by increasing the steric demand at C-10 of the bornane skeleton through use of the phenyl 
sulfonate derivative 72. 
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H
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ARD 228 ARD 31 ARD 231a-c
 
 
Ying-Yuan Chu et al.38 have also achieved remarkable stereoselective induction through C-10 
modification (Scheme 1.11). Treatment of ketopinic acid methyl ester 74 with 
phenylmagnesium bromide resulted in the alcohol 75, which afforded the ester 76 on 
treatment with sodium hydride and methyl iodide. Exo-10,10-diphenyl-2,10-camphanediol 77 
and exo-10,10-diphenyl-10-methoxy-2-camphanol 78 were prepared under similar conditions 
from 75 and 76, respectively. Various α-keto esters 79a-d, derived from 77 and 78, were 
subsequently reduced with excellent diastereomeric excesses (>99 % d.e.), affording the 
hydroxy esters 80a-d and 81a-d. In most instances the (S)-isomer predominated i.e. 80a-c, the 
notable exception being predominant formation of the (R)-isomer 81d from ester 79d. 
71 72 73 
R 
a Me 
Pr 
c Ph 
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Scheme 1.11: C-10 modification and stereoselective reduction of C-2 esters.38 
 
Generally, modification at the C-10 position has involved the introduction of bulky 
stereodirecting groups. However, Eliel et al.39 prepared the auxiliary, 10-mercaptoisoborneol 
82 with a reactive functionality at C-10. This auxiliary 82, was used to prepare atrolactic acid 
methyl ester with excellent stereocontrol (97 % d.e.), via a hemithioacetal intermediate. De 
Lucchi et al.40,41 subsequently used the exo-hydroxy mercapto auxiliary 82 and the isomeric 
endo-alcohol in asymmetric Diels-Alder reactions; the route taken for the exo-isomer is 
shown in Scheme 1.12. The addition reaction between the auxiliary 82 and the alkynyl 
sulfone 83 produced the (Z)-adduct 84. This was followed by oxidation of the thioether 84 
using MCPBA to afford the chiral sulfoxide 85 with high stereoselectivity. Hydrogen bonding 
between the oxidizing agent, MCPBA, and the alcohol group of the auxiliary 84 is believed to 
be responsible for the high diastereomeric excess observed. This was verified by performing 
the oxidation in polar solvents, such as MeOH, where lower stereoselectivity was observed, 
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due to competitive hydrogen bonding interactions. Furthermore, when the oxidation was 
attempted with the endo-alcohol isomer, lower stereoselectivity was observed and this was 
attributed to the less favourable geometry of the alcohol group for hydrogen bonding with the 
oxidant. The alkenes 84 and 85 were then reacted with cyclopentadiene to give Diels-Alder 
products. Excellent stereoselectivity was obtained with the sulfoxide 85, which afforded 86 in 
98 % d.e; however, low stereoselectivity was observed with 84. De Lucchi et al.40,41 deduced 
that chirality was directed by the asymmetric sulfoxide group of 85. Use of polar solvents in 
the Diels-Alder reactions failed to change the diastereomeric excesses. Similarly, the use of 
the endo-alcohol isomer of 85 did not affect the degree of stereoselectivity indicating that 
hydrogen bonding was not necessary for stereocontrol in the Diels-Alder reaction and, thus, 
that the orientation of the alcohol group has no effect on stereoselectivity. 
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Scheme 1.12: C-10 modification and Diels-Alder reactions of sulfoxide derivatives. 
 
In 1929, Lipp et al.42 obtained the camphene sultone 87 whilst attempting to acylate 
camphene with acetic anhydride in the presence of sulfur trioxide. Asahina, in 1938, 
suggested that the structure was in fact 92.43 Only years later, when IR and NMR techniques 
became powerful enough, did Wolinsky et al. demonstrate that a unique thermal 
rearrangement of 87 led to the formation of 92 or 94,44 and suggested that the mechanism 
involves 2,3- and 2,6-hydride shifts and Wagner-Meerwein type rearrangements.45 More 
efficient synthetic routes to the sultones 87, 92 and 94 were developed (Scheme 1.13),46,47 
which yielded additional compounds, including β-santalol 93, the sulfinates 88 and 95, the 
methyl sulfonyl alcohols 89 and 96, the mercapto alcohols 82 and 98, the methyl sulfones 90 
and 97 and the sulfur-free alcohols 91 and 99. 
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Scheme 1.13: Camphor derivatives arising from initial C-10 modification.44,46,47 
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Oppolzer et al.48 have subsequently reported nucleophilic ring opening of the sultone 87, with 
phenyllithium in ethanol to afford the sulfonate ester 100 in moderate yield (53 %).  
H
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O O
OH NH
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O
HN
S
O
O
 
 
Perhaps the most studied of all chiral camphor auxiliaries and the basis for numerous 
derivatives are the sultams developed by Oppolzer et al., the (-)-bornane-10,2-sultam 101 and 
its enantiomer 102.49 They are easily derived from the corresponding camphor sulfonyl 
chlorides in high yield (76 %) and have found use in many reactions including Diels-Alder 
additions,50 aldolizations,51 alkylations52 and aminations.53 
 
The primary purpose of Oppolzer’s sultams was initially for use in Diels-Alder additions as a 
dienophile auxiliary (Scheme 1.14).50 The reaction was performed both in the presence of the 
Lewis acid, TiCl4,54 and in the absence of Lewis acid catalysts.49 High stereoselectivity and 
high rates of reaction were observed with catalysis, even at low temperature, and higher than 
expected stereoselectivity without catalysis, albeit with slower reaction rates (Table 1.1). X-
ray diffraction analysis showed that, while both the uncoordinated N-crotonyl sultam 103b 
and the Lewis acid-coordinated N-crotonyl sultam 104b have an s-cis conformation about the 
C(O)-C(α) bond, they differ in the arrangement of the carbonyl and sulfonyl groups about the 
N-C(O) bond. The uncoordinated sultam 103b has an s-trans arrangement about the N-C(O) 
bond as well as a pyramidal nitrogen atom, whereas the coordinated N-crotonyl sultam 104b 
exhibits chelation to titanium resulting in an s-cis arrangement. The stereoselectivity observed 
in the uncatalyzed reactions has been attributed to a transfer of chiral information from the 
bornane skeleton to the distant C(α)=C(β) bond via the pyramidal nitrogen, resulting in exo 
C(α)-Re face attack.53 The presence of a Lewis acid resulted in higher π-face stereoselectivity 
with endo C(α)-Re attack by cyclopentadiene, occurring at increased rates even at lower 
temperatures. 
100 101 102 
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Scheme 1.14: C(α)-Re directed attack on Oppolzer’s sultam derivatives 103. 
 
Table 1.1: Data for Diels-Alder reactions to afford sultam derivatives 105. 
Entry R Lewis Acid T/ ºC Time/ h % Endo % d.e.  % Yield
1 H --- 21 72 89 66 80 
2 Me --- 21 79 96 52 51 
3 H TiCl4 -130 6 97 94 89 
4 Me TiCl4 -78 18 99 93 98 
 
Oppolzer's sultam derivatives, such as 106, have also found use in aldol reactions, especially 
as the absolute configuration of products can be predicted (Scheme 1.15 and Table 1.2).51 
Good stereoselectivity was achieved in the synthesis of the syn-aldols 108 and 110. The 
enolate intermediates formed with B(III), Li(I) or Sn(IV) counterions, e.g. 107 and 109 are 
believed to favour a (Z)-configuration, but the differences in stereoselectivity reflect the 
degree of coordination that the counterion undergoes. As boron is not able to undergo 
multiple coordination, an s-trans arrangement of the carbonyl and sulfonyl groups about the 
C(O)-N bond of the enolate is favoured and endo attack at the C(α)-Si face occurs affording 
108. With Li(I) or Sn(IV), however, the multiple coordinative ability of the counterions 
facilitates interaction with the sultam derivative oxygens, resulting in an s-cis arrangement of 
the carbonyl and sulfonyl groups about the C(O)-N bond, and endo attack at the C(α)-Re face 
occurs, away from the nitrogen lone pair, affording 110. Alternatively, the presence of a 
Lewis acid allows the synthesis of anti-aldols 112 and 114 via the O-t-butyldimethylsilyl-
ketene aminal 111 or the enolate 113, respectively.55,56 In both cases attack occurs at the C(α)-
Re face affording the corresponding products. It is important to mention that the conformation 
 104 105 
 R 
a H 
b Me 
Reagents: i)  TiCl4 
  ii) Cyclopentadiene
103
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of the bornyl enolate 113 is reversed, as compared to 107, due to the presence of a Lewis acid; 
the direction of attack is thus also reversed, affording the product 114. 
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Scheme 1.15: Stereoselective aldol and anti-aldol reactions with Oppolzer’s sultam 
derivative 106.  
 
Table 1.2: Aldol and anti-aldol reactions with Oppolzer's sultam derivative 106. 
Entry Counter-ion Lewis acid Syn:anti Major product  % d.e.  % Yield
1 B(III) --- 100:0 108 >99 76 
2 Sn(IV) --- 97.5 : 2.5 110 >99 44 
3 Si TiC4 0.8 : 99.2 112 >99 76 
4 B(III) TiC4 0.6 : 99.4 114 >99 75 
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Derivatives of Oppolzer’s sultam, such as 106a-c have been found particularly useful in 
alkylation reactions (Scheme 1.16 and Table 1.3).52 The N-acylsultam 106a-c undergoes 
addition reactions via the (Z)-enolate 115a-c affording disubstituted carboxylic acid 
derivatives 116a-c. The sultam is very reactive permitting non-activated alkyl halides to be 
used. However, it is necessary to have NHMDS (sodium hexamethyldisilazide) or BuLi 
present to prevent competitive alkylation at C-10. Attack at the enolate π-bond occurs from 
the endo-face and opposite to the position of the nitrogen lone pair. Reversal of the alkyl 
groups R and R’, or use of the sultam antipode 102, results in enantiomeric products of 
opposite configuration at C(α). 
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Scheme 1.16: Alkylation of Oppolzer’s sultam derivative 106.  
 
Table 1.3: Results for the alkylation of Oppolzer’s sultam derivative 106 
 R R’ Base % d.e. % Yield
a Me PhCH2 NHMDS >98 89 
b Me PhCH2 BuLi >98 89 
c PhCH2 Me BuLi >99 88
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1.2.2.7 C(1)-C(2)-Cleavage 
 
Numerous methods have been used to bring about ring cleavage between the C-1 and C-2 
positions of camphor and its derivatives, examples of which are illustrated in Schemes 1.17 to 
1.20. 
O
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Scheme 1.17: C(1)-C(2) cleavage of camphor 16.57 
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Scheme 1.18: C(1)-C(2) cleavage of 2-nitrocamphor 119.58 
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Scheme 1.19: C(1)-C(2) cleavage of the (-)-camphor derivative 121.59 
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Scheme 1.20: C(1)-C(2) cleavage of the dibromocamphor derivative 123.60 
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1.2.2.8 C(2)-C(3)-Cleavage 
 
C(2)-(3) ring cleavage has been widely observed with the use of strong acids and oxidizing 
agents, as illustrated in Schemes 1.21 and 1.22. 
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Scheme 1.21: C(2)-(3) cleavage of camphor 16 and camphorquinone 22.28,62 
 
CO2H
CN
O
N
OH
i)  Ac2O
ii) OH-
ARD 300 ARD 301  
Scheme 1.22: C(2)-(3) cleavage of the camphor derivative 127.28 
 
 
1.2.2.9 C(1)-C(7)-Cleavage 
 
Few examples of cleavage of this bond exist due to the low reactivity of the quaternary 
carbons C-1 and C-7 compared with the highly reactive centres at C-2 and C-3. The 9-
bromocamphor derivatives 62 and 130 undergo ring cleavage between C(1)-C(7) affording 
the alkenes 12963 and 131,64 respectively (Schemes 1.23 and 1.24). 
125 
 126 
 22 
16 
 128127 
Introduction 
- 25 - 
O
ARD 303
Br ONa-K,
Et2O
ARD 304  
Scheme 1.23: C(1)-C(7)-Cleavage of the 9-bromocamphor derivative 62.63 
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Scheme 1.24: C(1)-C(7)-Cleavage of the 9-bromocamphor derivative 130.64 
 
The ability of an auxiliary to stereo-direct attack in any reaction is directly related to its 
conformation in the transition state, which is often a function of its ability to co-ordinate to 
some counterion. Consequently, the presence or absence of such a counterion is usually vital 
in determining which enantiomer is produced or the degree of diastereoselectivity. These 
factors are routinely exploited in the selective formation of a particular enantiomer. Moreover, 
in most reactions, attack occurs from the endo-face of camphor and its derivatives. 
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1.3 THE MORITA-BAYLIS-HILLMAN REACTION 
 
Fundamental carbon-carbon bond forming reactions,65-68 are key steps in the total synthesis of 
natural products. An important, albeit initially overlooked, contribution to this type of 
reaction was made in a German patent application in 1972 by A.B. Baylis and M.E.D. 
Hillman.69 Morita,70 however, had reported a similar reaction involving tertiary phosphines as 
catalysts, five years earlier, and the reaction is sometimes referred to as the Morita-Baylis-
Hillman Reaction.71 This reaction involves the formation of a carbon-carbon bond between 
the α-carbon of an activated alkene (Michael acceptor) 133 and carbon electrophiles 132 
containing an electron-deficient sp2 carbon atom under the influence of a suitable catalyst, 
usually a tertiary amine. The reaction is typically conducted using carbonyl compounds as the 
Michael acceptor (EWG = CO.R) resulting in the production of a β-hydroxy-α-methylene 
carbonyl derivative 134 as the major product (Scheme 1.25).72 
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R = aryl, alkyl, heteroaryl 
R’ = H, COOR, alkyl 
X = O, NCOOR, NSO2Ph 
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Scheme 1.25: Generalised Morita-Baylis-Hillman reaction.73 
 
In general, the Morita-Baylis-Hillman reaction has been found to be chemo- and 
regioselective, requiring mild conditions and producing synthetically useful multifunctional 
molecules.74 However, the greatest drawback is the prolonged reaction times that are often 
required. Rate acceleration has been achieved by altering the reaction temperature,72 applying 
pressure75 or microwave irradiation,74,76 and by substituting trialkylphosphines77 or 3-
hydroxyquinuclidine for DABCO.78  
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1.3.1 Mechanism 
 
The mechanism of the Morita-Baylis-Hillman reaction has been investigated79,80 and the 
generalized mechanism for the DABCO-catalyzed reaction of an aldehyde with methyl 
acrylate is illustrated in Scheme 1.26. 
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Scheme 1.26: The Morita-Baylis-Hillman reaction mechanism. 
 
The nucleophilic DABCO catalyst 135 attacks the activated alkene, in this case methyl 
acrylate, affording the zwitterion 136, which reacts with the electrophilic aldehyde giving a 
second zwitterion 137I. One of two possible elimination routes is then possible viz, a base-
assisted anti E2 elimination of the catalyst followed by protonation, or proton transfer giving 
the resonance stabilized zwitterion 137II followed by E1cB elimination. Both routes would 
afford the free catalyst 135 and a β-hydroxy-α-methylene carbonyl derivative 138 – the 
Morita-Baylis-Hillman product. 
 
 137II 
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Van Rosendaal et al.79 determined that both pathways exist, but the E1cB process was shown 
to be favoured by molecular orbital calculations. Furthermore, Roth et al.80 showed that the 
Morita-Baylis-Hillman reaction is reversible in at least several instances. The reaction has 
also been shown to be first-order in each reactant and hence third-order overall.81 Neither the 
proton transfer nor the elimination steps have been found to be rate determining, thus the 
second step, involving attack of the zwitterion by the electrophile (136 → 137I) is considered 
to be the rate determining step. 
 
Bode and Kaye83 reacted acrylate esters with pyridinecarbaldehydes, in the presence of 3-
hydroxyquinuclidine (3-HQ) 139 or 1,4-diazabicyclo[2.2.2]octane (DABCO) 135 and, 
through use of 1H NMR spectroscopy, investigated the mechanism of the reaction. The 
authors determined that the data were consistent with third-order kinetics overall or, assuming 
the concentration of tertiary amine to be constant, pseudo second-order kinetics. Thus, the 
reaction rate is dependent on the concentration of both the aldehyde and the activated alkene. 
Rate-enhancement was observed on substitution of 3-hydroxyquinuclidine 139 for DABCO 
135 – an effect rationalised in terms of hydrogen-bonding stabilization of the dipolar 3- 
hydroxyquinuclidine intermediate 140 (Figure 1.1) and a consequent increase in the 
equilibrium constant. However, the results of computational studies suggest that 
intramolecular hydrogen bonding is likely to be much more significant in the Morita-Baylis-
Hillman zwitterionic adduct rather than the initial zwitterion 140.84 
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Figure 1.1: Possible hydrogen bonding interactions using 3-hydroxyquinuclidine as 
 catalyst. 
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1.3.2 Reaction Parameters 
 
1.3.2.1 Solvents 
 
Many Morita-Baylis-Hillman reactions are carried out neat, without the use of solvents, since 
the reaction is third order and dilution adversely affects the rate.84 There are, however, 
instances where the use of solvent is necessary (where substrates are poorly soluble) or even 
beneficial (where small quantities of protic solvents have been found to increase the rate of 
reaction).71  
 
1.3.2.2 Temperature and Microwave Irradiation 
 
In general, amine catalyzed Morita-Baylis-Hillman reactions are carried out at room 
temperature to minimize the potential of side reactions, which are known to compete at higher 
temperatures especially over extended periods of time.71 The use of microwave irradiation 
(together with the addition of a radical inhibitor, to avoid polymerization of the activated 
alkene) has been shown to reduce reaction times to seconds or minutes.76,85 
 
Several studies have revealed an unprecedented increase in the rate of reaction by lowering 
the temperature.72,77 This temperature effect is counter-intuitive in that the formation of the 
product can apparently be accelerated by either heating or cooling the reaction! One possible 
explanation is that the product is formed via two different zwitterions (Scheme 1.27).72,77 
These E- or Z-enolates should both be formed under equilibrating conditions, and are likely to 
react with the aldehydes at different rates. At a given temperature there could be a greater 
concentration of one enolate over the other while at another temperature, the relative 
concentrations could change. 
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Scheme 1.27: Competing enolates in the Morita-Baylis-Hillman reaction. 
 
1.3.2.3 Pressure and Sonication 
 
Pressure effects on the rate of the Morita-Baylis-Hillman reaction have been well 
documented. Hill and Isaacs81,86 have shown that an increase from atmospheric pressure to 5 
kbar reduces the time required for the DABCO-catalyzed α-hydroxyethylation of acrylonitrile 
from 5 days to 5 minutes. Furthermore, previously unreactive ketones and crotonic derivatives 
become reactive at 10 kbar. The effect of pressure on rate acceleration has been attributed to 
the large negative volume of activation of the reaction as a result of bond formation and 
charge development prior to, and during the rate determining step.71 
 
Subjecting reaction mixtures to ultrasound has also revealed rate enhancements71 and 
increased reactivity of acrylamide.74 However, the rate acceleration is far less significant than 
that observed with microwave irradiation.87 
 
1.3.3 Stereocontrol 
 
The production of enantiomerically pure compounds is an ongoing challenge for organic 
chemists. The Morita-Baylis-Hillman reaction typically involves addition to an sp2 carbon and 
 143 
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the generation of a new chiral centre, thus raising the possibility for asymmetric induction.74 
In principle any of the three essential components (electrophile, activated alkene or catalyst) 
could be used to introduce chirality in the reaction. Numerous attempts have, in fact, been 
made to promote asymmetric Morita-Baylis-Hillman reactions. Use has been made of chiral 
catalysts,88-90 electrophiles,74,88,91,92 activated alkenes74,88 and co-catalytic Lewis acids.93,94 The 
literature on the asymmetric Morita-Baylis-Hillman reaction has grown significantly, but 
there are relatively few methods available for achieving effective stereocontrol,71 the most 
significant of these involving the use of the optically pure camphor-derived activated alkenes 
103a and 145.72,95 
 
 
 
 
 
 
 
 
The role of hydrogen bonding interactions in rate enhancement and asymmetric induction in 
these reactions is well known.88,90,94,96-99 Hydrogen bonding may stabilize the reaction 
intermediates and/or transition state complexes and increase the steric demands for attack of 
the electrophile. Thus the effect of hydrogen bonding on stereocontrol is significant. 
 
1.3.3.1 Diastereoselectivity 
 
Reactions in which the electrophile and/or the activated alkene already contain asymmetric 
centres may result in two or more diastereomers being formed. Rationalization of the 
observed stereoselectivity has been followed by optimization procedures in an attempt to 
produce selected diastereomers, but with limited success.71 
 
1.3.3.1.1 Chiral activated alkenes 
 
Acrylic acid esters 146 of chiral alcohols (ROH) have been the most widely studied of all 
chiral activated alkenes as they are readily accessible and removal of the chiral auxiliary is 
N
N
O
ARD 138
Ph
N
S
O
O
O
ARD 136 
145 103a 
Introduction 
- 32 - 
*
easily achieved. Unfortunately, the relative inaccessibility of optically active forms of vinyl 
ketones, sulfones and phosphonates has limited their usefulness. 
 
 
 
 
 
Perhaps the earliest reported study of chiral acrylates in the Morita-Baylis-Hillman reaction 
was undertaken by Brown et al.100 who reacted (-)-menthyl acrylate 147 with acetaldehyde 
148 in the presence of DABCO, producing 149 with low diastereoselectivity (d.e. 16 %) 
(Scheme 1.28). 
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Scheme 1.28: Early diastereoselective Morita-Baylis-Hillman reaction.100 
 
Gilbert et al.86 undertook similar reactions with the (+)-menthyl esters 150a-b and a range of 
aldehydes. The experiments were conducted between atmospheric pressure and 8.5 kbar. In all 
instances, higher stereoselectivity was observed in reactions of 150b and the stereoselectivity 
increased with the bulk of the aldehyde and with increasing pressure. The highest 
stereoselectivity (86 - 100 % d.e.) was observed using aromatic aldehydes at 8.5 kbar.   
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It has been suggested that, in these systems, preferential si-face attack of the initial zwitterion 
on the aldehyde results in an (S)-configuration at the new chiral centre and the greater 
diastereoselectivity exhibited by the 8-phenylmenthyl ester 150b has been attributed to a π-
stacking effect.61 It also seems that the reactivity of the aldehyde substrate influences the 
degree of diastereoselectivity, rather than its steric bulk, as the faster the reaction, the lower 
the likelihood of equilibration via the reverse reaction.61 The reactions of the lactone ester 151 
with selected aldehydes occurs very quickly, but only moderate, if any, diastereoselectivity is 
observed, perhaps due to the lack of an effective blocking group (Scheme 1.29).101 
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Scheme 1.29: High-rate Morita-Baylis-Hillman reaction.101 
 
One of the most successful syntheses involving the asymmetric version of the Morita-Baylis-
Hillman reaction71 was reported by Leahy and co-workers,72,102 who used the commercially 
available, optically pure camphor-derived Oppolzer’s sultam49 and introduced acrylate 
functionality. The resulting acrylamide 103 was reacted in the presence of a variety of achiral 
aldehydes with DABCO, as catalyst. Oppolzer’s sultam was found to be an excellent chiral 
auxiliary, affording cyclic intermediates 154 in good yield and in excess of 99 % d.e.; 
subsequent cleavage gave the Morita-Baylis-Hillman product 155 (Scheme 1.30). However, 
the acrylamide 103 was noted to be inactive towards more hindered aldehydes. 
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Scheme 1.30: Enantioselective synthesis using an N-acryloyl derivative of Oppolzer’s 
sultam 103.72,102 
 
Stereoselective induction in the acrylamide 103 has been demonstrated to rely on two factors: 
- i) preferential addition to the Cα re-face; and ii) the requirement of an “open” transition 
state. The Z-enolate intermediate, produced on the addition of catalyst, could exist in either of 
two rotameric forms 156I or 156II (Scheme 1.31). The rotamer 156II has the carbonyl oxygen 
orientated anti to the sulfonyl group in order to minimize dipole interactions between the two 
groups and is favoured in non-chelated reactions. Conversely, in the presence of a Lewis acid 
co-catalyst, chelation of the carbonyl and sulfonyl groups occurs, resulting in arrangement of 
the carbonyl group syn to the sulfonyl group 157 (Figure 1.2). This should lead to the 
formation of enantiomeric products based on the presence, or lack thereof, of a Lewis acid. 
Furthermore, experimental evidence suggests that, in all reactions with acrylate 103, addition 
to the exo-face is favoured, due to steric constraints imposed by the axial oxygen of the 
sulfonyl group, which effectively prevents addition from the endo-face. 
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Scheme 1.31: Arrangement of the acrylate zwitterion 156 (R3N = DABCO) in the absence of 
chelation.72,102 
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Figure 1.2: Arrangement of the acrylate anion 157 undergoing chelation with a Lewis 
acid.72,102 
 
Development of a highly efficient enantiopure acryloylhydrazide 145 was achieved by Yang 
and co-workers (Scheme 1.32).95 The Baylis-Hillman adducts were produced in very high 
diastereoselectivities (>94 % d.e.) using this hydrazide, and reversal of stereoselectivity was 
found to be possible by changing the solvent from DMSO to THF-H2O. It was assumed that 
the zwitterion intermediate in THF-H2O is stabilized by intermolecular hydrogen bonding 
with solvent molecules, whereas destabilisation of the zwitterion occurs in DMSO. 
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Scheme 1.32: The Morita-Baylis-Hillman reaction involving the camphor-derived 
acryloylhydrazide 145.95 
 
Several other camphor-derived acrylic esters, such as 159,103 160,103 16199,82 and 162,99,82 have 
been explored as Baylis-Hillman substrates. However, none of these have been particularly 
successful in inducing stereoselectivity. Presumably the steric demands are not sufficient to 
favour addition to a particular face of the enolate intermediate. 
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1.3.3.1.2 Chiral electrophiles 
 
Research into the asymmetric version of the Morita-Baylis-Hillman reaction has been 
concentrated on the use of chiral Michael acceptors and little attention has been given to the 
use of chiral electrophiles.92 Most studies involving chiral electrophiles have focused on the 
addition of single enantiomers of α-branched aldehydes to acrylates and methyl vinyl ketone 
(MVK). Drewes et al.104 reacted the (S)-(-)-2-(methoxymethyloxy)propanal 163 with methyl 
acrylate 140 and methyl vinyl ketone (MVK) 164 in the presence of DABCO or 3-
hydroxyquinuclidine (3-HQ) to obtain mixtures dominated by the anti-isomer 165 (Scheme 
1.33). 
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Scheme 1.33: Use of optically active aldehydes in the Morita-Baylis-Hillman reaction.104 
 
Manickum et al.105 also found that use of the heterocyclic aldehyde 167 afforded the anti-
product 168 with high stereoselectivity (78 % d.e.) (Scheme 1.34).  
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Scheme 1.34: Use of bulky aldehydes in the Morita-Baylis-Hillman reaction.105 
 
Kundig et al.106,107 have achieved good to excellent diastereoselectivity (68 - 95 % d.e.) with 
tricarbonylchromium complexes of ortho-substituted aromatic benzaldehydes, e.g. 170 
(Scheme 1.35). The nature of the ortho substituent was found to be critical in achieving high 
levels of diastereoselectivity.  
Cr(CO)3
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O
Cr(CO)3
OMe
CN
DABCO,
r.t., 11 h
+
H
OH
NC
(S,S)-(-): 88 % yield, > 95 % d.e..  
Scheme 1.35: Tricarbonylchromium complexes of ortho-substituted aromatic 
benzaldehydes.106,107 
 
Krishna et al.92,108 have investigated the use of sugar-derived aldehydes 173a-c as chiral 
electrophiles with an activated alkene in dioxane/water (1:1) with low to high 
diastereoselectivity (36 – 86 % d.e.) and good yields (56 – 82 %) (Scheme 1.36). The 
observed stereoselectivity was explained by favoured attack of the zwitterion at the si-face of 
the aldehyde, resulting in a predominance of the S-isomer. The stereochemistry of the newly 
created centre accords with the non-chelation Felkin-Anh model.109 
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Scheme 1.36: The use of sugar-derived aldehydes 173a-c as chiral electrophiles.92,108 
 
Alcaide et al.91 reported the synthesis of 3-oxo-2-azetidinones 175 from 2-hydroxy-β-lactams 
via Swern oxidation, and their use in the asymmetric Morita-Baylis-Hillman reaction with 
excellent diastereoselectivity (94 – 100 % d.e.), high yields (69 – 90 %) and fast rates of 
reaction (1 – 72 h) (Scheme 1.37). 
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Scheme 1.37: The use of 3-oxo-2-azetidinones in the asymmetric Morita-Baylis- Hillman 
reaction.91 
 
In some rare instances, imines have been utilized as electrophiles in place of aldehydes in the 
Morita-Baylis-Hillman reaction, affording entry to the corresponding β-amino products;110,111 
however, very few attempts have been made to render this process asymmetric. Recently 
Aggarwal et al.93 investigated the effectiveness in this reaction of optically pure N-p-
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toluenesulfinimines 177a-d and N-tert-butylsulfinimine 178 with methyl acrylate both in the 
presence and absence of Lewis acids (Scheme 1.38). 
 
  
 
 
 
 
 
 
The study aimed to optimize reaction conditions and the results, not surprisingly, varied 
widely. However, in every instance there was a predominance of the S-isomer (44 – 82 % 
d.e.). The highest yielding conditions involved the use of 3-hydroxyquinuclidine (3-HQ) as 
catalyst with the Lewis acid In(OTf)3 (89 % yield, 64 % d.e.), but greatest stereoselectivity 
was achieved using optically pure (S)-3-hydroxyquinuclidine (21 % yield, 82 % d.e.). 
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Scheme 1.38: The Morita-Baylis-Hillman reaction utilizing imines as the electrophile.93 
 
In the preferred conformation of the imine the bulky sulfur substituents lie out of the plane of 
the double bond. Nucleophilic attack by the catalyst is considered to occur anti to the large p-
tolyl substituent, resulting in the observed diastereoselectivity (Scheme 1.39), while 
coulombic attraction between the sulfinyl oxygen and the quaternary ammonium moiety 
coupled with hydrogen bonding to the 3-hydroxy group serve to stabilize the transition state 
TS1. Alternatively, when a Lewis acid is present, the transition state TS2 adopts a chair-like 
conformation in which the metal coordinates with the imine nitrogen, the sulfinyl oxygen and 
the acrylate oxygen, such that C-C bond formation takes place within a rigid coordinated 
species. 
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Scheme 1.39: Transition state conformations for stereoselective reactions of the imine 
electrophile 177a.93 
 
1.3.3.1.3 Solvent Effects 
 
Perhaps the most interesting solvent effect was noted by Yang and co-workers as described 
earlier (Scheme 1.32, p. 35),95 where the chiral acryloylhydrazide 145 was reacted with 
aldehydes in the presence of DABCO. Either diastereomeric product could be obtained in 
high optical purity by changing the solvent. When DMSO was used, the S-isomer 
predominated (94 – 98 % d.e.), whilst the R-isomer predominated (94 – 98 % d.e.) when the 
solvent system was changed to THF/H2O (5:1). It seems that the transition state conformation 
is highly solvent-dependent. Cai et al.112 also undertook an investigation of the rate 
acceleration in Morita-Baylis-Hillman reactions and noted excellent diastereoselectivity (83 – 
99 % d.e.) on using 1,4-dioxane as solvent in the trimethylamine catalyzed reaction. 
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1.3.3.2 Enantioselectivity 
 
1.3.3.2.1 Chiral catalysts 
 
The use of chiral catalysts, usually tertiary amines, in the Morita-Baylis-Hillman reaction 
theoretically provides a means of effecting chiral discrimination, as the catalyst participates in 
the step in which the chiral centre is created. This method of achieving enantioselectivity has, 
however, only enjoyed limited success. It would appear that many catalysts fail to pass on 
steric information, even if the chiral centre is in close proximity to the nitrogen atom, and 
additionally, they often demonstrate low conversion efficacy and the use of high pressure is 
usually necessary.71 
 
Wynberg has, however, successfully demonstrated the usefulness of chiral catalysts.113 
Benzaldehyde was reacted with diethyl zinc in the presence of quinine 181 and afforded (R)-
(+)-1-phenylpropanol with moderate stereoselectivity (68 % e.e.), while use of 2-
ethoxybenzaldehyde as the substrate, afforded even better stereoselectivity (90 % e.e.). 
Motivated by these results, Drewes et al.88 attempted to use quinine 181, as well as several 
other tertiary amines (such as quinidone, retronecine, cinchonidine and brucine), in the 
Morita-Baylis-Hillman reaction with limited success (≤ 10 % e.e.). 
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Drewes et al.88 suggested the possibility of a protic species causing stabilization of a catalyst-
acrylate system by hydrogen bonding interactions. These authors then reported enhancement 
of the rate of the reaction, as well as increased asymmetric induction when a hydroxy group 
was suitably disposed on the amine catalyst. 96 The reaction involved the use of methanol as 
the protic species and 3-hydroxyquinuclidine 139 as catalyst. Participation of a cyclically 
stabilized anion intermediate 182 appeared to be supported by the considerably longer 
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reaction times observed when the hydroxyl group in 3-hydroxyquinuclidine was blocked or 
when the non-hydroxylated 3-quinuclidinone 183 was used. As described earlier (Section 
1.3.1, p. 28), Bode83 also noted a significant increase in rate with the use of 3-
hydroxyquinuclidine 139 as compared to DABCO 135.  
 
Marko90 attempted to take advantage of the hydrogen bonding phenomenon by using a range 
of hydroxy-amine catalysts to effect enantioselective syntheses; however, the enantiomeric 
excesses achieved were poor (0-25 % e.e.). The two most selective compounds, cinchonine 
185 and quinidine 186, were subsequently used in a study to determine conditions for 
achieving high enantioselectivity. 
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The suggestion, by Marko,90 was that the role of the hydroxyl group is two-fold: - i) to lock 
the conformation of the ternary complex by hydrogen bonding to one of the lone pairs of the 
aldehyde carbonyl; and ii) to lower the energy of the transition state, by stabilizing the 
incipient negative charge developed on the oxygen atom during the aldol condensation, thus 
accelerating the reaction and providing an asymmetric environment (Scheme 1.40). Another 
important aspect of these results was the observation that the size of the aldehyde R-group 
relates directly to the observed enantioselectivity, the increased steric interactions between the 
R-group and the two hydrogens at Cα favouring intermediate 186II. 
 186  185 
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Scheme 1.40: Proposed mechanistic model of the interactions involving the   
 intermediate species of quinidine 186.90 
 
Iwabuchi et al.98 furthered Marko’s work by using several suitably modified hydroxy-
quinidine derivatives 189-19290 and achieved good yields and a wide range of 
enantioselectivities (10 - 91 % e.e.). 
 
 
 
 
 
 
The cyclic ether 192 showed particular promise (64 – 91 % e.e.) and, upon optimization of the 
reaction conditions, reacted with a number of aldehydes at -55 ºC in DMF to give the chiral 
alcohols 194 in good yield and excellent enantiomeric excess (91 – 99 % e.e.), the R-
enantiomer predominating in each case (Scheme 1.41); the dioxanones 195 were isolated as 
side products. These authors subsequently used the hydroxyquinidine derivative 192 as a 
catalyst in a Morita-Baylis-Hillman reaction to synthesise the α-methylene-statine framework 
198 as part of the overall synthesis of epopromycin B 196 (Scheme 1.42).97 Iwabuchi et al.94 
successfully used the same hydroxyquinidine derivative 192 in the synthesis of the ester 199 
as an intermediate in the complete synthesis of (-)-mycestercin E 200 (Scheme 1.43). 
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Scheme 1.41: Catalysis of the Morita-Baylis-Hillman reaction using the tertiary amine 192.98 
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 Scheme 1.42: Synthesis of the α-methylene-statine framework of epopromycin B 196.97 
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1.3.3.2.2 Chiral Co-Catalysts 
 
The concept of using a Lewis acid-chiral ligand complex to catalyse the Morita-Baylis-
Hillman transformation has been documented.114 The role of the chiral ligand is twofold:  
- i) to act as a chiral nucleophilic Morita-Baylis-Hillman catalyst, and; ii) to coordinate to the 
metal. The stereochemical elements for achieving enantioselective carbon-carbon formation 
with a Lewis acid co-catalyst rely on the correct choice of metal and chiral ligand for a 
particular substrate.114 The design and synthesis of a tuneable chiral ligand were clearly 
critical, since the Lewis acidity of the metal, and thus its potential for activation, is controlled 
by the donor atoms of a ligand.115 The donor group functionality is also important in directing 
enantioselectivity.114  
 
Barrett et al.116 examined the use of the achiral Lewis acid BF3.OEt2 together with alkali metal 
salts in the synthesis of Morita-Baylis-Hillman products in the presence of the chiral ligand 
201. Initially the reactions were conducted in the absence of a Lewis acid, and the products 
were isolated in good yields and exhibited a range of enantiomeric excesses (21- 47 % e.e.).  
 
 
 
 
 
 
 
Addition of a co-catalyst, however, was observed to increase the rate and, in most cases, more 
than double the enantioselectivity (up to 72 % e.e.). The stereocontrol was explained in terms 
of hydrogen bonding to the co-catalyst and a lowering of the energy of the transition state 
conformation 201I relative to 201II (Figure 1.3). 
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Figure 1.3: Mechanistic model of the interactions on use of the chiral co-catalyst 201  
  during Morita-Baylis-Hillman reactions.116 
 
Aggarwal et al 117 have also investigated the use of Lewis acid co-catalysts, including 
lanthanides and group III metal triflates, and have achieved significant rate acceleration. 
However, the authors were unable to achieve acceptable enantioselectivity (5 % e.e.). Yang et 
al.114 were far more successful in using Lewis acid co-catalysts; synthesizing and making use 
of camphor-derived dimerized amino ligands to achieve high enantioselectivity (up to 95 % 
e.e.). The authors then decided to incorporate carboxylic acid functionality into a number of 
ligands to take advantage of the oxophilic nature of the metal. The most successful ligand was 
found to be 202, when used in conjunction with the Lewis acid La(OTf)3. When this system 
was used with a range of acrylate esters and aldehydes, high to excellent enantioselectivity 
was achieved (65 – 95 % e.e.); with the S-isomer predominating in all cases and the products 
being obtained in moderate to excellent yields (35 – 89 %). The proposed coordinated 
complex is shown in Figure 1.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Proposed coordination of the reactants in the enantioselective Morita-Baylis-
Hillman reaction in the presence of the lanthanum-dimer 202 complex.114 
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Bauer et al.118 achieved a wide range of enantioselectivities (2 -67 % e.e.) using 
bisulfonamide camphor-derived ligands, the metal complex, titanium tetraisopropoxide (Ti(O-
iPr)4), and the promoter diethylzinc (ZnEt2). The greatest success was achieved with the 
ligand 203 (52 – 67 % e.e.). The authors concluded that C-2 symmetry was not always 
advantageous to stereoselectivity as both sides of the C-2 symmetric molecules they 
developed were able to act independently. 
 
 
 
 
 
 
1.3.3.2.3 Chiral solvents 
 
In most instances, it has been found that the presence of a solvent in the Morita-Baylis-
Hillman reaction adversely affects the rate of the reaction.84 However, it is not unreasonable 
to expect that a chiral solvent should induce some degree of enantioselectivity.71 Gilbert et al.  
were amongst the first to study solvent effects on enantioselectivity.86 Acrylonitrile was 
reacted with acetaldehyde in the presence of  3-hydroxyquinuclidine in (+)-ethyl lactate but, 
unfortunately, exceedingly poor enantioselectivity was achieved (3 % e.e.).  
 
1.3.3.2.4 Resolution of Racemic Products 
 
A popular method for obtaining Morita-Baylis-Hillman-derived products of high 
enantiomeric purity is through resolution. Brown et al.119 kinetically resolved α-methylene-β-
hydroxyalkanoates, sulfones and α-methylene-β-aminoalkanoates via homogenous 
hydrogenation using chiral phosphines-rhodium catalysts. The recovered alcohols were 
obtained in high enantiomeric excess (>90 % e.e.). Kitamura et al.120 obtained 
enantiomerically pure α-hydroxylalkyl acrylates through fractional crystallization of 
diastereomeric salt mixtures of the corresponding acids and by kinetic resolution involving 
hydrogenation with chiral rhodium biphosphine. Trost et al.121 were also able to achieve 
excellent resolution of enantiomers (85 – 96 % e.e.) through a dynamic kinetic asymmetric 
transformation process.  
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1.4 PREVIOUS WORK BY THE RHODES RESEARCH GROUP 
 
The ability of camphor and its derivatives to participate as auxiliaries with high chiral 
discriminatory properties is well established. The origin of the stereocontrol achieved by 
camphor derivatives arises from the overall rigidity of the bicyclic skeleton and the 
stereodirecting groups innately present or introduced. These properties combined with the 
numerous transformations that camphor is capable of undergoing have made it a significant 
focal point for various members of our group for a number of years. 99,122-125 The most recent 
research has focused on the origin and optimization of stereocontrol in several reactions 
including the following. 
 
i) In a highly successful cyclopropanation study, Molema37 developed the camphor-
derived chiral auxiliary 204. Cyclopropanation of acetal intermediates 205a-c afforded 
the cyclopropyl derivatives 206a-c in 76 – 95 % yield and in > 99 % d.e. The chiral 
auxiliary 204 was then released through transthioacetalisation and the corresponding 
dithiones 207a-c were isolated in 87 – 92 % yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ii) In a search for a synthetically viable route to α-alkylated α-amino acids, Ravindran123 
successfully developed the 2-iminolactone 208 and the regioisomeric 3-iminolactone 
209. Monoalkyation of the 3-iminolactone was successfully achieved by Matjila122 
R 
a Me 
b Pr 
c Ph 
205a-c 
206a-c 207a-c 
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and Klein124 in good yields (63 – 82 %) and in 43 - >99 % d.e. Dialkylation of the 2-
iminolactone was also achieved but efforts to obtain monoalkylated products failed.122 
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iii) Bulky groups were introduced to the camphor moiety by Evans99 and Ravindran123 to 
afford, for example 210 and 211, in an attempt to increase the stereodirecting ability. 
Klein124 subsequently illustrated the potential of the alcohol 211 by achieving the α-
benzylation of the ester-derivatives to produce the diastereomeric products 212 in 60 – 
83 % d.e. 
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iv) Ravindran’s attempted synthesis of the borneol derivative 213, containing a bulky 3-
catechol blocking group,123 led to the unexpected formation of camphor dibornyl 
ethers 214 and 215. With a view to developing reagents analogous to the highly 
successful BINOL reagents, Matjila122 undertook preliminary studies on the reduction 
of the dimers and reported a monohydroxy and dihydroxy product. 
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v) Evans99 explored use of camphor-derived acrylate esters such as 216 and 217, in 
Morita-Baylis-Hillman reactions. Application of the novel camphor-derived acrylate 
ester 216 resulted in high yields (71 – 91 %) but indifferent stereoselectivity (5 – 59 % 
d.e.), whereas use of the ester 217 failed to attain even moderate stereoselectivity (0 – 
34 % d.e.).99  
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1.5 AIMS OF THE PRESENT INVESTIGATION. 
 
The development of camphor derivatives with the ability to enhance stereocontrol in various 
reactions remains a priority in our research programme. Throughout the investigation of 
numerous camphor derivatives, a primary objective has been to rationalize the interactions 
responsible for the observed stereocontrol. The present investigation represents a continuation 
of this programme and has focused on the following objectives. 
 
i) Extension of the earlier work done on camphor derived dibornyl ethers and their 
reduction to produce asymmetric hydroxy dimers. 
 
ii) Synthesis and stereoselective monoalkylation of the 2-iminolactone.  
 
iii) The development and evaluation of novel camphor-derived chiral auxiliaries for use in 
the Morita-Baylis-Hillman reaction. 
 
iv) Elucidation of an unexpected intramolecular transesterification of bornane-2,3-diol 
monoacrylate esters. 
 
v) Computational analysis at the density functional (DFT) level of the intramolecular 
transesterification. 
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2. DISCUSSION 
 
This research has involved the modification of (1R)-(+)-camphor 16 (Figure 2.1) to yield a 
variety of novel chiral auxiliaries with potential for application in a range of asymmetric 
reactions. In the discussion which follows, attention will be given to: - the synthesis of exo-
hydroxybornanones and an extension of earlier work involving their dimerisation (Section 
2.1); further investigations into the preparation of chiral iminolactones and their use in the 
asymmetric synthesis of α-amino acids (Section 2.2); the development of chiral Morita-
Baylis-Hillman substrates (Section 2.3); and kinetic-mechanistic and DFT computational 
studies of the intramolecular transesterification of bornane-2,3-diol monoacrylates (Sections 
2.33 and 2.34, respectively). 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: DFT Geometry optimized representation of (1R)-(+)-camphor 16. 
 
2.1  SYNTHESIS and DIMERISATION REACTIONS of EXO-
HYDROXYBORNANONES 
 
Stereo-directing groups have been the subject of numerous studies and have been found to 
influence the formation of specific diastereomers. The general synthetic principle involves the 
introduction of steric constraints into a relatively rigid substrate to promote stereofacial 
selectivity by an attacking species at a prochiral centre, resulting in the preferential, if not 
exclusive production of a single diastereomer.  
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The synthesis of sterically hindered camphor acetals as chiral auxiliaries has attracted 
considerable interest in our own laboratories.123 Thus, Ravindran attempted to increase steric 
bulk at positions C-2 or C-3 of the camphor system by preparing the monocatechol acetals 
218 and 219.123 However, monoketalisation of camphorquinone proved to be unexpectedly 
difficult and dicatechol 220 appeared to be formed exclusively. Various protection strategies 
were investigated to achieve the desired products, but without success.  
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Ravindran123 attempted to synthesise the 3-hydroxy derivative of the monoketal 219 by 
heating 3-exo-hydroxybornan-2-one 231 with catechol and p-TsOH. However, an unexpected 
product was obtained, 13C analysis of which indicated the presence of twenty different carbon 
atoms. Similar treatment of the 2-exo-hydroxybornan-3-one analogue afforded a second, 
isomeric compound. These two novel products were identified as the camphor dimers 214 and 
215, respectively. Matjila122 reproduced these results and in the course of his research, isolated 
a third isomer, formulated as 221. The present study focused, initially, on confirming the 
earlier results, establishing the structural assignments by thorough 1- and 2-D NMR 
spectroscopy, furthering the reaction sequence and exploring the mechanistic implications.  
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The synthesis of carbon-carbon linked camphor dimers has been achieved by several 
researchers. Manasse126 reported the production of a 2-endo-hydroxyepicamphor dimer, 
218 219 220 
214 
“Dimer I” 
215 
“Dimer II” 
221 
“Dimer III” 
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which later was identified by Banks et al.127 as a bridged bis(methyl ketal). Rautenstrauch et 
al.,128 followed by Pradhan et al.,129 obtained several (C-2)–(C-2’) linked pinacols by alkali 
metal-ammonia reduction of (+)-[3,3-D2]camphor, while the synthesis of bithiocamphor 
derivatives 222 and 223, with C–C linkages, was reported by Bonnat et al.130 Ito et al.131 
synthesised a mixture of bicamphor epimers, 224, 225 and 226, with C–C linkages. McNulty 
et al.132 repeated Ito’s research but altered the conditions to stereoselectively synthesise 3-exo-
3’-exo-bicamphor 224 and the dioxobisbornanylidenes 227 and 228. An extensive literature 
search, however, has failed to reveal any syntheses of the ether dimers isolated in our 
laboratories. 
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The investigation necessitated the synthesis of the two distinct hydroxybornanone precursors 
231 and 233 (Scheme 2.1) and the maintenance, through several steps, of their chiral 
information. Several methods of obtaining these α-ketols were considered, most of which: 
afforded little or no stereocontrol; involved many steps and poor yields; produced unwanted 
products13 or led to enantiomers of opposite configuration13 to our requirements. This last-
227 228 
226 
224 
225 
222 223 
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mentioned approach involved biological metabolism to afford the endo-hydroxy product and, 
moreover, it was not immediately obvious how it was extracted from the canine involved!13 
Previous researchers in our laboratories had, however, introduced protecting groups in the 
form of ketals at either the C-2 or C-3 position.122-124 Reduction of these ketals gave the chiral 
auxiliaries 210, 211, 229 and 230, which were subsequently used in the diastereoselective 
syntheses of alkylated esters with moderate123 to high stereocontrol.124 Of particular 
significance to the present study was the fact that deprotection of these auxiliaries provides 
access to the desired α-hydroxybornanones.122  
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2.1.1 Synthesis of α-Ketols 
 
The methodologies developed within our group were thus followed to access the required 2-
exo-hydroxybornan-3-one 233 and the 3-exo-hydroxybornan-2-one 231 (Scheme 2.1). The 
basic rationale behind the synthesis was to protect either the C-2 or C-3 carbonyl group in 
camphorquinone as the corresponding ketal, then reduce the unprotected carbonyl group to 
give an alcohol functionality and, finally, remove the protecting group.  
 
The first step was to produce camphorquinone 22 via selective oxidation of camphor. This is 
possible as the C-3 methylene group of (+)-camphor is adjacent to the carbonyl and is thus 
easily oxidized to an α-diketone using SeO2.133,134 A yield of 84 % was achieved for this 
reaction. The mechanism as initially proposed by Corey and Schaefer,135 is mediated by a 
protonated selenic acid species generated in situ, and is shown in Scheme 2.2. 
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Scheme 2.1: Selective synthesis of 2-exo- and 3-exo-hydroxybornanones. 
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Scheme 2.2: Mechanism of (+)-camphor oxidation by selenium dioxide.135 
 
The subsequent protection of the C-3 carbonyl function was achieved by ketalisation with 
ethylene glycol, the resulting ketal being expected to be inert under the conditions required for 
the reduction of the C-2 carbonyl by LAH. The ketalisation procedure developed by 
Ravindran123 was followed, affording the sterically favoured monoketal 232 in 51 % yield 
together with the diketal 234 in 43 % yield. The reversibility of the reaction necessitated the 
use of a Dean-Stark trap to collect azeotropically distilled H2O, thus driving the equilibrium to 
favour the ketalisation products. Klein124 found that diketal 234 could be obtained as the 
major product by increasing the reaction time to five days and increasing the amount of 
ethylene glycol ten-fold. It is noteworthy to mention that, while diketalisation occurs readily, 
formation of the monoketal 235 appears to be inhibited by the proximity of the 10-methyl 
group and was only found to be present in trace amounts in the crude reaction mixture. The 
diketal 234 was then selectively deprotected at the less hindered C-3 position by refluxing 
with aqueous HCl for 72 h to afford 235, in 36 % yield.  
 
In an alternative approach, refluxing the diketal 234 in a solution of p-toluenesulfonic acid in 
MeOH for 9 h resulted in a greatly improved yield of 91 %. Scheme 2.1 illustrates the overall 
sequence of reactions for the interconversion between mono- and diketals, and it is apparent 
that either of the desired products are accessible by manipulation of the reaction conditions.  
 
 16 236 237 
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LAH was chosen to effect the reduction of monoketals 232 and 235 as it is known to reduce 
even sterically hindered ketones in excellent yield.136 It is important to conduct the reaction in 
diethyl ether or THF to facilitate dissolution of the LAH.136 The diastereoselectivity of the 
reduction is, of course, a major consideration. The rigidity of the camphor skeleton, together 
with the steric bulk of the 8-, 9- and 10-methyl groups, favour attack of the carbonyl oxygen 
by the complexed hydride ion from the endo-face of the molecule, resulting in the exo-
hydroxy diastereomer124 (Scheme 2.3). Simple attack by a free hydride ion would result in 
predominance, rather than exclusivity of one diastereomeric product. Stereoselective 
reduction of the monoketals 232 and 235 under the chosen conditions was achieved producing 
the respective exo-hydroxy ketals 210 and 211 in 75 % and 87 % yields (Scheme 2.1).  
 
The mechanism for the LAH reduction (Scheme 2.3)137 is believed to involve a dative 
covalent bond from the carbonyl oxygen to lithium. This brings a hydrogen, attached to the 
aluminum complex, within close proximity of the carbonyl carbon. Hydride ion transfer, loss 
of the LiAlH3+ complex and hydrolysis upon work-up results in the product 210. Overall, the 
sp2 hybridized C-2 is converted into a new sp3 stereogenic centre with exclusive S-
configuration. Significantly, attack of the hydride ion complex can only occur from the endo-
face of the molecule due to the overall size of the LAH complex. This appears to be the most 
significant factor responsible for the production of only one diastereomeric product. 
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Scheme 2.3: Mechanism of LAH reduction of monoketal 232.137 
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The last step in this sequence of reactions was the deprotection of monoketals 210 and 211, 
which was achieved by acid-catalysed hydrolysis in THF to afford 233 (45 %) and 231 (57 
%), respectively. The yields were not optimized as this was felt to be unnecessary at this 
stage.  
 
In an alternative approach to the α-ketol 231, direct, regio- and stereoselective reduction of 
camphorquinone 22 with Raney nickel afforded the 3-exo-hydroxy isomer exclusively.138 This 
well-known heterogeneous transition metal hydrogenation catalyst has found use in reduction 
of carboxylic esters to alcohols, hydrogenation of double and triple bonds in quantitative 
yields and desulfurization of thiols and thioethers. Diketones can be reduced stereoselectively 
to an intermediate ketol or to the diol depending on the catalyst and solvent system used.139  
 
Raney nickel catalyzed hydrogenation of camphorquinone 22 resulted in a high yield of 3-
exo-hydroxybornan-2-one 231 (94 %). The mechanism of Raney nickel  hydrogenation is not 
fully understood, but is considered to involve adsorption of the substrate onto the surface of 
the metal catalyst, followed by addition of adsorbed molecular hydrogen139 (Scheme 2.4). The 
reaction is believed to involve free radicals with hydrogen transfer occurring at the relatively 
unhindered endo-face of the adsorbed substrate molecule. The absence of the 2-
hydroxybornanone isomer may be attributed to the fact that access to the 2-carbonyl group is 
hindered by the close proximity of the 10-methyl group. 
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Scheme 2.4: Raney nickel reduction of camphor quinone. 
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2.1.2 Rearrangement and Dimerization of α-Ketols 
 
The current research was aimed at confirming the previous work and in particular: - verifying 
the selective synthesis of the dimers based on the 2- or 3-hydroxybornanone precursor; 
isolation of the third dimer 221 (and possibly a fourth); and clarifying the synthesis of the 
mono- and dihydroxy products. 
 
The dimerization of the hydroxybornanones 231 and 233 was achieved using Ravinidran’s 
revised methodology which excludes the unnecessary catechol (Schemes 2.5 and 2.6).122 The 
acid-catalysed condensation was effected by refluxing 3-exo-hydroxybornan-2-one 231 with 
p-toluenesulfonic acid in anhydrous benzene overnight, using a Dean-Stark trap to 
azeotropically remove the H2O generated by the reaction. Two crystalline products “dimer I” 
(214; 44 %) and “dimer II” (215; 41 %) were obtained. Similar treatment of 2-exo-
hydroxybornan-3-one 233 afforded “dimer II” 215 exclusively in 81 % yield. 
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Scheme 2.5: Dimerisation of 3-exo-hydroxybornan-2-one 231. 
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Scheme 2.6: Dimerisation of 2-exo-hydroxybornan-3-one 233. 
 
The structures of “dimer I” and “dimer II” were confirmed through a thorough investigation 
of the 1-D and 2-D NMR spectroscopic and high resolution chemical ionisation mass 
spectrometric (HRCIMS) data. Assignment of spectral peaks to the corresponding 1H and 13C 
nuclei was relatively straightforward, being facilitated primarily by the HMQC spectra 
(Figures 2.2 and 2.6), which also allowed the deduction of the regiochemistry and endo or 
exo stereochemistry of the ether links through comparative analysis of chemical shifts and 
coupling constants. HMBC (Figures 2.3 and 2.7), COSY and NOESY spectra permitted 
confirmation of signal assignments to the nuclei in each case. 
 
The HMQC spectrum of 214 (Figure 2.2) clearly shows the presence of 18 carbon signals 
(the two carbonyl signals are not included in the figure) and the corresponding signals for the 
30 protons expected for this compound. In practically every instance there are two resonances 
for a particular type of proton or carbon, which indicates the presence of a dimeric compound 
that does not exhibit symmetry.  
 
The HMBC spectrum of 214 (Figure 2.3), which shows all 20 carbon signals, illustrates some 
of the correlations that allowed assignment of regiochemistry to each monomeric unit. In the 
case of the first monomer: the 3-H nucleus (3.93 ppm) couples with C-1 (57.3 ppm), C-4 
(49.3 ppm), C-5 (24.9 ppm), C-1’ (50.3 ppm) and C-2’ (85.5 ppm); 4-H couples with C-1 
(57.3 ppm), C-2 (218.4 ppm), C-3 (84.2 ppm), and the 10-Me nuclei (0.87 ppm) couples with 
C-1 (57.3 ppm) and C-2 (218.4 ppm). The couplings observed with the second monomeric 
unit include: the 2’-H nucleus (3.97 ppm) with C-3’ (217.3 ppm), C-6’ (25.9 ppm), and C-10’ 
(13.0 ppm); and the 4’-H nucleus (2.14 ppm) with C-3’ (217.3 ppm) and C-7’ (46.3 ppm). 
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Figure 2.2: 400 MHz HMQC spectrum of 214 in CDCl3.  
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Figure 2.3: 400 MHz HMBC spectrum of 214 in CDCl3.  
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Assignment of the regiochemistry and stereochemistry of the ether linkage is based on an 
analysis of the multiplicities of the 2’-H, 3-H, 4-H and 4’-H signals and the C-1, C-1’, C-4 
and C-4’ chemical shifts. The significant deshielding of the C-1 and C-4’ nuclei, reflect their 
close proximity to the magnetically anisotropic carbonyl group on their respective monomeric 
units (Table 2.1), whereas the corresponding C-1’ and C-4 nuclei resonate at higher fields, 
which is indicative of more shielded environments, further away from the carbonyl moieties.  
 
Table 2.1: Summary of selected 13C chemical shiftsa for 214 (“dimer I”) reflecting the 
increasing deshielding and its structural implications. 
 
Nucleus  δ (ppm) Environment   
 
(C-1’) quaternary 50.29  near ether link 
(C-1) quaternary 57.32   adjacent to carbonyl 
(C-4) CH  49.25   near ether 
(C-4’) CH  60.03   adjacent to carbonyl 
(C-3) CH-O  84.22   ether carbon 
(C-2’) CH-O  85.45   ether carbon 
(C-3’) C=O  217.29   carbonyl 
(C-2) C=O  218.43   carbonyl 
a
 100 MHz data in CDCl3. 
 
In order to assign the stereochemistry of the ether link in the dimer, use was made of the 1H 
signal multiplicities. The 3-H nucleus resonates at 3.93 ppm as a singlet, inferring the absence 
of vicinal coupling and implying its endo-orientation while the 4-H nucleus resonates as a 
doublet (J 4.8 Hz) at 2.17 ppm, showing coupling with 5-Hexo nucleus only. The lack of 
vicinal coupling between the 4-H and either the 3-Hendo or the 5-Hendo nuclei is consistent with 
torsion angles approaching 80º as determined by solving the Haasnoot-de-Leeuw-Altona 
equation,140 which is a variation of the traditional Karplus relationship141 with β-substituent 
correction. The equation allows for a second solution, i.e. 260º, but this is an impossible angle 
given the structure of the molecule. The torsion angle between the 3-H and 4-H nuclei was 
also calculated using this equation with the aid of the Mestre-J142 software package and was 
found to be ca. 82.5º - a value which corresponds to the curve minimum. The calculated 
relationship between torsion angle and coupling constant is shown in Figure 2.4. 
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Figure 2.4: Prediction of 3-H and 4-H dihedral angle for “dimer I” 214.142 
 
 Further support for the structural assignment was provided by the NOESY spectrum as 
illustrated by the observed interactions summarised in Figure 2.5. Significant NOE 
interactions between the 3-H, 4-H, 5-Hendo and 6-Hendo nuclei, suggest that they are all on the 
same (endo)-face of one monomeric unit. Additionally, interactions between the 2’-H and the 
8’-methyl, the 9’-methyl and the 5’-Hexo nuclei and the 2’-H and 10’-methyl nuclei confirm 
the position of these groups on the exo-face of the second monomeric unit. No NOE 
interactions between the two monomeric units were obvious, presumably due to their distance 
from one another as a result of twisting about the ether linkage. 
 
 
 
 
 
 
 
 
 
Figure 2.5: Structure showing selected NOE interactions observed for 214. 
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The second dimer to be isolated, “dimer II” 215, was characterised using similar arguments. 
The HMQC spectrum (Figure 2.8) reveals the 13C and 1H signals expected for the C20H30 
molecular composition and permits more definitive assignment of the methylene signals due 
to better resolution of the spectrum. Correlations provided by the HMBC spectrum are shown 
in Figure 2.9 and were essential to the assignment of regiochemistry in the monomeric units. 
In the first monomeric unit, the 2-H nucleus (3.81 ppm) couples with C-1 (50.0 ppm), C-2 
(85.6 ppm), C-3 (217.9 ppm), C-4 (59.2 ppm), C-6 (33.4 ppm) and C-3’ (81.6 ppm), while the 
4-H nucleus (2.05 ppm) couples with C-6 (33.4 ppm). Interactions in the second monomeric 
unit include: the 3’-H nucleus (4.25 ppm) with C-4’ (48.3 ppm), C-2’ (218.0 ppm) and C-8’ 
(19.9 ppm); and the 4’-H nucleus (2.31 ppm) with C-5’ (31.8 ppm). As for “dimer I” 214, the 
2’-H, 3-H, 4-H and 4’-H signal multiplicities and the C-1, C-1’, C-4 and C-4’ chemical shifts 
were vital in definitive identification of the isolated product as the 2-exo, 3’-endo-ether. The 
proximity of C-1’ and C-4 to the magnetically anisotropic carbonyl group on their respective 
monomeric units resulted in their chemical shifts being significantly greater than their more 
shielded counterparts, C-1 and C-4’ respectively. Table 2.2 shows critical data used in the 
determination of the regiochemistry of the ether linkage. 
 
Table 2.2: Summary of the 13C chemical shiftsa for “dimer II” 215 reflecting the 
increasing deshielding and its structural implications. 
 
Nucleus  δ (ppm) Environment   
 
(C-1’) quaternary 58.36  adjacent to carbonyl   
(C-1) quaternary 49.96  near ether link 
(C-4) CH  59.20   adjacent to carbonyl   
(C-4’) CH  48.27   near ether 
(C-3’) CH-O  84.62   ether carbon  
(C-2) CH-O  85.57   ether carbon  
(C-3) C=O  217.88   carbonyl  
(C-2’) C=O  218.99   carbonyl   
a
 100 MHz data in CDCl3. 
 
Consideration of the signal multiplicities of the vicinal 3’-H and 4’-H nuclei and their 
coupling (J 5.0 Hz) suggests that the 3’-H nucleus is exo-orientated and, hence, that the ether 
link is endo-orientated. Confirmation of the geometry is again provided by solving the 
Haasnoot-de-Leeuw-Altona equation, which indicates that the coupling constant of 5.0 Hz 
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corresponds to a dihedral angle of 49.9°, the other three possible solutions to the equation 
again being considered unlikely or impossible given the molecule’s rigidity (Figure 2.6). 
 
O
H C 2
4
R
CH2RH
R
O
R49.9
o
J~ 5Hz
  
 
degrees
0 60 120 180 240 300 360
Hz
2
4
6
8
10
chi[R1=CC3]=0.17
chi[R2=CH2C]=0.32
chi[R3=OC]=1.22
chi[R4=CCO2]=-0.17
Angle=49.90 degrees
J=4.99 Hz
Altona (E set) equation
 
 
Figure 2.6: Prediction of the 3’-H and 4’-H torsion angle corresponding to a coupling of 
 5.0 Hz for “dimer II” 215.142 
 
Further verification of the structure of “dimer II” is provided by the NOE interactions, which 
are illustrated in Figure 2.7. 
 
 
 
 
 
 
 
 
 
Figure 2.7: Selected NOE interactions observed for 215. 
 
Coupling 
constant 
J 
Torsion angle (degrees)
ARD 13 "Dimer II"
2'
3'
4'
O
O
H
H
O H
H
H
 
ARD 13 "Dimer II"
5
6
1
2
3
4
7
H3C 8
H3C
2'
3'
4'
5'
6'
1'
7'H3C8' CH39'
O
O
H
H
O
H
H
H
 2 5 
“Dimer II” 
Discussion 
- 68 - 
 
 
 
 
Figure 2.8: 400 MHz HMQC spectrum of 215 in CDCl3. 
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Figure 2.9: 400 MHz HMBC spectrum of 215 in CDCl3.  
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The study of these compounds has raised some interesting questions. Initially, it was assumed 
that one α-ketol precursor would result in the stereocontrolled synthesis of one dimer. From 
the experimental results, however, it became obvious that the mechanism was more complex 
than might have been anticipated. While the condensation of 2-exo-hydroxybornan-3-one 233 
resulted in the exclusive formation of “dimer II”, the condensation of 3-exo-hydroxybornan-2-
one 231 gave three products, “dimer I” (as the major product), dimer II and a third dimer 
isolated in trace quantities (Scheme 2.7).122 
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Scheme 2.7: Overview of the acid-catalysed condensation of α-hydroxybornanones 231 
and 233. 
 
The mixture of dimers I – III obtained from the reaction of the 3-exo-hydroxy precursor 231 
suggested the possibility of contamination of the reactant by the 2-exo-hydroxy analogue 233. 
However, this was not the case as the α-ketols had been synthesised via different routes and 
were shown to be pure by NMR spectroscopy prior to the reaction. Another possibility is that 
α-ketol-enediol tautomerism results in a mixture of 231 and 233 under the reaction conditions, 
as illustrated in (Scheme 2.8). 
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Scheme 2.8: α-Ketol-enediol tautomerism of the 2-exo- (233) and 3-exo-hydroxybornanone 
231. 
 
In the presence of p-toluenesulfonic acid these tautomers are likely to be rapidly 
interconvertable via the common enediol 243 with the α-ketol forms existing almost 
exclusively at equilibrium. It should be noted that the enediol moiety is planar, which raises 
the possibility of four diastereomeric α-ketol products. However, due to the steric bulk of the 
8-methyl group, endo protonation should be favoured resulting in formation of the exo-α-
ketols shown in Scheme 2.8. A further consideration is whether the equilibria between the 
two α-ketols and the enediol favour one α-ketol over the other. The fact that only one dimer is 
formed from the 2-exo-hydroxy precursor 233 may give substance to such a view. 
 
While the p-toluenesulfonic acid could catalyze tautomerism of the α-ketols, it could also 
catalyze the etherification reaction leading to the dimerization. The mechanism for 
dimerization could be expected to involve SN2 displacement of H2O from the protonated 
alcohols 246 and 247 by the hydroxyl oxygen of a second alcohol (Scheme 2.9). The different 
directions of attack “a”-“d” could lead to the formation of the four isomeric dimers I-IV, three 
of which have been isolated – the fourth, as yet, unobserved. It is important to note that this 
mechanistic rationalisation (which is presented in our paper143) relies implicitly on 
tautomerisation of the precursor α-ketols.  
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Scheme 2.9: Acid-catalysed etherification pathways involving α-ketol-enediol tautomerism 
and SN2 displacement. 
 
However, an alternative or parallel mechanistic pathway could be envisaged, involving the 
formation of hemiacetal and enol intermediates, which ultimately yield “dimer I” (Scheme 
2.10) or similarly “dimer II”.  
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Scheme 2.10: Acid-catalysed mechanism involving hemiacetal and enol intermediates to 
yield “dimer I” 214. 
 
Considering the formation of “dimer I”, initial protonation of the C-2 carbonyl oxygen 
strongly polarizes the carbonyl group, thus facilitating subsequent nucleophilic attack by a 
second 3-exo-hydroxybornan-2-one molecule 231. Loss of a proton yields the neutral 
hemiacetal 248, acid-catalyzed dehydration of which results in the formation of an enol 
intermediate 250. Acid-catalyzed tautomerism then leads to “dimer I”. An analogous 
mechanism would account for the formation of “dimer II” from two 2-exo-hydroxybornan-3-
one molecules 233. 
 
The crucial feature of this hemiacetal-enol pathway is that prior isomerization of the precursor 
is unnecessary for the production of the major dimeric products 214 and 215, since they can 
be formed solely from the corresponding exo-hydroxybornanones 231 or 233, respectively. 
However, the formation of dimers II and III (albeit in minor proportions) in the reaction of 3-
exo-hydroxybornane-2-one 231 requires the presence of some 2-exo-hydroxybornan-3-one 
233. This leads to the conclusion that prior isomerization must contribute to the complex of 
reactions – at least in the formation of dimers II and III from 231 and 233. The apparently 
exclusive formation of “dimer II” from the 2-exo-hydroxybornan-3-one 233 may reflect 
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dominance of the hemiacetal-enol pathway – a possibility which will form part of a future 
computational study. 
 
2.1.3 Reduction of the α-Ketol Dimers 
 
Aldehydes can be reduced to primary alcohols and ketones to secondary alcohols by a number 
of reducing agents, of which metal hydrides, such as lithium aluminum hydride (LAH) and 
sodium borohydride (NaBH4), are the most commonly used. The two most attractive qualities 
that hydrides have over other reducing agents are that they: - i) do not generally reduce 
carbon-carbon double or triple bonds; and ii) they generally provide a high proportion of 
active hydride. Reduction of specific functional groups can be controlled to some degree by 
selection of the reagent; however, regioselective and stereoselective reductions are far more 
difficult and require considerably more specialized reducing agents, such as the rhodium-
phosphorus complexes DIPAMP144,145 or (R)-(S)-BPPFOH.146 Lithium N-dihydropyridyl-
alumium hydride reduces diaryl ketones in preference to dialkyl or alkyl aryl ketones,147 and 
zinc borohydride reduces saturated ketones in preference to α,β-unsaturated ketones.148 
 
Asymmetric reduction of ketones with high % e.e. values has been achieved using a variety of 
chiral reducing agents, each being more effective for certain types of ketones than for others. 
Such as chiral reducing agents including binaphthyl reagents and their derivatives, such as 
BINAP-ruthenium acetate,149-151 BINOL-diethyl zinc 253a,155 BINOL-aluminum hydride 
253b-c152 and hydroborating reagents, such as Ipc2BH 252 developed by H.C. Brown 
(Scheme 2.11).153,154 The chiral Ipc2BH 252 is prepared by controlled hydroboration of the 
chiral alkene, α-pinene 251,153 while the binaphthyl derivative, BINOL aluminum hydride 
reagent 253b, is prepared from lithium aluminum hydride, 2,2’-dihydroxy-1,1’-binapthyl and 
an alcohol.152  253b has previously been shown to exhibit complete topological control in the 
reduction of carbonyl compounds.152 
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Scheme 2.11: Hydroboration of α-pinene 251.154 
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The restricted rotation about a single bond that causes chirality in the binaphthyl derivatives152 
is also known as atropisomerism.157 The potential of our dimers 214 and 215 to provide 
scaffolds for the construction of reagents analogous to the atropisomeric BINOL reagents 
(253a-c)151,152,155 prompted a study of their reduction to chiral diols.  
 
Previous work in our laboratories was conducted by Matjila, who attempted the synthesis of 
the 2-exo-3’-exo-dihydroxy analogue of “dimer I” 214,122 using NaBH4 in ethanol; however, 
only the 3’-exo-monohydroxy compound 254 (Scheme 2.12) was obtained in low yield (48 
%). In a second reaction, the reduction of “dimer II” with LAH afforded a dihydroxy 
compound, identified as the 3-exo-2’-exo-dihydroxy product 255 (Scheme 2.13), in excellent 
yield (99 %). 
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Scheme 2.12: Reduction of “dimer I” 214.122 
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Scheme 2.13: Reduction of “dimer II” 215.122 
 
In an extension of their work involving the dimerization of camphor enolates to give 
dioxobornanylidenes, McNulty et al. 132 reported the reduction of their dimers with LAH to 
give the diols 256 and 257. As expected for camphor systems, it was found that nucleophilic 
attack occurred mainly at the endo-face of each carbonyl group owing to steric hindrance by 
the 8-methyl group and the 3-exo-substituent. The authors did not attempt reduction with the 
more selective reducing agent, NaBH4,136 nor did they observe any monohydroxy products.132 
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In our own investigation, reduction of the camphor ether dimers was, in fact, explored using 
NaBH4. Two separate reactions were conducted in which “dimer I” 214 and “dimer II” 215 
were treated with 2 equivalents of NaBH4 in ethanol at 0 ºC followed by stirring at room 
temperature for 12 h. Work-up and flash chromatography afforded the corresponding mono- 
and dihydroxy derivatives: 254, 258 and 259 (Scheme 2.14); and 260 and 255 (Scheme 2.15, 
p. 82). 1-D and 2-D NMR spectroscopy and HRCIMS data were utilized to tentatively 
identify the three compounds as the 3’-exo-hydroxy product 254 (3.2 %), 2-exo-3’-endo-
dihydroxy product 258 (45.3 %) and the 2-exo-3’-exo-dihydroxy 259 (41.2 %) 
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Scheme 2.14: Reduction of “dimer I” 214. 
 
At this stage, no attempt was made to optimize yields or effect exclusive synthesis of any of 
the products, but it is expected that this could be achieved by increasing the ratio of NaBH4 
and fine tuning the reaction conditions. Consideration was first given to the dihydroxy 
derivatives, for which the 13C and 1H NMR spectra showed the presence of the expected 20 
carbons and 34 protons. Furthermore, the absence of carbonyl signals and the presence of two 
new methine signals confirmed that reduction of both carbonyls had occurred (Figures 2.11, 
2.12 and 2.13). The realization that two isomers of the dihydroxy derivative had been 
synthesised necessitated careful analysis of the data in order to determine their 
stereochemistry. NaBH4 is responsible for providing a source of hydride ions which, as 
indicated earlier, are expected to attack the carbonyl groups of “dimer I” 214 predominantly 
from the endo-face (path “a” or “b”; Figure 2.10). In the case of “dimer I”, however, 
monomeric unit M1 is located on the endo-face of monomeric unit M2, partially blocking the 
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endo-face of M2. This arrangement would thus account for the observed exo-face attack (path 
“c”) of M2 affording the 3’-endo-hydroxy product 258 together with the expected analogues 
254 and 259 arising from “normal” endo-face hydride attack.  
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Figure 2.10: Possibilities for nucleophilic hydride attack on “dimer I” 214. 
 
The 1H and 13C NMR spectra of compounds 258 (Figures 2.11 and 2.12) and 259 (Figure 
2.13), reveal that both molecules have two hydroxylic protons, and comparison of the spectra 
allowed the stereochemistry of the hydroxyl groups to be assigned.  
 
The stereochemistry of the 3-exo-2’-endo ether linkage is established in the precursor 214, 
while the exo-orientation of the 2-hydroxy group is based on the expectation of endo-hydride 
delivery at the 2-carbonyl carbon. The stereochemistry of the 3’-hydroxy group on 
monomeric unit M2 was confirmed through analysis of the multiplicity of the 4’-H signal, 
which appears as a triplet (1.83 ppm) in compound 258 due to coupling with 5’-Hexo and 3’-
Hexo, whereas in compound 259 it resonates as a doublet (1.64 ppm), as 4’-H only couples 
with the 5’-Hexo nucleus (3’-Hendo being at an angle of ca.. 80º to 4’-H). The compounds were 
thus characterized as the 2-exo-3’-endo-dihydroxy derivative 258 and the 2-exo-3’-exo-
dihydroxy derivative 259. 
 
More evidence for the formation of the dihydroxy derivatives 258 and 259 is provided by 
analysis of their HRCI mass spectra (illustrated for compound 258 in Figure 2.14), which 
reveal peaks at m/z 322.24999 and m/z 322.25012, respectively, which correspond to the 
expected molecular formula C20H34O3 (calculated m/z 322.25080). 
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Figure 2.11: 400 MHz 1H NMR spectrum of 258 in CDCl3. 
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Figure 2.12: 100 MHz 13C NMR spectrum of 258 in CDCl3. 
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Figure 2.13: 400 MHz 1H spectrum of 259 in CDCl3. 
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Figure 2.14: HRCI mass spectrum of the dihydroxy derivative 258. 
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Figure 2.15: Mass Spectrometric fragmentation of compound 258. 
 
A fragmentation study of both dihydroxy products was carried out and several dominant 
peaks were accounted for as illustrated for compound 258 in Figure 2.15. The molecular ion I 
undergoes elimination of H2O from either the exo-monomeric unit, forming the odd electron 
fragment II, or from the endo-monomeric unit giving the analogous fragment III. Elimination 
of the neutral CO molecule from fragment III gives the odd-electron species IV. Heterolytic 
cleavage at the ether linkage of the molecular ion I gives the carbocation V and/or the 
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rearranged even-electron fragment VI. Loss of an H atom from the latter affords the odd-
electron species VII, which is responsible for the base peak in the spectrum. Lower m/z peaks 
indicate fragmentation of the camphor skeleton to afford, inter alia, the characteristic 
fragments VIII and IX.156 
 
The third compound to be isolated from the NaBH4 reduction of “dimer I” 214 was 
characterised as the 3’-exo-hydroxy product 254.  A molecular formula of C20H32O3 
corresponds to the monohydroxy derivative (observed m/z 320.23498; calculated m/z 
320.23513), while the NMR signal assignments were based on the arguments discussed 
above. The 1H NMR spectrum indicates the presence of a broad 3’-hydroxylic signal at 2.20 
ppm. The corresponding 3’-H nucleus resonates as a singlet at 2.59 ppm, the lack of coupling 
to either the 2’- or 4’-proton suggesting that it is endo-orientated, implying that the 3’-
hydroxylic group is exo. The spectroscopic data for the monohydroxy product 254 indicated 
that it was, in fact, the same as the compound isolated by Matjila,122 X-ray analysis of which 
had confirmed the 3-exo-2’endo-orientation of the ether linkage and the exo-orientation of the 
hydroxy group at C-3’.  
 
Similar reduction of “dimer II”, using NaBH4, afforded two products (Scheme 2.15) that were 
tentatively identified through analysis of the 1-D and 2-D NMR spectroscopic and HRCIMS 
data as the 3-exo-2’-endo-dihydroxy derivative 260 (47 %) and the 3-exo-2’-exo-dihydroxy 
derivative 255 (5 %). 
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Scheme 2.15: Reduction of “dimer II”. 
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Nucleophilic attack on the endo-face of each monomeric unit (paths “a” and “b”; Figure 
2.16) should, in principle, be favoured and would result in the alcohol groups being exo-
orientated. A blocking effect by monomer M1 on the endo-face of monomer M2, however, 
could disfavour endo attack (path “b”; Figure 2.16) at C-2’ thus permitting competitive 2’-
exo attack (path “c”). The net result is the formation of the isomeric 3-exo-2’-endo- and the 3-
exo-2’-exo-dihydroxy derivatives 260 and 255, respectively. 
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Figure 2.16: Possibilities for nucleophilic hydride attack on “dimer II” 215. 
 
The structure elucidation of the dihydroxy derivatives 260 and 255 was achieved by analysis 
of the NMR spectroscopic data (e.g. Figures 2.17 and 2.18) in a similar manner to the 
dihydroxy derivatives of “dimer I”, 258 and 259.  
 
It was evident that the stereochemistry of the M1 monomeric unit of both compounds was 
identical, based on the multiplicity of the 4-H signal, which appears as a triplet due to 
coupling with 5-Hendo and 3-Hendo, thus the 3-OH is of exo-orientation. Comparison of the 
resonances for the 2’-H and 3’-H protons on the second monomeric unit M2 of both 
compounds allowed for the determination of stereochemistry of the 2’-OH. The 3’-H of 
structure 255 resonates as a broad triplet due to coupling with 4’-H and a long-range 
interaction with 2’-OH. The 2’-H signal appears as a broad singlet due to its proximity to 2’-
OH. The 3’-H proton of structure 260 resonates as a multiplet due to coupling with 4’-H and 
2’-Hexo and, the 2’-Hexo resonates as a multiplet (unfortunately somewhat obscured by the 3-H 
resonance) due to coupling with 3’-H. Thus the compounds were assigned as the 3-exo-2’-
endo-dihydroxy derivative 260 and the 3-exo-2’exo-dihydroxy derivative 255. 
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Figure 2.17: 400 MHz 1H NMR spectrum of 260 in CDCl3.  
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Figure 2.18: 400 MHz 1H NMR spectrum of 255 in CDCl3. 
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The reduction of “dimer I” and “dimer II” followed predictions for the directional attack of 
the hydride anion. In the case of both dimers, attack of the lower monomeric unit M1 
occurred exclusively from the endo-face, generating the exo-hydroxy monomer and 
furthermore attack of the second monomer M2 occurred from either the endo- or exo-face. 
Attack of M2 on “dimer I” showed no clear preference of either direction of attack, however, 
attack of “dimer II” was 90 % more likely from the exo-face generating the endo-hydroxy 
monomer. It is probable that with “dimer II” the combination of the blocking effect of M1 and 
the 10’-methyl group highly disfavour approach from any position except the exo-face of M2, 
whereas the approach of “dimer I” is constrained to a similar degree by blocking from M1 
and the 8’- and 9’-methyls but does not have another vicinal methyl to further reduce attack 
from the endo-face. Figure 2.19 illustrates the expected directions of nucleophilic hydride 
attack (bold arrows), lesser favoured (dashed arrows) and strongly disfavoured (red arrows) 
directions of attack of the dimers 214 and 215. 
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Figure 2.19: Direction of attack of the dimers. 
 
In conclusion, a multi-step process has been developed which is able to supply a range of 
mono- and dihydroxy camphor ether dimers, which have potential as scaffolds for the 
construction of chiral reagents. 
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2.2  ASYMMETRIC SYNTHESIS OF α-ALKYLATED α-AMINO ACIDS 
 
Given the importance of α-amino acids, the asymmetric synthesis of these vital biological 
building blocks is of considerable interest. Their inherent chirality is crucial to their function 
and is of primary concern in their synthesis. 
 
The alkylation of glycine enolate derivatives has been widely used in the synthesis of 
optically pure amino acids, the most well known example being that involving Oppolzer’s 
sultam-derived glycine equivalent 106 158,52 (Scheme 2.16). This versatile auxiliary permits 
almost total stereocontrol and, due to its efficiency, has also found use in the synthesis of 
enantiopure deuterium labeled amino acids as precursors in peptide synthesis.159 
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Scheme 2.16: Oppolzer’s sultam as an auxiliary in α-alkylation reactions. 
 
Porzi et al.160 reported the use of Oppolzer’s sultam in the synthesis of both natural and 
unnatural α-amino acids in good yield and with high enantiomeric purity. They have also 
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reported the alkylation of lactim auxiliaries e.g. 264 (Scheme 2.17) to form natural and 
unnatural dipeptides with moderate to good stereoselectivity.161 The most recent focus of 
Porzi’s research162 has been the dialkylation of a mixture of the diastereomeric alkylated 
products 265a and 265b, to form uncommon C-α,α’ dialkyl dipeptides 267a and 267b 
(Scheme 2.18). These examples merely touch the surface of diverse alkylation studies 
involving the synthesis of proteinogenic and non-proteinogenic α-alkylated amino acid 
derivatives. 
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Scheme 2.17: Alkylation of lactims and cleavage of selected products. 
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Scheme 2.18: Dialkylation of a mixture of monoalkylated chiral synthons. 
264 
265a 265b 
major  
266 
265a-b 267a 267b 
Discussion 
- 88 - 
2.2.1 Synthetic Rationale 
 
Research in our laboratory over the last few years has focused on the use of the regioisomeric 
camphor-derived iminolactones 208 and 209 as convenient scaffolds to provide access to 
chiral α-amino acids 268 and 269 (Scheme 2.19). 
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Scheme 2.19: Synthesis of enantiomeric α-amino acids. 
 
The conjugated enolates derived from the iminolactones 208 and 209 are expected to be 
conformationally rigid and the 8-methyl group should exert steric hindrance on the exo-face 
of both systems. These two factors should encourage preferential electrophilic alkylation from 
the less hindered endo-face. Mild hydrolysis should release both the alkylated α-amino acid 
and the chiral auxiliary. The configuration at the stereogenic centre in the α-amino acid could 
thus be controlled either by the regiochemistry of the iminolactone 208 or 209 or by the 
enantiomeric form of camphor used as a starting material. 
 
The iminolactone work pioneered by Ravindran123 initially met with little success. An early 
attempt was made to synthesise the 2-iminolactone 208 by a one-pot reaction of the α-ketol 
231 with glycine 270 and a catalytic amount of para-toluenesulfonic acid (Scheme 2.20), in 
the hope that the hydroxyl and carbonyl groups of the α-ketol would react with glycine to give 
the iminolactone 208 directly. However, none of the desired product was obtained. 
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Scheme 2.20: Ravindran’s attempt at direct synthesis of the 2-iminolactone 208.123 
 
The next method attempted involved reacting ethyl glycine hydrochloride 271, generated in 
situ, with the α-ketol 231 under reflux. This again failed to produce any lactone product but 
did afford the hydroxy enamine derivative 272 (Scheme 2.21) in low yield. Several other 
methods of synthesis were attempted without success until finally, using a carbonyl 
diimidazole coupling agent and CBZ-protected glycine, Ravindran123 obtained 273 and its 
regioisomer 274 in good yields. Following deprotection and cyclization (Scheme 2.22), 
alkylation of the 3-iminolactone 209 was achieved by Matjila122 and Klein124, but similar 
treatment of the 2-iminolactone analogue 208 failed to yield any of the monoalkylated 
product, affording dialkylated products instead.122 One of the aims of the present study was to 
confirm the reproducibility of these earlier results, and to achieve stereoselective 
monoalkylation of the 2-iminolactone 208.  
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Scheme 2.21: Formation of enamine 272.123 
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Scheme 2.22: Deprotection and cyclization of the CBZ-protected compound 273. 
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2.2.2 Synthesis of the 2-Iminolactone  
 
The overall route to the tricyclic 2-iminolactone 208 is outlined in Scheme 2.23. Approaches 
to the α-ketol intermediate 231 have been discussed in detail in Section 2.1. Following the 
approach developed by Ravindran,123 esterification of the α-ketol 231 was effected using N-
carbobenzyloxyglycine (CBZ-gly)163 in the presence of the coupling agent N,N’-carbonyl-
diimidazole (CDI) to afford the ester 274 in 68 % yield. 
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Scheme 2.23: Synthetic pathway for the 2-iminolactone 208. 
 
The carbobenzyloxy group is widely used as a protecting group in organic synthesis164,165 and 
CBZ-protected amino acids are readily available. Many coupling reagents have been 
developed, the most well known probably being dicyclohexylcarbodiimide (DCC).136 While 
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DCC has been used extensively,166 it gives variable yields and N-acyl urea side products [e.g. 
dicyclohexylurea (DHU)]. The mode of action of N,N’-carbonyldiimidazole (CDI)167 is 
similar to that of DCC and the only side product is imidazole, which is easily removed. 
 
Ester 274 was fully characterised using 1- and 2-D NMR methods. The 1H NMR spectrum of 
the purified sample (Figure 2.20) shows the diastereotopic 2’-methylene protons resonating 
as multiplets at 4.01 ppm, reflecting their magnetic non-equivalence in the chiral environment 
provided by the camphor moiety. The 4’-methylene protons, however, resonate as a singlet at 
5.11 ppm, apparently unaffected by the chiral auxiliary due to their distance from it. The 
deshielded 3-Hendo nucleus resonates as a singlet at 4.82 ppm. This is characteristic of the 
camphor systems that have been studied previously where no coupling with the adjacent 4-
methine proton is observed due to a torsion angle of ca. 80º. For the same reason the 4-
methine proton exhibits no coupling with the 5-Hendo nucleus but resonates as a doublet at 
2.10 ppm due to coupling with the 5-Hexo nucleus alone. 
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Figure 2.20: 400 MHz 1H NMR spectrum of 274 in CDCl3. 
 
Removal of the CBZ-protecting group was readily achieved by palladium catalyzed 
hydrogenolysis166,168 following the methodology described by Bodansky et al.163 Thus, a 
solution of the CBZ-protected system 274 in absolute ethanol was heated to 50 ºC for 2 h 
274 
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under a hydrogen atmosphere in the presence of 10 % palladium-on-carbon. Work-up and 
chromatography gave the 2-iminolactone 208 directly in 56 % yield, due to spontaneous 
cyclization via intramolecular nucleophilic attack at the electron-deficient carbonyl carbon by 
the amino lone pair electrons, following deprotection (Scheme 2.24). 
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Scheme 2.24: Deprotection and intramolecular cyclization of the intermediate ester 274. 
 
Interestingly El Achqar et al.166 reported that analogous deprotection of the α-pinene-derived 
system 276 also proceeded with spontaneous ring closure, to afford the α-pinene-derived 
iminolactone 277 (Scheme 2.25).  
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Scheme 2.25: Deprotection and intramolecular cyclization of the α-pinene glycine ester 
276.166 
 
Confirmation of the structure of the 2-iminolactone 208 was provided by 1- and 2-D NMR 
analysis. The 13C NMR spectrum shows 12 carbon resonances, including the characteristic 
ester carbonyl carbon at 183.7 ppm and an α carbon at 52.6 ppm. The 1H NMR spectrum 
(Figure 2.21) shows the diastereotopic 2’-methylene protons resonating at significantly 
different chemical shifts (3.89 and 4.53 ppm) due to their different magnetic environments. 
The 2’-Hendo proton resonates at 3.89 ppm as a doublet of doublets due to geminal coupling 
with the 2’-Hexo-proton (4.53 ppm, J 17.9 Hz) and remarkably long-range homoallylic 
coupling to the 3-Hendo nucleus (4.49 ppm, J 1.6 Hz).  
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Figure 2.21: 400 MHz 1H NMR spectrum of 208 in CDCl3. 
 
It is important to note that the relative instability of the 2-iminolactone 208 necessitates its use 
reasonably soon after synthesis, otherwise it undergoes degradation involving fission of the 
imine bond and consequent opening of the lactone ring. Klein124 noted similar degradation of 
the 3-iminolactone 209, and suggested that this property might be advantageous, as isolation 
of the subsequently α-alkylated amino acid and recovery of the auxiliary by hydrolysis might 
also be very easy. 
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2.2.3 Alkylation of the 2-Iminolactone 
 
The presence of the two adjacent activating groups (imino and ester carbonyl) is expected to 
enhance the acidity of the 2’-methylene protons in the lactone 208, hence facilitating 
formation of the corresponding enolate anion in the presence of a suitable base. Subsequent 
attack by alkyl halides is expected to be favoured at the less hindered face, resulting in endo-
alkylation.169 One point of concern, however, has been the uncontrolled dialkylation observed 
in earlier studies,122 and its minimization was of particular interest in the present 
investigation.  
 
Lithium diisopropylamide (LDA) would seem to be an obvious choice as the base for the 
deprotonation of the iminolactone. However, problems experienced by other researchers122,166 
in the group and the success achieved by El Achqar et al.166 using potassium tert-butoxide 
(KOBut) in their work on the α-pinene-derived iminolactone 277 prompted us to use KOBut. 
Catievela et al.170 also used KOBut in their synthesis of (S)-amino acids. Thus, treatment of 
the iminolactone 208 with KOBut in THF under anhydrous conditions at -78 ºC led to the 
formation of the enolate 278 (Scheme 2.26). To ensure complete enolization, the mixture was 
stirred for a further 1 h before a solution of the alkyl halide in THF was added. The reaction 
mixture was maintained at -78 ºC for a further 2 h before allowing it to warm to room 
temperature overnight. Work-up followed by 1H NMR spectroscopic analysis of the crude 
reaction mixtures permitted the level of stereocontrol to be determined. The integrals of 
corresponding but unobscured signals (typically the 2’-H or 3-H signals) were used to 
determine the relative proportions of the endo- and exo-diastereomeric products in each 
instance, as illustrated for 279a and 279b (Figure 2.22). 
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Figure 2.22:  Partial 1H NMR spectrum for determining stereoselectivityalkylation of 279. 
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Purification of the crude reaction mixtures and separation of the diastereomers was achieved 
using a chromatotron. Each isolated diastereomer was then fully characterised by NMR 
spectroscopy; the 1H NMR spectra of the benzylated diastereomers 279a and 279b are 
illustrated in Figures 2.23 and 2.24. The overall yields were typically moderate and, in all 
cases, the exo product predominated, in contradiction with initial predictions. The highest 
stereoselectivity (84.8 % d.e.) was found, as expected, in the benzyl product. This was 
attributed to the steric demands of the aromatic ring. The predominance of exo products in all 
cases was most likely a direct result of the use of KOBut as the base (Table 2.3). It has 
previously been established that the mode of interaction of the base directly corresponds with 
the direction of alkylation at the activated centre and that substitution of the base could 
potentially reverse the facial selectivity.136 It is important to note that 1H NMR analysis of 
each reaction mixture showed the successful and exclusive synthesis of monoalkylated 
products and no trace of any dialkylated product. 
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Scheme 2.26: Alkylation of iminolactone 208. 
 
Table 2.3: Data for the alkylation of the iminolactone 208. 
 
Product RX Yield ( %) Endo: Exo %
d.e. 
279 C6H5CH2Br 64.9 7.6   :  92.4 84.8 
280 CH3(CH2)2I 52.1 25.4 :  74.6 49.2 
281 CH3I 53.2 38.5 :  61.5 23.5 
282 CH3(CH2)3I 56.9 25.8 :  74.2 48.4 
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Figure 2.23: 400 MHz 1H NMR spectrum of 279a in CDCl3.  
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Figure 2.24: 400 MHz 1H NMR spectrum of 279b in CDCl3. 
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1H- and 13C NMR spectroscopy was used to confirm the structure of the alkylated products. 
Use was made of the 2-iminolactone 208 as a reference and signal assignments were carried 
out for all the alkylated products. The assignment of exo- or endo- stereochemistry was based 
predominantly on the positions and splitting patterns of the 2’-H and 3-H signals (Figure 
2.25).  
 
Generally, when the 2’-H is endo (and, hence the alkyl group is exo), long range homoallylic 
coupling with the 3-H nucleus is observed. This is unusual and only possible due to the 
degree of eclipsing of the two protons.171 The coupling was also noted to be very small (ca. 
1.2 Hz). The chemical shifts of the 3-H and 2’-H nuclei of the exo- and endo-isomers were 
also observed to be significantly different. With the exception of the benzylated products, in 
which magnetic anisotropic effects are likely to be significant, it was found that deshielding of 
both the 3-H and the 2’-H protons occurs when they are on opposite faces of the molecule. 
For exo-alkylated products, 2’-Hendo is in a constrained position relatively close to 3-Hendo and, 
additionally, 2’-Hendo is within the shielding environment of the carbonyl π-bond, and both 
endo-protons are shielded. For endo-alkylated products, the 2’-Hexo and 3-Hendo protons do not 
experience mutual van der Waals shielding and, more importantly the 2’-exo proton lies in the 
deshielding zone of the lactone carbonyl group (Figure 2.25), and thus resonates at lower 
field. Endo alkyl groups appear to have little effect on the 3-Hendo chemical shift. The endo-
benzyl group, however, appears to be responsible for significant shielding of the 3-Hendo 
nucleus due to the magnetic anisotropic effect illustrated in Figure 2.26. Assignment of 
signals for the 1H NMR spectra of the mono-alkylated products 279 - 282 are shown in 
Figures 2.26 - 2.29.  
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Figure 2.25: Putative 1,4-diaxial interactions of the 2’-Hendo and 3-Hendo protons in exo-
alkylated products and the carbonyl anisotropic deshielding of the 2’-Hexo 
nucleus in endo-alkylated products. 
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Figure 2.26: Specific 1H NMR chemical shift and coupling data for 279a and 279b. 
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Figure 2.27: Specific 1H NMR chemical shift and coupling data for 280a and 280b. 
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Figure 2.28: Specific 1H NMR chemical shift and coupling data for 281a and 281b. 
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Figure 2.29: Specific 1H NMR chemical shift and coupling data for 282a and 282b. 
 
Hydrolysis of the corresponding alkylated iminolactone products was not attempted due to the 
paucity of material. Hydrolysis has, however, been carried out on the analogous alkylated α-
pinene-derived iminolactone 277166 and also on the predominantly endo-alkylated 3-
iminolactone product(s) to generate (R)-amino acids.124 Hence it is expected that hydrolysis 
would likewise proceed smoothly with the 2-iminolactone analogues generating α-amino 
acids. 
 
In summary, a route has been developed from (1R)-(+)-camphor to produce 3-exo-hydroxy 
bornanone, which undergoes condensation with CBZ-protected glycine, deprotection and 
cyclization giving the 2-iminolactone and then finally exclusive monoalkylation to give a 
range of predominantly exo-alkyl-2-iminolactones. In no instance was any dialkylated product 
observed for any of the alkylated iminolactones. 
 
Unfortunately, subsequent to the completion of the iminolactone study and the earlier 
research, published in PhD theses from as far back as 1994, by Ravindran,123 Matjila122 and 
Klein,124 it was noted that Xu et al.172,173 had in 2002 published similar work to that done in 
our laboratories involving essentially identical pathways to the 2- and 3-iminolactones. Their 
results, however, confirmed our structure assignment through X-ray analysis and revealed that 
the sense of diastereoselectivity could be reversed by using LDA in place of KOBut (endo-
isomer in up to 98 % d.e.). 
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2.3  SYNTHESIS OF CAMPHOR-DERIVED MORITA-BAYLIS-HILLMAN 
SUBSTRATES 
 
2.3.1 Synthetic Rationale 
 
The presence of a stereogenic centre in the activated alkene should induce asymmetry in the 
reaction intermediates and transition state complexes and, consequentially, cause the 
preferential formation of one diastereomer. However, this is not generally the case due to the 
distance between chiral and reacting centres.71 It has been theorized that the presence of a 
chiral hydroxyl moiety, with its associated hydrogen bonding potential, could increase the 
reaction rate, through stabilization of the reaction intermediates and, additionally, promote 
asymmetric induction.  
 
Thus, our requirements for an effective auxiliary were that it should induce a high degree of 
stereoselectivity, promote the rate of the reaction as much as possible and be recyclable. It 
was determined that important structural criteria for an effective chiral auxiliary in the Baylis-
Hillman reaction were: - i) a rigid scaffold to minimize conformational flexibility; ii) the 
presence of a proximate asymmetric moiety to induce asymmetry; iii) a hydroxylic group to 
facilitate intramolecular hydrogen bonding, thus increasing conformational rigidity in the 
transition state and increasing the rate of the reaction; and iv) an efficient “blocking group” to 
promote stereofacial attack. 
 
The readily available chiral camphor system provides a rigid scaffold upon which sterically 
demanding and chemoselective groups can be attached, and two general approaches to the 
construction of chiral acrylic esters as Morita-Baylis-Hillman substrates were considered. In 
the first, the introduction of a hydroxyl group at C-2 with the potential for hydrogen bonding 
might be expected to stabilize both the intermediate Morita-Baylis-Hillman zwitterion and the 
developing negative charge on the aldehyde oxygen (Figure 2.30). In the second, introduction 
of a bulky substituent R at C-10, might be expected to favour an arrangement of the 
corresponding Morita-Baylis-Hillman zwitterion whereby attack by the electrophile would 
occur from the endo-face. Of course, in both approaches the preferred orientation of the 
aldehyde would be a major factor in determining overall stereocontrol. Thus the generalised 
model compound 283 was envisaged. 
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Figure 2.30: Expected transition state interactions involving the 2-exo-hydroxy-3-exo-
bornyl enolate intermediate 283. 
 
The first compound to be targeted using this model was the hydroxy ester 285, which contains 
the requisite hydroxyl group and a 10-methyl group.  
 
 
2.3.2 Monoacrylate Esters of Dihydroxybornane 
 
Several possible routes were considered to access the chiral Morita-Baylis-Hillman substrate 
285. These included the use of protecting groups to direct the acrylate moiety to the desired 3-
hydroxy group. This, however, seemed an over-complication as the camphor moiety is known 
to react preferentially at the less hindered C-3 position first. Selective acylation of the diol 
284 was thus a reasonable expectation; and the route outlined in Scheme 2.27 was explored. 
The oxidization of camphor 16 was followed by reduction of both carbonyl groups in the 
resulting camphorquinone 22. Regioselective esterification at C-3 of 284 with one equivalent 
of acryloyl chloride was expected to afford the substrate 285, which could then be reacted 
with a range of aldehydes to afford chiral Morita-Baylis-Hillman products 286. 
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Scheme 2.27: Proposed synthetic route to the 2-exo-hydroxy Baylis-Hillman products 286. 
 
 
2.3.2.1 Synthesis of the Acrylate Esters. 
 
The oxidation of camphor 16 was achieved using SeO2 in acetic anhydride to produce 
camphorquinone 22 in high yield (84 %) (Scheme 2.27).133,134 The choice of reducing agent 
was then considered. NaBH4 has been used previously for the reduction of camphor 
derivatives,174 as has hydrogenation in the presence of nickel catalysts.175 However, previous 
success with LiAlH4 in the synthesis of the alcohols 210 and 211 and its reported ability to 
readily reduce even hindered ketones99,134, or diketones175 to secondary alcohols prompted its 
selection as the reducing agent. LiAlH4 is a powerful reducing agent requiring anhydrous 
conditions. Diethyl ether or THF are generally the solvents of choice for such reductions,136 
and the latter was chosen, so as to maximize the reaction temperature and thus increase the 
rate of reduction. Due to the steric bulk of the 8-methyl group, endo attack by the hydride ion 
is expected. The reduction of both carbonyl groups was readily achieved with this reducing 
agent and 2-exo-3-exo-dihydroxybornane 284 was obtained in excellent yield (96 %). 13C 
NMR and DEPT analyses confirmed the presence of the requisite 10 carbons, while the 1H 
NMR spectrum was used to assign the stereochemistry at the new chiral centres (Figure 
2.31). The coupled 2-H (3.58 ppm) and the 3-H (3.81 ppm) nuclei resonate as doublets, the 2-
H nucleus being more shielded due to its proximity to the 10-methyl group. The lack of 
vicinal coupling between the 3-H and 4-H nuclei is consistent with a torsion angle 
22 284 16 
285 286 
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approaching 80º and confirms the endo-orientation of the 3-H proton, while the vicinal 
coupling constant J2,3 = 7.0 Hz is consistent with eclipsing of the 2-H and 3-H nuclei. Since 
the 2-H and 3-H nuclei are thus both endo-orientated, the attached 2- and 3-hydroxy groups 
must both be exo-orientated. This conclusion is consistent with preferential delivery of 
hydride ion by LiAlH4 at the endo-face. In fact, there was no evidence of the formation of the 
other possible stereoisomers. 
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Figure 2.31: 1H NMR spectrum of 284 (400 MHz, CDCl3).  
 
Following the synthesis of the diol 284, regioselective esterification of the 3-hydroxy group 
was required. The acid catalyzed reaction of carboxylic acids with alcohols to form esters is a 
well established equilibrium process.176,177 However, the reactions can be slow and generally 
require a significant excess of the alcohol to ensure complete esterification.178 Various 
coupling reagents have been developed to facilitate esterification176,179 and, in previous 
studies in our laboratories (Section 2.2.2), carbonyldiimidazole (CDI) has been used for this 
purpose with considerable success; hence it was decided to use this reagent. 
 
Esterification of 2,3-dihydroxybornane 284 was attempted using acrylic acid in the presence 
of CDI in both anhydrous THF and anhydrous DMF (Scheme 2.28), as it has been suggested 
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that the choice of solvent can influence the yield.136 After work-up, 1H NMR spectra were 
obtained for the crude reaction mixtures and it was observed that, in both cases, the acrylic 
acid signals were weak and that new signals were present, indicating the formation of 
products. However, the lack of any vinylic proton signals ruled out the possibility of the 
desired acrylic ester 285. Subsequently, a 1H NMR spectrum was obtained for the commercial 
acrylic acid, which indicated a high degree of polymerization. The use of acryloyl chloride in 
the esterification of 284 was then explored under various reaction conditions. The first 
method to be attempted involved the use of 4Å molecular sieves as they are known to 
scavenge small molecules such as H2O or HCl,99,122,134,180 thus preventing acid catalyzed 
polymerization.99,122,180 
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Scheme 2.28: Esterification of dihydroxybornane 284.  
 
 
Dihydroxybornane 284 was therefore reacted with acryloyl chloride in dichloromethane in the 
presence of 4 Å molecular sieves, at 40ºC for 17 h (Scheme 2.28). 1H NMR analysis of the 
crude reaction mixture indicated the successful synthesis of one or more esterified products. 
Thin layer chromatography (TLC) of the crude sample showed the presence of at least eight 
compounds, and separation on a chromatotron was attempted. However, since effective 
separation proved difficult and it was apparent that this method was not sufficiently selective, 
other methods of esterification were considered. 
 
The use of strong bases to deprotonate the alcohol, followed by reaction of the resulting 
alkoxide with an acid chloride, is a well established method for obtaining esters from 
alcohols.136 The base of choice is often NaH,124, 181,182 and this was consequently used in the 
present study. The diol 284 was added to a pre-washed suspension of NaH in anhydrous THF 
and the resulting mixture was boiled under reflux to generate a monoalkoxide. Acryloyl 
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chloride was then introduced and the mixture again boiled under reflux. The diol 284 was 
used as the limiting reagent, due primarily to its economic value but also as excess acrylic 
acid (produced by hydrolysis of the acid chloride during work-up) is more easily removed 
from the crude reaction mixture (by washing with aqueous NaHCO3) than excess auxiliary 
would have been.124 1H NMR analysis indicated the crude product to be significantly cleaner 
than the product obtained in the previous reaction with 4Å molecular sieves. Purification on a 
chromatotron gave four fractions, which were unambiguously characterised as 2-exo-3-exo-
bornanyl diacrylate 288, 2-exo-hydroxy-3-exo-bornanyl acrylate 285, 3-exo-hydroxy-2-exo-
bornanyl acrylate 287 (Scheme 2.29) and starting material 284.  
 
The reaction was repeated several times in attempts to increase the yields of the three new 
compounds 285, 287 and 288. However, it was noted that increasing the reflux period resulted 
in the formation of numerous side products and eventual generation of insoluble polymeric 
material. Polymerization of reactive α,β-unsaturated systems is catalyzed by traces of free 
acid, which are inevitably present during such reactions and which have been found to be the 
cause of low yields.136 The maximum yield obtained after five reactions were: 288; 2.3 %; 
285; 13.2 %; and 287; 15.3 %.  
 
Given the low yields obtained for the acrylate esters it was decided to abandon the use of NaH 
in favour of the stronger base BuLi.99 The addition of BuLi to the diol 284 was done over 20 
min at 0 ºC and was followed by the addition of acryloyl chloride also at 0 ºC. This mixture 
was stirred for 2 h and then warmed to room temperature overnight. 1H NMR spectroscopy 
was used to monitor the formation of products, and confirm that the reaction was complete. 
After purification of the crude mixture on the chromatotron, the pure esters 285, 287 and 288 
were obtained in moderate yield (overall < 50 %). Although the yield was lower than desired, 
it was significantly better than the best yield using NaH as base. Optimization studies resulted 
in the complete disappearance of starting material and an excellent overall yield of 93 % (285; 
34 %; 287; 47.8 %; 288; 10.8 %). 
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Scheme 2.29: Esterification of 284 producing monoesters 285 and 287 and diester 288. 
 
Unambiguous characterization of the esters 285, 287 and 288 was achieved using 1-D and  
2-D NMR spectroscopic (Figures 2.32 – 2.36) and HRCIMS data (Figures 2.37 and 2.38). 
The spectroscopic data indicated that compound 288 has the molecular formula C16H22O4 
(Found M+ 278.15199, calculated m/z 278.15181) and that compounds 285 and 287 both have 
the same molecular formula, C13H20O3 (Found M+ 224.14161, C13H20O3 requires m/z 
224.14124). The two latter compounds were found to be regioisomers differing only in the 
position of the ester and alcohol functional groups.  
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Both sets of 1H NMR data for the isomeric compounds 285 and 287 were remarkably similar 
(Figures 2.32 and 2.33). The COSY, HMQC and HMBC data were consistent with the 
expected monoesters but the relative positions of the acrylate and alcohol groups could not, 
initially, be deduced. Careful examination of the 1H NMR spectra was critical in the final 
characterisation of the compounds as 2-exo-hydroxy-3-exo-bornanyl acrylate 285 and 3-exo-
hydroxy-2-exo-bornanyl acrylate 287. NOESY experiments were also run in the hope that 
they would be of use in establishing the relative positions of the acrylate and alcohol groups 
but, in the event, they were of no assistance. 
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Figure 2.32: 400 MHz 1H NMR spectrum, with expansion, of the monoester 285 in 
purified§ CDCl3.  
 
The 2-H, 2-OH and 3-H signals of the monoester 285 (Figure 2.32) were instrumental in 
characterizing its structure. The primary aspects to be explored were the multiplicities and 
coupling constants; the 2-hydroxyl proton (1.84 ppm) resonates as a doublet and only couples 
(J ca. 5.2 Hz)‡ with the 2-H nucleus (3.81 ppm) which, in turn, resonates as a doublet of 
doublets due to further coupling (J ca. 6.8 Hz) with the 3-H nucleus (4.68 ppm, doublet).  
 
§ The reason for specifying purified chloroform, will be made clear in section 2.3.3.2  
 ‡ The value is approximate due to the labile nature of the hydroxylic proton, see section 2.3.3.2 
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Additionally, the 4-H nucleus (1.88 ppm) resonates as a doublet (J 4.9 Hz) due to coupling 
with the 5-exo-proton. The lack of vicinal coupling between the 4-H and the endo-3- and 
endo-5-proton is characteristic of the camphor derivatives examined in this research and 
clearly locates both the 3-H and 2-H nuclei on the endo-face of the molecule.  
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Figure 2.33:  400 MHz 1H NMR spectrum, with expansion, of the monoester 287 in purified 
CDCl3. 
 
Similar arguments can be used in the assignment of the 1H NMR signals for the monoester 
287 (Figure 2.33). The 3-OH proton (1.87 ppm) resonates as a doublet (J ca.  4.2 Hz), 
coupling with the 3-H nucleus (doublet of doublets at 4.02 ppm), which also couples (J ca. 
6.7 Hz) with the 2-H nucleus (doublet at 4.54 ppm). The 4-H nucleus resonates as a doublet at 
1.79 ppm due to coupling (J 4.8 Hz) to the 5-exo-proton. The crucial difference between the 
two compounds 285 and 287 is the position of their acrylate and alcohol groups relative to the 
10-methyl group. This group causes shielding of nuclei in close proximity (i.e. at C-2) and, 
thus, an upfield shift of their proton resonances. Conversely nuclei further away from the 10-
methyl group (i.e. at C-3) are somewhat deshielded and thus resonate further downfield. Thus, 
comparison of the relative chemical shifts for the 3-endo, 2-endo and 2-hydroxyl protons in 
monoester 285 with the 2-endo, 3-endo and 3-hydroxyl protons in monoester 287 confirms 
the indicated assignments. The HMBC spectrum of the monoester 285 confirmed the relative 
δ p m
δ ppm
287 
3-OHexo 
Discussion 
- 109 - 
positions of the acrylate and alcohol groups. Thus, the 2-endo proton, is seen to be close to C-
6 and the 3-endo proton, adjacent to the acrylate moiety, is seen to be close to C-5. The 
spectrum of 287, on the other hand, shows the reverse relationships: i.e. the 2-endo proton, 
adjacent to the acrylate moiety, is close to C-6, while the 3-endo proton is close to C-5. 
 
Examination of 1-D and 2-D NMR spectra, including HMQC, HMBC and COSY methods, 
confirmed the structure of the diester 288. Specifically, the 13C spectrum (Figure 2.34) 
indicates the presence of 16 carbon atoms, with two quaternary carbon signals at 47.5 and 
48.8 ppm (C-1 and C-7); three tertiary at 49.6 ppm (C-4), 77.1 ppm (C-2) and 79.8 ppm (C-
3); two secondary at 23.8 ppm (C-6) and 32.9 ppm (C-5), three primary at 10.9 ppm, 20.4 
ppm and 20.9 ppm (C-8, C-9 and C-10), and two pairs of acrylate sp2 carbon signals at 128.4 
ppm (C-2’), 128.5 ppm (C-2”), 130.47 ppm (C-3’), 130.54 ppm (C-3”) and two ester carbonyl 
signals at 164.89 ppm (C-1’) and 165.00 ppm (C-1”). Analysis of the corresponding 1H 
spectrum (Figure 2.35) showed: one methine (4-CH); two methylene (5- and 6-CH2); three 
methyl (8-, 9- and 10-Me); and two sets of acrylate resonances (C-1’, C-1”, C-2’, C-2”, C-3’ 
and C-3”) and, significantly no OH signal. Somewhat surprisingly, the singlet at 4.91 ppm, 
which integrates for two protons, must then be assigned to the 2- and 3-endo protons. These 
protons might well have been expected to resonate as doublets at different frequencies but, 
with the assistance of the HMQC spectrum (Figure 2.36), it was established that the observed 
singlet actually arises from the fortuitous coincidence of two signals corresponding to two 
protons attached to two different carbon nuclei. The absence of visible coupling between 
these nuclei is a result of their isochronous nature. 
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Figure 2.34: 100 MHz 13C NMR spectrum of the diester 288 in CDCl3. 
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Figure 2.35:  400 MHz 1H NMR spectrum, with expansion, of the diester 288 in purified 
CDCl3. 
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Figure 2.36: 400 MHz HMQC spectrum of the diester 288 in CDCl3. 
pp
m
 (t
2)
0.
50
1.
00
1.
50
2.
00
2.
50
3.
00
3.
50
4.
00
4.
50
5.
00
5.
50
6.
00
25 50 75 10
0
12
5
15
0
pp
m
 (t
1
C-8, C-9, C-10 C-5 C-6 
C-2 C-2’ 
C-2” 
C-3’ 
C-3” 
5
6 1
2
3
4
79
8
10
O 1'
2'
3'
O
O
1" 2"
O 3"
ARD 27
9-Me 
5-CH2 
6-CH2 
4-H 
2-H, 3-H 
2’-H 
2”-H 
3’-H 
3”-H 
C-1’ 
C-1” 
C-1 
C-7 
C-4 
C-3 
288 
δ 
pp
m
 
δ 
pp
m
 
Discussion 
- 112 - 
Confirmation of the molecular composition was provided by HRCI mass spectrum analysis 
(Figure 2.37) which revealed a molecular ion at m/z 278.15199 corresponding to the 
molecular formula C16H22O4 (calculated m/z 278.15181). The proposed fragmentation 
pathways are illustrated in Figure 2.38. Although fragmentation is described for the 3-
acrylate ester moiety, analogous fragmentation of the 2-acrylate ester group is likely. 
Elimination of an acyl radical from the molecular ion affords the even-electron species II, 
which undergoes elimination of an H atom to form the odd-electron fragment III (or its keto 
tautomer). Correspondingly, homolytic fission α to the carbonyl of the molecular ion I results 
in the acylium ion IX with elimination of a 13-carbon radical. Fission of the O-alkyl-ester 
linkage eliminates an acrylate radical and affords the 2º carbocation IV, which may undergo a 
1,2-hydride shift to give the resonance stabilized carbocation V. Elimination of an H atom 
from V then affords the odd electron species VI. Also shown in Figure 2.38 are the fragments 
VII and VIII, which are characteristic of bornane systems,156 together with structures IX and 
X, which have been tentatively assigned to the fragments responsible for peaks at m/z 152 and 
123, respectively.  
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Figure 2.37:  HRCI mass spectrum of the diester 288.  
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Figure 2.38:  Mass spectrometric pathways for the fragmentation of diacrylate ester 288. 
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Mono-acylation of the diol 284 was expected to occur mainly, if not exclusively, at C-3, the 
steric effects of the 10-methyl group typically disfavouring reaction at C-2. Thus while 
formation of the 2-acylated analogue 287 seemed to provide an additional substrate for 
exploring asymmetric Morita-Baylis-Hillman products, its isolation as the major product was, 
initially, very surprising. During the optimization studies, it was observed that prolonged 
exposure of purified monoester fractions to heat, or high vacuum drying resulted in 
polymerization, whereas impure samples appeared far less likely to undergo polymerization. 
Incidentally, it was also noticed that the pure monoesters 285 or 287 were isolated as oils, 
whereas a mixture of the two compounds crystallised!  
 
Polymerization of alkenes is known to occur by three mechanisms: radical, cationic and 
anionic.183 The presence of the electron-withdrawing, anion-stabilizing ester groups, as well 
as the presence during the acylation reaction of a strong base (NaH or BuLi) suggested that 
polymerization follows the anionic pathway to products such as 289. Consequently, 
hydroquinone was added as a polymerization inhibitor during the purification and storage of 
products. However, while the hydroquinone was found to minimize polymerization, removal 
of the black competitive oxidation products proved tedious, and it was found that, provided 
extreme care was taken to exclude heat, EtOAc (which was found to exacerbate 
polymerization) and prolonged drying, the polymerization was not a major problem. 
 
 
 
 
 
 
 
Purification of crude reaction mixtures was effected on a chromatotron plate. The resolution 
was generally good (Figure 2.39), but NMR analysis revealed that “purified” fractions of 
monoester 285 inevitably contained significant quantities of the isomer 287. This observation 
was paralleled in purified fractions of the monoester 287, which were shown to contain the 
isomer 285.   
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Figure 2.39:  Representation of the TLC analysis following chromatotron separation of the 
acylation products 288, 285 and 287 [hexane-EtOAc (7:3)].  
 
Initially, it was assumed that tailing or, perhaps, inadvertent errors were responsible for the 
contaminating ester in each case. However, 1H NMR analysis of a sample of purified 
monoester 285 in CDCl3 at 12 h intervals for 4 days revealed that the concentration of the 
monoester 285 decreased while the concentration of the isomer 287 increased until virtually 
equal amounts of the two isomers were present. It was thus concluded that transesterification 
was occurring between the isomeric esters 285 and 287 (Scheme 2.30)!  
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Scheme 2.30: Transesterification of monoesters 285 and 287. 
 
2.3.3 Kinetic Study of the Monoacrylate Ester Rearrangements. 
 
Transesterification, a well known equilibrium reaction, which the chemical and 
pharmaceutical industries use in the production of organic ester intermediates,184-186 is 
achieved most frequently by acid or base catalysis (Scheme 2.31),136,187 although it has been 
known to occur under neutral conditions.188 Acid catalysis involves protonation of the 
carbonyl oxygen, which results in a significantly more positive carbonyl carbon making it 
more susceptible to nucleophilic attack. Ester hydrolysis, and therefore transesterification, is 
also known to be catalyzed by metal ions.186 The detailed transesterification mechanism was 
investigated by means of NMR-based kinetic189-199 and quantum mechanical computational 
studies. 
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Scheme 2.31: Transesterification Reaction. 
 
Understanding the mechanism by which a reaction occurs involves, inter alia, knowledge of 
which bonds are broken, in what order, the number of steps involved and the relative rate of 
each step.136 Although no mechanism can be considered to be known completely and 
absolutely, it is possible to determine, with reasonable accuracy, much of the information 
about a reaction sequence. Kinetic studies allow insight into the mechanism by which 
chemical change occurs and reveal details of the interaction of the reactant molecules. The 
reaction mechanism is validated only where experimentally determined data correspond to 
theoretical treatments of the reaction kinetics. The rate law of a reaction is a mathematical 
expression that is unique to that reaction and describes the dependence of the rate of reaction 
on the concentration of reactants and defines the number of steps of the reaction.200 
 
In the present studies, preliminary investigations involved HPLC purification of a small 
quantity of each of the acrylates 285 and 287, followed by NMR analysis of solutions in 
CDCl3 over a period of time. The data so obtained showed that the acrylate esters were indeed 
undergoing transesterification and that complete equilibration was achieved after 
approximately five days.  
 
It was also noted that although HPLC separation of the two compounds was virtually 
absolute, the compound ratio changed to ca. 80:20 within the time taken to remove solvent 
and set up the NMR experiment (ca. 2 h). This led to the obvious conclusion that the time 
delay between purification and analysis would have to be minimized. It was found, however, 
that on lowering the temperature of the pure compounds, to -78 ºC (195 K), equilibration 
could be slowed to such an extent that the pure compounds could be stored for a number of 
days with only minimal change in composition. The only serious disadvantage of storing the 
pure compounds at reduced temperature became evident later, in that polymerization appeared 
to occur without warning. It has in fact been suggested that low temperature could be a 
contributing factor in initiating polymerization.201 Consequently the experimental 
290 291 292 293 
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methodology was fine-tuned to minimize equilibration prior to sample analysis, and initial 
compound ratios of ≥ 95:5 were generally achieved at the beginning of the NMR analysis. 
 
In order to obtain data that would permit elucidation of the mechanistic details, it was 
necessary to measure the rate at different temperatures and concentrations, with different 
solvents and in the presence or absence of a catalyst. Figure 2.40 illustrates the flow diagram 
of the steps taken to purify the compounds and obtain the necessary data. While representative 
calculations, data and graphs are presented throughout this section, full details are to be found 
in the Experimental Section 3.3 and Appendix II (CD) 
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Figure 2.40: Flow diagram of the processes involved in the synthesis, purification and, 
where relevant, acquisition of kinetic data for the transesterification of the 
acrylate esters 285 and 287. 
 
195 K 
285, 287 & 288 
285 & 287 288 
O
O
O
O
Unpurified 
CDCl3  
287 
OH
O
O
HPLC Purification 
Purified 
CDCl3 & 
N2 
Purified 
CDCl3 & 
O2 
DMSO  DMSO & 
H2SO4
DMSO & 
p-TsOH
285 
OH
O
O
 
Chromatotron Purification 
301-329 K 301-323 K 313-315 K  301-323 K 301 K  301-323 K 
284 
OH
OH
 
1H NMR-based kinetic studies 
Discussion 
- 119 - 
2.3.3.1 Reaction of Acrylate Esters in Unpurified CDCl3  
 
One of the first complete kinetic experiments was performed on the monoester 285 in 
unpurified CDCl3 at 323 K over a period of ca. 42 h, affording a total of 60 sequential 1H 
NMR data sets. Analogous kinetic experiments were conducted, in the same unpurified 
CDCl3, using samples of the pure isomeric ester 287, at temperatures ranging from 301 – 323 
K, to obtain data for the calculation of kinetic and thermodynamic properties. Experiments in 
which CDCl3 was used as solvent were conducted at temperatures which did not exceed 323 
K as the solvent boils at 334 K. Figure 2.41 illustrates the 1H NMR spectrum of an 
equilibrium mixture of 285 and 287. 
 
 
ppm (f1) 1.001.502.002.503.003.504.004.505.005.506.006.507.00
ppm (f1) 4.004.254.504.75
 
 
Figure 2.41: 1H NMR spectrum at equilibrium, with expansion to show relevant peaks used 
to calculate the integral ratios of 285 and 287 (323 K; 400 MHz; unpurified 
CDCl3). 
 
The 2-H and 3-H signals of both compounds are well resolved and, in most instances, 
sufficiently distant from other signals, such that they proved to be excellent probes to monitor 
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the transesterification. The sum of the integral values of these two signals, in each compound, 
was used in all kinetic experiments, unless otherwise stated, for the determination of the ratios 
of the acrylates 285 and 287.  
 
The full 1H NMR data sets obtained for each experiment were analyzed, using a specially 
developed automated programme202 to process the F.I.D. data and to integrate the selected 
signals. A representative selection of the 1H NMR data, for the equilibration from pure 285 at 
323 K, is reproduced as a stack-plot in Figure 2.42. For the sake of clarity and due to the 
importance of these specific signals, only the 2-H and 3-H signals are shown. Although the 
data is perhaps not the most aesthetically pleasing of all the experiments completed, i.e. 
having only 90.4 % pure staring material, 285, it was selected as the majority of the data was 
obtained in one unbroken kinetic run, only final equilibrium values being determined after 
several days. This was possible as the rate was the greatest of all the reactions examined, 
having been conducted at elevated temperature (323 K).  
 
  
 
 
Figure 2.42: Stack-plot of partial 400 MHz 1H NMR spectra recorded over 42 h, showing 
equilibration commencing with 285 at 323 K in unpurified CDCl3. 
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The integral ratios were then plotted against time to illustrate graphically the change in 
relative concentration of the two acrylate esters (Figure 2.43). 
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Figure 2.43: Plot of the integral ratios of the 2-H and 3-H signals of the corresponding 
acrylate esters 285 and 287 at 323 K in unpurified CDCl3. 
 
The graph demonstrates a smooth decline in the concentration of 285 and a correspondingly 
smooth increase in concentration of 287 to a point where there is no significant observable 
change in the relative concentrations of the isomeric esters. Additional data were obtained to 
determine the exact concentration ratios at equilibrium. This was achieved by placing the 
NMR tube, containing the reaction mixture, in a constant temperature water bath, at 323 K, 
immediately on termination of the kinetic run; 1H NMR spectra were then recorded at regular 
intervals over a period of fourteen days. Once the integral ratio for the selected signals was 
relatively constant for a sustained time period (ca. 12h), equilibrium was deemed to have been 
established, and the equilibrium ratio was used to calculate the equilibrium constant K, as 
described below. The experimental data were found to fit a first-order reversible kinetic 
model, 199,200,203,204 in which the forward and reverse reactions occur simultaneously. The rate 
of the reaction will change with time as it is proportional to the reactant concentration which 
decreases with time. The initial rate, which corresponds to the highest ratio of reactant to 
product, approximates to the rate of the forward reaction alone. However, in view of the great 
difficulty in obtaining ca. 95 % pure starting material (and the virtual impossibility of 
obtaining > 99 % pure material), the method of initial rates was not considered to be a 
satisfactory option. 
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The monoester 287 was arbitrarily defined as the starting material, as most of the reactions 
initially involved use of 287 as a starting compound; however, as the species are in dynamic 
equilibrium, either acrylate could have been defined as such. Assuming the intermediacy of a 
transient tricyclic species 294, the overall process can be summarized as indicated in Scheme 
2.32.  
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Scheme 2.32: Transesterification of monoesters 285 and 287. 
 
Since there was no experimental evidence for the presence of the intermediate 294, it was 
assumed that, if involved at all, its existence was transient, i.e. once formed it would 
transform rapidly to 285 or 287. Thus, while the formation of the intermediate 294 might be 
rate determining in the forward reaction (k1 << k2) and the reverse reaction (k3 << k4), its 
contribution to the rate equation can be ignored. Such assumptions are common in similar 
cases.136 The reversible first order reaction can thus be represented by: 
  
ARD 30 ARD 29
k+1
k-1  
 
Where k+1 and k-1 are the rate constants for the forward and reverse reactions respectively, and 
the overall rate coefficient is the sum of the rate constants for the opposing reactions.  
The rate of disappearance of 287 thus equals the rate of formation of 285 (Equation 2.1), 
while the equilibrium constant (K) is the quotient of the rate constants for the forward and 
reverse reactions (Equation 2.2). Algebraic combination of these equations, followed by 
integration affords the integrated rate equation for a reversible first order reaction (Equation 
2.3), where [287]o is initial concentration of 287 and [287]eqm is the equilibrium 
concentration. This equation can then be expressed in the form, “y = mx + c” (i.e. the 
equation for a straight line; Equation 2.4). This useful relationship permits the plotting of 
287 294 285 
285 287 
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graphs of ln ([287] – [287]eqm) versus t to give a straight line of slope – (k+1 + k-1). Equations 
2.5 and 2.6 can then be used to determine the individual rate constants. 
 
 
–  
td
]287[ d    =   
td
]852[ d    =   k+1 [287] – k-1 [285]  (2.1) 
 
K   =   
eqm
eqm
]287[
]285[
   =   
1-
1
k
k+     (2.2) 
 
eqmo
eqm
]287[]287[
]287[]287[
ln −
−
   =   – (k+1 + k-1)t   (2.3) 
 
ln ( eqm]287[]287[ − )  =  – (k+1 + k-1)t + ln ( eqmo ]287[]287[ − )   (2.4) 
 
1+k    =   ( )]285/[]287[1
k  - k 1-1
+
+     (2.5) 
 
1−k    =   1+k ⎟⎟⎠
⎞⎜⎜⎝
⎛
]285[
]287[      (2.6) 
 
Of course, the same holds true for data in which 285 is the starting compound and the 
resulting graph for the equilibration of 285 at 323 K is shown in Figure 2.44. Following 
established methodology described by March136 and Jordan,199 as outlined above, the 
calculation of kinetic and thermodynamic data was undertaken. 
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Figure 2.44: Plot of ln ([285]-[285]eqm) against time for the equilibration of acrylate esters 
285 and 287 at 323 K in unpurified CDCl3. 
 
The linear relationship (r2 = 0.9998) clearly confirms the operation of a first order reversible 
reaction. Regression analysis of the data afforded the slope (- 4.91 × 10-5) and, hence from 
Equation 2.4, the sum of the forward and reverse rate constants, i.e.   
 
 
 
Application of Equations 2.5 and 2.6 permitted the determination of values for k+1 and k-1.  
 
 
 
 
 
Due to the nature of an equilibrium reaction, the respective rate constants (k+1 and k-1) 
obtained from data using either starting material should be the same. To demonstrate this, the 
kinetic study at 323 K was repeated using pure 287 instead of 285 (Table 2.4). The data 
varied by < 1 % from the mean of the experimentally determined values of k+1 and of k-1 
confirming the validity of subsequent comparisons. 
 
 
k+1 + k-1 =  4.91 (± 0.07) × 10-5
1+k    =   2.58 (± 0.08) × 10
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Table 2.4: Summary and comparison of kinetic data for the equilibration of the acrylate 
esters 285 and 287 in unpurified CDCl3 at 323 K.  
 
Expt. Starting 
Compound 
T/K [287]eqm [285]eqm k+1/k-1 k+1+k-1
(s-1) 
k-1 
(s-1) 
k+1
(s-1) 
A8 287 323 0.47 0.53 1.11 
(± 0.01) 
5.00 (± 0.08) 
× 10-5 
2.37 (± 0.02) 
× 10-5 
2.63 (± 0.04) 
× 10-5 
A9 
 
285 
 
323 
 
0.47 
 
0.53 
 
0.90  
(± 0.01) 
4.91 (± 0.08) 
× 10-5 
2.33 (± 0.05) 
× 10-5 
2.58 (± 0.08) 
× 10-5 
 
Information about the energetics of a reaction requires that the temperature dependence of the 
rate constant be determined.199 Consequently, starting with “pure” 287, the same general 
approach was followed to obtain kinetic data for the equilibration at different temperatures. 
The data obtained at 8 different temperatures, in the range, 301 – 323 K, are summarized in 
Table 2.5. Once kinetic experiments had been completed on several samples of 287, 
determination of the activation energy (Ea) of the equilibrium reaction was possible by 
applying the Arrhenius equation (Equation 2.7) or its logarithmic form (Equation 2.8). The 
activation energy of a reaction is the energy in excess of that possessed by ground state 
molecules that is required for the reaction to proceed and is independent of temperature. 
 
k   =   Ae RT
Ea
     (2.7) 
 
ln k   =   
RT
Ea−  + ln A    (2.8) 
 
In the equations, A is the frequency factor (a constant for a given reaction which relates to the 
relative orientation of the reactants and the rate of interaction of the reactive centres), R is the 
gas constant (8.314 × 10-3 kJ-1mol-1) and T is the temperature (K). This relationship was used 
to plot graphs of ln k+1 and ln k-1 versus 1/T, and the gradient Ea was obtained by linear 
regression analysis. A summary of the data for reactions using the monoester 287 is presented 
in Table 2.5 and graphically illustrated for the forward and reverse reactions in Figures 2.45 
and 2.46, respectively; the complete data sets can be found in the experimental (Section 3.3.2) 
and Appendix II (CD).  
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Table 2.5: Summary of the kinetic data for equilibration of the acrylate esters 285 and 
287, in unpurified CDCl3 from pure 287 at different temperatures. 
 
Expt. T 
(K) 
[287]eqm [285]eqm k+1/k-1 k+1+k-1
(s-1) 
k-1
(s-1) 
k+1
(s-1) 
lnk-1 lnk+1 1/T
(K-1) 
A1 301 0.47 0.53 1.15 
(± 0.01) 
5.68 (± 0.03)
× 10-6 
2.64 (± 0.02)
× 10-6 
3.04 (± 0.05)
× 10-6 
-12.8 
(± 0.1) 
-12.7 
(± 0.2) 
3.32 (± 0.01)
× 10-3 
A2 307 0.48 0.52 1.08 
(± 0.01) 
9.96 (± 0.02)
× 10-6 
4.80 (± 0.04) 
× 10-6 
5.16 (± 0.08)
× 10-6 
-12.2 
(± 0.1) 
-12.2 
(± 0.2) 
3.26 (± 0.01)
× 10-3 
A3 313 0.49 0.51 1.04 
(± 0.01) 
1.41 (± 0.01)
× 10-5 
6.92 (± 0.06)
× 10-6 
7.18 (± 0.10)
× 10-6 
-11.9 
(± 0.1) 
-11.8 
(± 0.2) 
3.19 (± 0.01)
× 10-3 
A4 315 0.48 0.52 1.08 
(± 0.01) 
2.27 (± 0.01)
× 10-5 
1.09 (± 0.01)
× 10-5 
1.18 (± 0.02)
× 10-5 
-11.4 
(± 0.1) 
-11.3 
(± 0.2) 
3.17 (± 0.01)
× 10-3 
A5 317 0.47 0.53 1.11 
(± 0.01) 
2.18 (± 0.01)
× 10-5 
1.03 (± 0.01)
× 10-5 
1.15 (± 0.02)
× 10-5 
-11.5 
(± 0.1) 
-11.4 
(± 0.2) 
3.15 (± 0.01)
× 10-3 
A6 319 0.49 0.51 1.05 
(± 0.01) 
3.75 (± 0.02)
× 10-5 
1.83 (± 0.01)
× 10-5 
1.92 (± 0.03)
× 10-5 
-10.9 
(± 0.1) 
-10.9 
(± 0.2) 
3.13 (± 0.01)
× 10-3 
A7 321 0.48 0.52 1.09 
(± 0.01) 
2.72 (± 0.01)
× 10-5 
1.30 (± 0.01)
× 10-5 
1.42 (± 0.01)
× 10-5 
-11.3 
(± 0.1) 
-11.2 
(± 0.1) 
3.12 (± 0.01)
× 10-3 
A8 323 0.47 0.53 1.11 
(± 0.01) 
5.00 (± 0.08)
× 10-5 
2.37 (± 0.02)
× 10-5 
2.63 (± 0.04)
× 10-5 
-10.6 
(± 0.1) 
-10.5 
(± 0.2) 
3.10 (± 0.01)
× 10-3 
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Figure 2.45: Plot of ln k+1 against 1/T for the forward reaction of the acrylate ester 287 in 
unpurified CDCl3. 
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Regression analysis of the data (Table 2.5; Figure 2.45) for the forward reaction gave: 
 
   Ea287 /R     =   9269 (± 868) K 
∴ 
y = -9361.5x + 18.209
R2 = 0.9458
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Figure 2.46: Plot of ln k-1 against 1/T for the reverse reaction of the acrylate ester 287 in 
unpurified CDCl3. 
 
Similar treatment of the data (Table 2.5; Figure 2.46) for the reverse reaction, gave: 
 
   Ea285 /R     =   9361 (± 847) K 
∴ 
 
The enthalpy (∆H‡), entropy (∆S‡) and Gibbs free energy (∆G‡) of activation for the formation 
of the activated (or transition state) complex in the forward and reverse reactions at 298 K 
were calculated using Equations 2.9 – 2.12 and the results are summarized in Tables 2.6 and 
2.7:  
  Ea    =   ∆H‡ + RT    (2.9) 
  ∆H‡   =   Ea – RT    (2.10) 
15.19
‡SΔ    =   log k – 10.753 – log T + 
T
E
19.15
a    (2.11) 
∆G‡ =   ∆H‡ - T∆S‡       (2.12) 
Ea287     =   77 (± 7) kJmol-1
Ea285     =   78 (± 7) kJmol-1
  Unpurified CDCl3  
Ln
k -
1 
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Table 2.6: Summary of kinetic and thermodynamic data for the activated complex of the 
reverse reaction, in unpurified CDCl3, (298 K, 1 atm). 
 
-Ea285/R 
(K) 
Ea285 
(kJmol-1) 
∆H‡285  
(kJ) 
k-1  
(s-1) 
∆S‡285 
(Jmol-1) 
∆G‡285 
(kJmol-1) 
-9361 (± 847) 78 (± 7) 76 (± 7) 1.84 (± 0.11) × 10-6 -363 (± 12.1) 183 (± 23) 
 
 
Table 2.7: Summary of kinetic and thermodynamic data for the activated complex of the 
forward reaction, in unpurified CDCl3, (298 K, 1 atm). 
 
-Ea287/R 
(K) 
Ea287 
(kJmol-1) 
∆H‡287 
(kJ) 
k+1 
(s-1) 
∆S‡287 
(Jmol-1) 
∆G‡287 
(kJmol-1) 
-9269 (± 963) 77 (± 7) 75 (± 7) 2.04 (± 0.12) × 10-6 -362 (± 12) 182 (± 23) 
 
The results are consistent with first order reversible kinetics for which:  
 
rate =     k+1[287] =    k-1[285] 
 
At all temperatures, the rate of the forward reaction is slightly faster than the rate of the 
reverse reaction – a result consistent with the observed equilibrium concentrations and, hence, 
for values of the chemical equilibrium constant K. The large negative entropy changes for the 
formation of the activated complex (∆S‡287: -362 Jmol-1; ∆S‡285: -363 Jmol-1) imply a decrease 
in entropy and, thus, an increase in order consistent with the formation of the transient cyclic 
intermediate 294 (Scheme 2.32). The activation energies for the forward and reverse reactions 
are very similar (Ea287, 77 kJmol-1, Ea285, 78 kJmol-1). 
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2.3.3.2 Reaction of the Acrylate Esters in Purified CDCl3 under N2 
 
During the course of the foregoing experiments, it became apparent that DCl or HCl present 
in the CDCl3 solution was probably responsible for catalyzing the reaction. Acidic impurities 
are known to develop on exposure of CDCl3 to atmospheric conditions, such as air, light and 
water vapour.171 The possible role of an acid catalyst in the transesterification reactions was 
then investigated and a pathway was envisaged for the interconversion of the acrylate esters 
285 and 287 (Scheme 2.33).136,205,206 Initially, the carbonyl oxygen of 285 is protonated by 
the acid catalyst giving 285-H. This is followed by intramolecular attack at the electron-
deficient carbonyl carbon affording intermediate 294-H2. Proton loss results in the cyclized 
intermediate 294 which then gains a proton affording 294-H1. Cleavage of the cyclic 
intermediate 294-H1 followed by deprotonation then affords the isomeric product 287.  
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Scheme 2.33: Proposed acid-catalyzed transesterification of the acrylate esters 285 and 287. 
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The possible involvement of diastereomeric cyclic intermediates 294 and 295 (in which the 
hydroxyl and vinyl groups are interchanged) was considered in the subsequent theoretical 
study (Section 2.3.2.3). 
 
 
 
 
 
A preliminary study was conducted on a sample of the monoester 285, in which the CDCl3 
had been purified by passing it through activated alumina and crushed 4 Å molecular sieves to 
remove practically all traces of HCl and H2O.171 A solution of the sample in the purified 
CDCl3 was prepared immediately and placed in a dry NMR tube under dry N2. The 
differences in the resulting 1H NMR spectrum, as compared to that of the acrylate ester in 
unpurified CDCl3, were immediately apparent. The most significant signal changes for 
acrylate 285 are shown in Figure 2.47 and summarized in Table 2.8. A similar procedure was 
employed using the isomeric ester 287 and the corresponding 1H NMR spectra are shown in 
Figure 2.48 and the data summarized in Table 2.9. 
 
In the purified CDCl3 additional coupling interactions became apparent in the 1H NMR 
spectra of both monoesters. The hydroxylic and vicinal proton signals are slightly broadened 
due to an intermediate rate of exchange of the hydroxylic protons with free protons in the 
medium; the associated coupling constants are consequently somewhat inaccurate (Tables 2.8 
and 2.9). Since the “purified” CDCl3 was not completely free of acid impurities, exchange of 
the labile proton was still possible, although at a slower rate. The assumption throughout 
subsequent experiments was that slow exchange of labile protons is characterised by sharp 
hydroxylic signals and, conversely, that broad signals indicate the presence of free acid and 
the consequent rapid exchange of labile protons.171 The purification of CDCl3 could thus be 
monitored and experiments were terminated or results disregarded if the line-shape of signals 
in the primary spectra was found to be significantly broadened. Slight modifications were 
made to improve the purification of the CDCl3. Small quantities were purified under a stream 
of N2 by passage through neutral alumina and crushed 4Å molecular sieves in a dry Pasteur 
pipette directly into the NMR tubes, which had been pre-filled with N2. The modifications 
may seem minor, but excluding contact of the purified CDCl3 with air resulted in far superior 
NMR spectra and the minimization of acid catalysis.  
O
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(a)  ppm (t1) 3.754.004.254.50    ppm (t1) 1.801.902.002.10  
 
(b) ppm (t1) 3.754.004.254.50   ppm (t1) 1.801.902.002.10  
 
Figure 2.47: Comparison of selected signals in the 400 MHz 1H NMR spectra of the 
monoester 285 at 301K in (a) unpurified CDCl3 and (b) purified CDCl3. 
 
 
Table 2.8: Comparison of 400 MHz 1H NMR data for the monoester 285 at 301 K in 
unpurified and purified CDCl3. 
 
285 Unpurified CDCl3 Purified CDCl3 
Proton assignment 2-OH 2-Hendo 3-Hendo 2-OH 2-Hendo 3-Hendo 
Chemical shift, δH (ppm) 2.16 3.76 4.64 1.84 3.81 4.68 
Multiplicity br s d d d dda d 
Coupling Constants, J (Hz) --- 6.8 6.8 5.0‡ 5.2b; 6.2b 6.8 
a Incompletely resolved. 
b Values for coupling constants are approximate due to the lability of the hydroxide proton. 
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(a) ppm (t1) 3.754.004.254.50   ppm (f1) 1.801.902.002.10  
 
(b) ppm (t1) 3.754.004.254.50   ppm (t1) 1.801.902.002.10  
 
Figure 2.48:  Comparison of selected signals in the 400 MHz 1H NMR spectra of the 
monoester 287 at 301 K in (a) unpurified and (b) purified CDCl3. 
 
 
 
Table 2.9:  Comparison of 400 MHz 1H NMR data of the monoester 287 at 301 K in 
unpurified and purified CDCl3. 
 
287 Unpurified CDCl3 Purified CDCl3 
Proton assignment 3-OH 3-Hendo 2-Hendo 3-OH 3-Hendo 2-Hendo 
Chemical shift, δH (ppm) 1.88 4.02 4.58 1.87 4.02 4.54 
Multiplicity br s d d d dda d 
Coupling Constants, J (Hz) --- 6.7 6.7 4.1‡ 3.7b; 6.2b 6.7  
a Incompletely resolved 
b Values for coupling constants are approximate due to the lability of the hydroxide proton.  
2-Hendo  
2-Hendo 
3-Hendo 
3-Hendo 
4-H 
4-H 
3-OHexo 
3-OHexo 
δ ppm
δ pm 4.50                        4.25                        4.00                       3.75                       2.20                 2.00                 1.80 
4.50                        4.25                        4.00                       3.75                       2.20                 2.00                 1.80                              .                         .                        .                         .                 .                  .  
    .                          .                         .                        .                         .                  .                  .  
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A study was then conducted to determine the stability of the purified CDCl3 under N2. The 
first part to the study related to the stability of the CDCl3 in a sealed NMR tube over a period 
of 72 h at 301 K. A sample of the monoester 287 was then added and the 1H spectrum was 
immediately recorded. The CDCl3 was found to have remained relatively pure, as the line-
shape of the hydroxylic proton was as sharp as or better than similar samples described 
previously. The second part of the study was to determine the stability of CDCl3 at elevated 
temperature. Purified CDCl3 was added to a sample of 287 in an NMR tube under N2. A 1H 
NMR spectrum of the acrylate ester was immediately recorded at 305 K; the temperature was 
then raised in increments of 2 K and, following optimization of the shimming at each 
temperature, a further spectrum was obtained. This proceeded to a maximum temperature of 
323 K over a period of 30 min. The sample was then allowed to cool to 301 K and a final 
spectrum was recorded. The resulting spectra are illustrated in Figures 2.49 and 2.50. 
 
 
 
 
Figure 2.49: Partial 400 MHz 1H NMR spectra showing the change in the 3-Hendo signal (δ 
4.02 ppm) relative to the 2-Hendo (δ 4.53 ppm) signal of the acrylate ester 287 
on warming (305 – 323 K; over 30 min) in purified CDCl3. 
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Figure 2.50: Partial 400 MHz 1H NMR spectra showing coalescence and migration of the 
3-OH signal (4.53 ppm) relative to the 4-H signal (1.79 ppm) of the acrylate 
ester 287 on warming (305 – 323 K; over 30 min) in purified CDCl3.  
 
Thus on warming the solution of the acrylate ester 287 in purified CDCl3, the corresponding 
1H NMR spectra showed coalescence of the 3-H and 3-OH signals and a significant upfield 
shift of the 3-OH signal, the latter effect presumably indicating a reduction in intramolecular 
hydrogen bonding interactions at the higher temperatures. The concern was that, on warming, 
HCl would be generated, but on cooling the spectrum returned to its former sharp line-shape 
implying that HCl was not being generated to any great extent and that heating the solution 
was unlikely to induce acid catalysis. 
 
In order to observe the effect of the acid catalysis and to obtain data for the transesterification 
under “neutral” conditions, the equilibration of 285 and 287 was repeated in “purified” CDCl3 
under N2 at a range of temperatures (301 – 315 K). The treatment of the data was identical to 
that for the reactions in unpurified CDCl3, and the results are presented in Tables 2.10 and 
2.11. The Arrhenius plot to determine Ea is illustrated in Figure 2.51. 
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Figure 2.51: Plot of the Arrhenius relationship for the forward reaction of the monoester 
287 in purified CDCl3. 
 
 
Table 2.10: Summary of kinetic and thermodynamic data for the reverse reaction from the 
monoester 285, in purified CDCl3, (298 K, 1 atm). 
 
-Ea285/R 
(K) 
Ea285 
(kJmol-1) 
∆H‡285  
(kJ) 
k-1  
(s-1) 
∆S‡285 
(Jmol-1) 
∆G‡285 
(kJmol-1) 
- 23089 (± 5430) 192 (±45) 189 (± 45) 7.2 × 10-8 (± 0.4 × 10-8) -389 (± 70) 306 (± 127) 
 
 
Table 2.11: Summary of kinetic and thermodynamic data for the forward reaction from the 
monoester 287, in purified CDCl3, (298 K, 1 atm). 
 
-Ea287/R 
(K) 
Ea287 
(kJmol-1) 
∆H‡287 
(kJ) 
k+1 
(s-1) 
∆S‡287 
(Jmol-1) 
∆G‡287 
(kJmol-1) 
- 23191 (± 5555) 193 (± 46) 190 (± 46) 8.0 × 10-8 (± 0.4 × 10-8) -389 (± 72) 306 (± 130) 
 
The values obtained for the rates of the forward and reverse reactions proved interesting. The 
forward rate constant, k+1 (8.0 × 10-8 s-1), was again ca. 10 % greater than the rate constant for 
the reverse reaction, k-1 (7.2 × 10-8 s-1). However, the rates of equilibration in unpurified 
CDCl3, k+1 (2.04 × 10-6 s-1) and k-1 (1.84 × 10-6 s-1) are of the order of 25 times greater than 
those in purified CDCl3. While fewer points and greater scatter (R2 = 0.8971) in the Arrhenius 
     287 
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plot (Figure 2.51) mean increased uncertainty in the absolute values of the kinetic parameters, 
the overall patterns are clearly discernable. Thus, the activation energies [Ea285 (192 kJmol-1) 
and Ea287 (193 kJmol-1)] were basically the same for both compounds 285 and 287 and were 
significantly higher than for equilibration in unpurified CDCl3 [Ea285 (78 kJmol-1) and Ea287 
(77 kJmol-1)]. The enthalpies of activation in purified CDCl3 [∆H‡285 (189 kJ) and ∆H‡287 (190 
kJ)] were also significantly greater than for the reaction in unpurified CDCl3 [∆H‡285 (76 kJ) 
and ∆H‡287 (75 kJ)] – a pattern repeated for the calculated free energies of activation [∆G‡285 
(306 kJmol-1) and ∆G‡287 (306 kJmol-1)] compared to those in unpurified CDCl3 [∆G‡285 (184 
kJmol-1) and ∆G‡287 (183 kJmol-1)]. The observed increases in Ea, ∆H‡ and ∆G‡ clearly reflect 
the absence of acid catalysis in the reaction conducted in purified CDCl3. Interestingly, the 
entropies of activation for both sets of reactions are comparable [∆S‡285 (-389 Jmol-1) and 
∆S‡287 (-389 Jmol-1)] compared to [∆S‡285 (-363 Jmol-1) and ∆S‡287 (-362 Jmol-1)] in unpurified 
CDCl3. This suggests that even in the absence of the acid catalyst, the activated complex for 
the transesterification possesses a similar degree of order. 
 
These results show conclusively that the acidic impurity in unpurified CDCl3 is responsible 
for catalyzing the reaction and increasing the rate of the reaction 25 fold, since the protonated 
species is far more likely to undergo intramolecular nucleophilic addition than the neutral 
substrate. 
 
 
2.3.3.3 Reaction of Acrylate Esters in Purified CDCl3 in Air 
 
Several similar experiments were then performed between 313 and 323 K, using purified 
CDCl3 in air to test the validity of running the experiments in purified CDCl3 under N2. 
Initially the reactions proceeded slowly, with rates similar to those observed using purified 
CDCl3 under N2. The rates then gradually increased over time (e.g. see Figures 2.52 and 
2.53), becoming comparable to those in the reactions in unpurified CDCl3, the general trend 
being the higher the temperature, the sooner the increase in the rate. The obvious conclusion 
is that catalytic, acidic impurities were being generated over time due to the degeneration of 
CDCl3 in air, the higher the temperature the faster the generation of the acid. At higher 
temperatures (321 and 323 K; see experimental section), further rate acceleration was 
observed in the later stages of the reaction. 
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Figure 2.52: The ratio of the sum of the 2-H and the 3-H integrals of the acrylate esters 285 
and 287 at 313 K in purified CDCl3 in air. 
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Figure 2.53: The logarithmic function of the integral ratio of the acrylate ester 285 at 313 K 
in purified CDCl3 in air. 
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2.3.3.4 Reaction of Acrylate Esters in Purified DMSO-d6  
 
In further consideration of the effect of the solvent on the transesterification, it was decided to 
explore the use of DMSO-d6. This was expected to obviate the acidic complications observed 
with CDCl3.183  
 
The DMSO-d6 was purified by passage through neutral alumina and crushed 4 Å molecular 
sieves (to remove the H2O invariably present) directly into a dry NMR tube containing the 
acrylate ester (285 or 287) which was then flushed with nitrogen. The methodology as 
described previously was followed and reactions were conducted at various temperatures in 
the range 301 – 329 K. Not surprisingly, chemical shifts for the compounds 285 and 287 in 
DMSO-d6 were observed at somewhat different values from those in CDCl3 (Table 2.12). In 
fact the 2-H, 3-H and 3-OH signals are all shifted downfield. Furthermore, the 2- and 3-H 
signals for the equilibrating esters are well resolved (Figures 2.54 and 2.55), permitting the 
course of the reaction to be readily monitored through comparison of the integrals of these 
signals (Figure 2.56) and, thus, the rate of reaction as well (Figure 2.57). The protons 
geminal to hydroxyl groups resonate as doublets of doublets in the DMSO-d6 spectra of the 
two compounds, reflecting coupling in each case with the proton on the adjacent carbon as 
well as the hydroxyl proton. 
 
Table 2.12: 400 MHz 1H NMR data of the isomeric acrylate esters 285 and 287 in DMSO-
d6 at 301 K. 
 
 285 287 
Proton assignment 2-Hendo 3-Hendo 2-OH 3-Hendo 2-Hendo 3-OH 
Chemical shift, δH (ppm) 3.59 4.65 4.97 3.79 4.53 4.87 
Multiplicity dd d  d dd d  d  
Coupling Constants,a J (Hz) 2.2; 6.4 6.8   6.0  5.1; 6.6 6.7   5.0  
a Values are approximate.  
 
The rate of equilibration was markedly slower than any of the previous experiments. In fact, 
no noticeable change was observed at lower temperatures; at 315 K the integral ratio change 
was less than 1 % over 12 h and less than 5 % over 11 h at 329 K. Consequentially, 
equilibrium was not achieved in any of the experiments over a three week period, precluding 
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estimation of the equilibrium integral ratios and, hence, calculation of reaction rates. It was 
observed that the samples, although stored under dry nitrogen in sealed NMR tubes, 
developed signals characteristic of H2O over the three week period. This is attributed to the 
highly hygroscopic property of DMSO and imperfect sealing of the NMR tubes. 
 
The slowness of equilibration in pure DMSO-d6 is attributed to the absence of the acid 
impurities needed to catalyze the reaction and, possibly, solvation and hydrogen-bonding 
stabilization of the substrate.171  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.54: Partial 400 MHz 1H NMR spectrum of the monoester 285 (301 K, purified 
DMSO-d6).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.55: Partial 400 MHz 1H NMR spectrum of the monoester 287 (301 K, purified 
DMSO-d6). 
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Figure 2.56: The ratio of the sum of the 2-H and the 3-H integrals for the acrylate esters 
285 and 287 at 329 K in purified DMSO-d6. 
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Figure 2.57: The logarithmic function of the integral ratio of the acrylate ester 285 at 329 K 
in purified DMSO-d6. 
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2.3.3.5 Reaction of Acrylate Esters in Purified DMSO-d6 in the presence of H2SO4  
 
Finally, based on the assumption that the transesterification is subject to acid catalysis, a 
preliminary reaction was carried out in DMSO-d6 in the presence of a catalytic amount of 
concentrated H2SO4 (in place of the HCl/ DCl present in CDCl3). The 1H NMR spectrum of 
the mixture, at the beginning of a reaction, is shown in Figure 2.58.  
ppm (t1) 0.501.001.502.002.503.003.504.004.505.005.506.006.50
ppm (t1) 3.253.503.754.004.254.504.75
 
 
Figure 2.58:  Initial 400 MHz 1H NMR spectrum, at 301 K, for the acrylate ester 285 in the 
presence of H2SO4 in purified DMSO-d6. 
 
The introduction of H2SO4 causes the discrete hydroxylic proton signal to disappear, while a 
new, broad signal appears under the 3-H signal. The resulting overlap made it impossible to 
use the 3-H integral in the calculation of the integral ratios; instead integrals for the 2-H signal 
of 285 and the 3-H signal of 287 were used to calculate the integral ratios. The forward and 
reverse rates [k+1 = 3.6 × 10-6 s-1 and k-1 = 3.1 × 10-6 s-1; Table 2.13] for the reaction of the 
acrylate ester 285 at 301 K are approximately 15 % faster than results obtained at the same 
temperature in unpurified CDCl3 [k+1 = 3.04 × 10-6 s-1 and k-1 = 2.64 × 10-6 s-1; Table 2.5, p. 
126]. Clearly the H2SO4 accelerates the reaction and confirms that protonation is critical in the 
transesterification process. However, further investigations with concentrated H2SO4 were not 
attempted as significant degradation of the organic material was apparent.  
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Table 2.13: Rates of the equilibration of the acrylate esters 285 and 287, in purified 
DMSO-d6 in the presence of H2SO4 at 301 K. 
 
k+1 (s-1) k-1 (s-1) 
3.6 (± 0.3) × 10-6  3.1 (± 0.3) × 10-6  
 
 
2.3.3.6 Reaction of Acrylate Esters in Purified DMSO-d6 in the presence of p-TsOH  
 
An alternate acid catalyst to H2SO4 was consequently explored, viz., para-toluenesulfonic 
acid (p-TsOH), as it is a milder acid than H2SO4, a solid (and thus easier to work with) and 
soluble in organic solvents. The p-TsOH was added to the sample in the NMR tube 
immediately after introduction of the purified DMSO-d6, and data acquisition was then 
commenced. The kinetic experiments were repeated at temperatures ranging from 302 – 323 
K, and the initial 1H NMR spectrum for the reaction at 301 K is presented in Figure 2.59. 
 
 
ppm (t1) 0.501.001.502.002.503.003.504.004.505.005.506.006.50
ppm (t1) 3.253.503.754.004.254.504.75
 
 
Figure 2.59:  Partial initial 400 MHz 1H NMR spectrum, at 301 K, of the acrylate ester 285 
in the presence of p-TsOH in purified DMSO-d6. 
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Due to the overlap of a broad residual H2O signal (from new commercially supplied p-TsOH 
and/or the highly hygroscopic DMSO-d6) with the 2-H signal of 285, the integral ratios, for 
all experiments, had to be calculated using the 3-H (for 285) and the 2-H (for 287) signals. 
Kinetic and thermodynamic parameters were calculated using data collected at different 
temperatures and are presented in Tables 2.14 and 2.15. 
 
Table 2.14:   Summary of kinetic and thermodynamic data for the “reverse” reaction from 
285 in the presence of p-TsOH in DMSO-d6 (298 K, 1 atm). 
 
-Ea285/R 
(K) 
Ea285 
(kJmol-1) 
∆H‡285  
(kJ) 
k-1  
(s-1) 
∆S‡285 
(Jmol-1) 
∆G‡285 
(kJmol-1) 
-  13182 (±  2442) 110 (±20) 107 (± 20) 1.2 × 10-6 (± 0.1 × 10-6) -367 (± 42) 216 (± 65) 
 
Table 2.15: Summary of kinetic and thermodynamic data for the “forward” reaction from 
287 in the presence of p-TsOH-DMSO-d6 (298 K, 1 atm). 
 
-Ea287/R 
(K) 
Ea287 
(kJmol-1) 
∆H‡287 
(kJ) 
k+1 
(s-1) 
∆S‡287 
(Jmol-1) 
∆G‡287 
(kJmol-1) 
-  13182 (±  2620) 109 (±  22) 107 (±21) 1.3 × 10-6 (± 0.1 × 10-6) -365 (± 45) 216 (± 70) 
 
The rate of the forward reaction, k+1 (1.3 × 10-6 s-1) was ca. 8 % faster than the rate of the 
reverse reaction, k-1 (1.2 × 10-8 s-1). The activation energies, Ea285 (110 kJmol-1) and Ea287 (109 
kJmol-1), were the same within the limits of error for both compounds as were the free 
energies of activation [∆G‡285 (306.3 kJmol-1) and ∆G‡287 (305.8 kJmol-1)]. Entropies and 
enthalpies of activation for the acrylate esters were indistinguishable [∆S‡285 (-367 Jmol-1) and 
∆S‡287 (-365 Jmol-1); ∆H‡285 (107.1 kJ) and ∆H‡287 (106.9 kJ)]. 
 
 
2.3.3.7 Comparison of Kinetic Data for Transesterification in Different Media 
 
Arrhenius plots and the comparative kinetic data obtained for the forward and reverse 
reactions of the acrylate ester 287 in different media are summarized in Tables 2.16 and 2.17, 
respectively, and illustrated in Figure 2.60. 
 
 285 287 
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Table 2.16: Comparative kinetic and thermodynamic data for the forward reaction of the 
acrylate ester 287 (298 K, 1 atm). 
 
 -Ea287/R 
(K) 
Ea287
(kJmol-1) 
∆H‡287
(kJ) 
k+1
(s-1) 
∆S‡287 
(Jmol-1) 
∆G‡287
(kJmol-1) 
Unpurified 
CDCl3 
-9361 (± 868) 77 (± 7) 75 (± 7) 2.0 (±  0.1) × 10-6 -362 (± 12) 182 (± 23) 
Purified 
CDCl3 
-23191 (± 5555) 193 (± 46) 190 (± 46) 8.0 (± 0.4) × 10-8 -389 (± 72) 306 (± 130)
DMSO-d6 
& p-TsOH -13159 (± 2620) 109 (± 22) 107 (± 21) 1.3 (± 0.1) × 10
-6 -365 (± 45) 216 (± 70) 
 
 
Table 2.17: Comparative kinetic and thermodynamic data for the reverse reaction of the 
acrylate ester 285 (298 K, 1 atm). 
 
 -Ea285/R Ea285 ∆H‡285  k-1  ∆S‡285 ∆G‡285 
 (K) (kJmol-1) (kJ) (s-1) (Jmol-1) (kJmol-1) 
Unpurified 
CDCl3 
-9361 (± 847) 78 (± 7) 75 (± 7) 1.8 (± 0.1) × 10-6 -363 (± 12) 183 (± 23) 
Purified 
CDCl3 
-23089 (± 5430) 192 (± 45) 189 (± 45) 7.2 (± 0.4) x10-8 -389 (± 70) 306 (± 127)
DMSO-d6 
& p-TsOH -13182 (± 2442) 110 (± 20) 107 (± 20) 1.2 (± 0.1) x10
-6 -367 (± 42) 216 (± 65) 
y = -9269x + 18.001
R2 = 0.9422
y = -13159x + 30.622
R2 = 0.9266
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Figure 2.60: Arrhenius plots for the forward reaction of acrylate ester 287 in different 
media. 
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In all cases, the rate of the forward reaction, k+1, is ca. 10 % faster than that for the reverse 
reaction, k-1. The rate of the reaction is influenced by the medium, increasing in the order: - 
DMSO-d6 § < purified CDCl3 < DMSO-d6 with p-TsOH < unpurified CDCl3 <DMSO-d6 with 
H2SO4‡. The activation energies, Ea, for both compounds, in a given medium, are very similar 
as are the activation parameters ∆H‡, ∆G‡ and ∆S‡. The entropy of activation, ∆S‡, was 
negative in all instances and comparable in magnitude. 
 
In summary it is evident that the experimentally determined kinetic data is consistent with:  
 i)   first order forward and reverse reactions occurring concurrently; 
 ii)  acid catalysis of the process; 
 iii) marginal dominance of the forward reaction (i.e. k+1 > k-1); and 
 iv) the mechanistic sequence outlined in Scheme 2.32 (p. 122). 
 
In the next phase of the investigation, a computational study was undertaken to examine the 
mechanistic details concerning the existence of suspected intermediates and thus the most 
likely pathway for the transesterification process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
§ Although rate constants could not be obtained in DMSO-d6 alone, the comparison is based on the extreme 
slowness of the observed reactions. 
‡ The rate was the fastest, but decomposition of the monoesters precluded accurate data acquisition for the 
equilibrium reaction. 
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2.3.4 Computational Study of the Transesterification of the Acrylate Esters. 
 
The NMR studies of the transesterification of the acrylate esters 285 and 287 provided kinetic 
and thermodynamic data for the reaction and, in an attempt to obtain further insights into the 
mechanism, a computational study of the reaction was undertaken. 
 
The experimental data had indicated that transesterification may occur under both neutral 
(albeit very slowly) and acid-catalyzed conditions. Pathways involving the likely 
intermediates were explored using Gaussian-03223 at the density functional theory (DFT) level 
with the basis set, B3LYP/6-311+G(d). This particular approach is considered to be one of the 
more accurate and, additionally, is fairly cost effective, time-wise.207 
 
The aim was to locate and determine the relative energies of the significant stationary points 
on the free energy surface. To this end, the following computational steps were performed. 
 
i) Geometry optimization of the “reactant” and “product” and the putative intermediates; 
ii) verification of the various minima through frequency calculations (the requirement 
being zero imaginary frequencies); 
iii) location of transition state structures by exploring the potential energy surfaces between 
the minima; 
iv) optimization of the transition states and confirmation of their nature through frequency 
calculations (one imaginary frequency required) 
v) calculation of the thermodynamic and kinetic parameters, ∆E, Ea, ∆G298, ∆G‡298; and 
vi) intrinsic reaction coordinate (IRC) calculations to validate the reaction pathways. 
 
Possible mechanistic pathways for the neutral and acid-catalysed processes are illustrated in 
Schemes 2.34 and 2.35 (p. 154) respectively. Similar calculations were performed on all 
structures present in each pathway. These and other structures, even unlikely ones, were 
included to assess the likelihood of their involvement in the reaction pathway.  
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2.3.4.1 Uncatalysed Transesterification 
 
The NMR-based kinetic study had confirmed that the acrylate ester 287 rearranges via 
migration of the acryloyl moiety to form the isomeric acrylate 285, and vice versa. It seemed 
likely that rearrangement in both directions involved the transient, cyclic, isomeric 
intermediates 294 and/or 295 and, consequently, the transition states 285I, 285II, 287I and 
287II connecting the intermediates to the “reactant” and “product” (Scheme 2.34). 
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Scheme 2.34: Possible pathways for transesterification under neutral conditions. 
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Once the “reactant” 287, “product” 285 and intermediate 294 and 295 structures had met the 
minimum requirements of the convergence criteria for geometry optimization, frequency 
calculations showed that all four structures were indeed minima on the potential energy 
surface with zero imaginary frequencies. Three distinct approaches for scanning the reaction 
trajectories were explored.  
 
i) Utilising the intermediates 294 and 295 as starting points, each of the O–C bonds, was 
stretched, in anticipation that the hydroxyl proton would spontaneously attach to the 
developing alkoxide oxygen. In the case of intermediate 294 (paths “a” and “b”; Figure 
2.61), the respective O–C bond broke and a zwitterion was formed without any proton 
shift occurring. These results suggested that, for this route to proceed, collapse of the 
cyclic intermediates is not initiated by cleavage of an O–C bond, but rather by a shift of 
the hydroxyl proton to one of the ester oxygens, followed by cleavage of an adjacent O–C 
bond. Of course, once formed, the zwitterionic species could readily undergo proton 
transfer to afford the respective monoesters. 
 
 
 
 
 
 
 
 
 
Figure 2.61: First approach in the search for transition states, illustrating the formation of 
the zwitterionic species from intermediate 294. 
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 Similar fission of intermediate 295 (paths “c” and “d”; Figure 2.62) resulted in the 
corresponding zwitterionic species and spontaneous proton shifts to the expected 
products.  
 
 
 
 
 
 
 
 
 
 
Figure 2.62: First approach in the search for transition states from intermediate 295. 
 
 No transition structures or the corresponding thermodynamic parameters were able to be 
obtained as the potential energy scans failed to provide stationary points.  
 
ii) In the second approach, the interatomic distance between the hydroxylic oxygen and 
carbonyl carbon was gradually decreased to < 1 Å, in both the “reactant” 287 and 
“product” 285 (Figure 2.63), in an attempt to locate the putative transition state 
complexes 287I, 287II, 285I and/ or 285II, respectively (from Scheme 2.34). One to two 
steps forward from either transition state gives the corresponding isomeric esters.  
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Figure 2.63: Second approach in the search for transition states. 
 
iii) The third approach was based on the assumption that migration of the proton is a critical 
factor. Use was again made of the intermediates 295 and 294, but in this approach, the 
reaction pathway was investigated by decreasing the interatomic distance between the 
hydroxyl proton and one or other of the ester oxygens (paths “g”–“j”) to < 1 Å (Figure 
2.64). Transition states were identified, geometry optimized and their nature verified 
through frequency calculations. A complete investigation of the potential energy surfaces, 
together with intrinsic reaction coordinate calculations, allowed the reaction pathways to 
be plotted (Figures 2.65 and 2.66) and the corresponding kinetic and thermodynamic 
parameters to be calculated (Tables 2.18 and 2.19). 
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Figure 2.64: Third approach in the search for transition states. 
 
 Geometry optimization and frequency analysis of all structures illustrated in Figures 2.65 
and 2.66 confirmed their identitiy as stationary points. Thus: -i) the geometry 
optimisations converged; and ii) a single imaginary frequency was exhibited by each 
transition state and no negative frequencies were exhibited by the “reactant”, intermediate 
and “product” structures. Furthermore, IRC calculations verified that the transition states 
connect the respective “reactants” and “products”. The theoretical data thus support the 
mechanism illustrated in Scheme 2.34, and indicate that pathway 1 (via the “exo-
hydroxy” intermediate 294) involves significantly higher activation barriers, in both 
directions, than pathway 2 (via the “endo-hydroxy” intermediate 295); the “endo-
hydroxy” intermediate 295 also appears to be 3 kcal mol-1 more stable than the isomeric 
“exo-hydroxy” analogue 294. However, both pathways exhibit large activation energy 
barriers. 
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Figure 2.65: Uncatalysed “exo-hydroxy” transesterification route, pathway 1. 
 
Table 2.18: Uncatalysed “exo-hydroxy” transesterification route, pathway 1. 
 
Reaction 
Step 
Δ G298 
(kcal mol-1) 
Δ G‡298 
(kcal mol-1) 
Δ E298 
(kcal mol-1)
Ea298 
(kcal mol-1)
Ea298 
(kJ mol-1) 
287 → 294  14.59 49.08 13.29 51.00 213.39 
294 → 285 -14.74 34.41 -13.68 37.72 157.81 
285 → 294 14.74 49.15 13.68 51.39 215.03 
294 → 287 -14.59 34.50 -13.29 37.71 157.78 
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Figure 2.66: Uncatalysed “endo-hydroxy” transesterification route, pathway 2. 
 
Table 2.19: Uncatalysed “endo-hydroxy” transesterification route, pathway 2. 
 
Reaction 
Step 
Δ G298 
(kcal mol-1) 
Δ G‡298 
(kcal mol-1) 
Δ E298 
(kcal mol-1)
Ea298 
(kcal mol-1)
Ea298 
(kJ mol-1) 
287 → 295  11.59 42.99 9.23 44.16 184.78 
295 → 285 -11.74 29.23 -10.11 32.06 134.12 
285 → 295 11.74 40.96 10.11 42.16 176.42 
295 → 287 -11.59 31.40 -9.23 34.44 144.08 
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2.3.4.2 Catalysed Transesterification 
 
The NMR-based kinetic experiments (Section 2.3.3) clearly indicated the importance of acid 
catalysis in the transesterification reactions. In light of these results, the mechanism illustrated 
in Scheme 2.35 was considered.  
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Scheme 2.35: Possible pathways for transesterification under acidic conditions. 
 
Geometry optimisations for protonated “reactants”, “products” and intermediates were 
performed. Successful convergence of the protonated “reactant” and “product” structures 
were achieved; however, initial attempts to optimise the geometry of the protonated cyclic 
intermediates resulted in dissociation to the corresponding non-cyclic cationic species 287-H-
endo, 287-H-exo, 285-H-endo or 285-H-exo (Scheme 2.36), and it became apparent that the 
potential energy surface was more complex than anticipated. Frequency calculations on the 
geometry optimized structures showed that all four non-cyclic structures were indeed minima 
on the potential energy surface with zero imaginary frequencies.  
294-H1 294-H2 
295-H1 295-H2 
287-H 285-H 
Discussion 
- 155 - 
O
OH
OH
O
OH
OH
OH
O OH
OH
OH
O
O
O
OH
O
O
OH
O
O OH
O
O OH
H
H
H
H
 
Scheme 2.36: Possible pathways for transesterification under acidic conditions. 
 
Two approaches were then followed in an attempt to map the reaction pathways for the 
catalysed reaction:  
 
i) The first approach involved decreasing the interatomic distance between the hydroxylic 
oxygen and protonated carbonyl carbon to < 1 Å, commencing with the geometry 
optimized structures 285-H-endo, 285-H-exo, 287-H-endo and 287-H-exo (Figure 2.67). 
In each case, the expected transition state could not be located. Instead fission of the 
C(2)–O or C(3)–O bond and migration of a hydroxyl anion from the camphor skeleton to 
the acrylate moiety was observed, followed by further dissociation. 
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Figure 2.67: First approach in the search for transition states arising from “exo-hydroxy” 
acrylate 285-H-exo and “endo-hydroxy” acrylate 285-H-endo in the acid-
catalysed reaction. 
 
ii) Initial attempts to optimise the geometry of the protonated putative cyclic intermediates 
(Scheme 2.36) had shown that localising the proton on either ether oxygen in the cyclic 
system raised the free energy to such a point that fission of the ring occurred. 
Consequently, in an alternative approach, it was decided to observe what would happen if 
a proton was brought towards the cyclic system from a non-bonding position to the point 
where an O–H bond formed (paths “m” and “n”), and beyond (Figure 2.68).  
 
Figure 2.68: Second approach in the search for transition states in the acid-catalysed 
transesterification via the “exo-hydroxy” intermediate 294. 
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 In the case of the “exo-hydroxy” systems, the transition states 287III and 285III (Figure 
2.69) were located, geometry optimized and single imaginary frequencies were obtained. 
Furthermore, the data obtained in the search gave more accurate representations of the 
structures on either side of the transition states, and these were used to obtain geometry-
optimized minima corresponding to structures 294-H1, 294-H2, 287-H-exo and 285-H-
exo (Figure 2.69). IRC calculations verified that the transition state structures connected 
the reactants and products. The kinetic and thermodynamic parameters for the acid-
catalysed transesterification via the “exo-hydroxy” intermediates 294-H1 and 294-H2 are 
summarised in Table 2.20. 
 
 The results indicate that the ground state monoesters are protonated at the carbonyl 
oxygen. The hydroxyl oxygen is then able to attack the electron deficient carbonyl carbon 
and in so doing forms a transient cyclic structure (294-H1 or 294-H2), with loss of the 
hydroxyl proton. In the acidic medium protonation of an ether oxygen in the cyclic 
intermediates is able to occur from either the front or back face, leading to the isomeric 
monoester or returning to the starting structure. 
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Figure 2.69: Acid-catalysed “endo-hydroxy” transesterification route, pathway 1.  
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Table 2.20: Acid-catalysed “endo-hydroxy” transesterification route, pathway 1. 
 
Reaction 
Step 
Δ G298 
(kcal mol-1)
Δ G‡298 
(kcal mol-1) 
Δ E298 
(kcal mol-1)
Ea298 
(kcal mol-1) 
Ea298 
(kJ mol-1) 
287-H-exo → 294-H1  30.06 33.01 35.78 36.96 154.64 
294-H2 → 285-H-exo -28.98 3.48 -36.07 0.10 0.4 
285-H-exo → 294-H2 28.98 32.46 36.07 35.97 150.93 
294-H1 → 287-H-exo -30.06 2.96 -35.78 1.18 4.95 
 
 Comparison of the results for the acid-catalysed “exo-hydroxy” route with those of the 
corresponding uncatalysed transesterification, clearly show significant differences in the 
free energy of activation for each step of the reaction, particularly those involving 
collapse of the cyclic intermediates. The significantly lower free energies of activation 
calculated for the former are clearly consistent with the experimentally observed acid-
catalysis. 
 
 Surprisingly, similar computational treatment of the corresponding endo-hydroxy 
intermediate species 295-H1 and 295-H2 (paths “o” and “p”) (Figure 2.70) and the 
related protonated species 287o, 287IV, 285p and 285IV gave very different results! 
Tentative transition state structures (285IV and 287IV) were located, exhibiting single 
imaginary frequencies (Figure 2.71) and the corresponding kinetic and thermodynamic 
parameters are presented in Table 2.21.  
 
Figure 2.70: Second approach in the search for transition states in the acid-catalysed 
transesterification via the “endo-hydroxy” intermediate 295. 
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Figure 2.71: Acid-catalysed “endo-hydroxy” transesterification route, pathway 2.  
 
 
Table 2.21: Acid-catalysed “endo-hydroxy” transesterification route, pathway 2. 
 
Reaction 
Step 
Δ G298 
(kcal mol-1) 
Δ G‡298 
(kcal mol-1) 
Δ E298 
(kcal mol-1)
Ea298 
(kcal mol-1)
Ea298 
(kJ mol-1) 
287o → 295-H1 23.03 50.19 24.78 51.79 216.69 
295-H2 → 285p -12.68 2.38 -11.44 1.62 6.77 
285p → 295-H2 12.68 15.06 11.44 13.06 54.62 
295-H1 → 287o -23.03 27.16 24.78 26.99 112.93 
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 However, the high energy transition state 287IV exhibits cleavage of the C(3)–O ether 
bond, and unconstrained geometry optimisation leads to the isomeric gem-diol 287o. The 
free-energy of activation for this step (295-H1 → 287o; ∆G‡ = 27.16 kcal mol-1) is 
significantly larger than any of the other acid-catalysed ring-opening pathways examined. 
The surprising structures of the transition state 287IV and the corresponding gem-diol 
moiety 287o were investigated further, and the calculations were modified to allow 
approach of the proton along different trajectories and re-run numerous times. Each result 
was analogous to the data presented above. Thus, in the absence of an appropriate low 
energy transition state connecting the cyclic intermediate 295-H1 and the protonated 
monoacrylate ester 287o, we conclude that the transesterification cannot proceed via the 
“endo-hydroxy” route. 
 
 
2.3.4.3 Mechanistic Conclusions. 
 
It must be recognised, of course, that the theoretical data have not been solvent-corrected, and 
gas-phase structures may differ from the corresponding solvated structures. However, based 
on both the experimental kinetic and theoretical data, it seems that the favoured pathway for 
the transesterification involves the protonated “exo–hydroxy” intermediates 294-H1 and 294-
H2 (Scheme 2.37). The involvement of these cyclic intermediates appears to be beyond 
doubt.205,206 However, at no point has it been possible to detect these elusive structures by 
spectroscopic means as their lifetime and concentration are likely to render them incapable of 
detection within the NMR timescale.208  
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Scheme 2.37: Favoured pathway for transesterification under acidic conditions. 
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2.3.5 Acrylate Esters of Phenyl 2-Hydroxybornane-10-Sulfonate 
 
In view of the transesterification problems encountered with the bornandiol monoacrylates, 
the search for a suitable camphor scaffold to act as a chiral auxiliary in Morita-Baylis-Hillman 
reactions was then steered in the direction of the phenyl 10-sulfonate system 296.  
 
 
 
 
 
 
 
 
It was suspected that the steric bulk of the 8-methyl group and the phenyl sulfonate group at 
C-10 would induce preferential approach of the attacking electrophile from a single face, 
resulting in a predominance of one enantiomeric Morita-Baylis-Hillman product. 
Additionally, the electron-deficient sulfur and the delocalized electron cloud of the phenyl 
group could stabilize the neighbouring enolate species 297 present during the course of the 
reaction, thus increasing enolate rigidity (Figure 2.72).  
 
 
Figure 2.72: Expected interactions of the reactive enolate species 297 undergoing a Morita-
Baylis-Hillman reaction.  
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The anticipated route to the phenyl 10-sulfonate substrate 296 and the associated Morita-
Baylis-Hillman product 299 is shown in Scheme 2.38. 
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Scheme 2.38: Proposed route to phenyl 2-exo-acryloyloxybornane-10-sulfonate 296 and the 
Morita-Baylis-Hillman product 299. 
 
 
2.3.5.1  Synthesis of Phenyl Camphor-10-sulfonate 
 
The proposed esterification to produce the phenyl 10-sulfonate 72 (Scheme 2.38) required the 
starting material to have a good leaving group; hence, commercially available camphor 
sulfonic acid 71 was chlorinated with phosphorus pentachloride (PCl5),136,211 giving 
camphorsulfonyl chloride 298. However, yields of the recrystallised product proved to be 
lower than reported,211 with a maximum of only 59 %. Synthesis of the phenyl 10-sulfonate 
72 was achieved by addition of phenol to the sulfonyl chloride 298 in pyridine. Nucleophilic 
substitution of the sulfonyl chloride 298 by the nucleophilic phenoxide anion resulted in 
phenyl camphor-10-sulfonate 72 in good yield (78 %).212,213  
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2.3.5.2 Reduction of Phenyl Camphor-10-sulfonate 
 
Careful consideration of the structure and reactivity of phenyl camphor-10-sulfonate 72 led to 
the concern that reduction or hydrolysis of the sulfonate might be possible even under mild 
conditions.136 Therefore, reaction conditions had to ensure reduction of the hindered ketone 
and, at the same time, be mild enough not to effect reduction of the sulfonate ester. 
Reductions are most often achieved using metal hydrides or through metal-catalysed 
hydrogenation. However, carbon-sulfur single bonds are known to be susceptible to metal-
catalyzed hydrogenolysis,169 a characteristic used to bring about the desulfurisation of 
thioacetal protecting groups in the presence of Raney nickel.169 Hydride-transfer reagents, 
136,169 such as lithium aluminium hydride (LAH) and sodium borohydride (NaBH4), are 
advantageous in that they contain a large amount of hydrogen for a small quantity of 
reagent,136 but LAH was considered too powerful a reducing agent for use in this reaction as it 
is not particularly selective.169 NaBH4 is significantly milder than LAH134 and in hydroxylic 
solvents reduces aldehydes and ketones rapidly at room temperature, while remaining 
essentially inert to other functional groups.138 It has also been found to reduce aldehydes 
faster than ketones whilst in isopropanol,214 reducing ketones first in aqueous ethanol at -15 
ºC in the presence of cerium trichloride,215, 216 and reducing the more hindered ketone in a 
mixture of two ketones.217 NaBH4 has been found to be very soluble in methanol, less soluble 
in ethanol and even less soluble in 2-propanol.138,153 However, Brown et al.218 observed that 
NaBH4 reacts readily to produce hydrogen with methanol, less readily with ethanol and not at 
all with 2-propanol over a 24 h period.  
 
In an attempt to selectively reduce the ketone function, phenyl camphor-10-sulfonate 72 was 
treated with NaBH4 in ethanol and in 2-propanol at 0 ºC (Scheme 2.39). In both cases the 
synthesis of the novel products phenyl 2-exo-hydroxybornane-10-sulfonate 100 and phenyl 2-
endo-hydroxybornane-10-sulfonate 300 were achieved in very low yields (see Table 2.22). 
The dominant product, however, was found to be 10-isobornyl sultone 87, which is well 
known and has been the subject of numerous studies, 44,45,47,219-222 and a large quantity of 
phenol 301 was also present. Removal of phenol from the reaction mixture was achieved with 
a basic wash, and subsequent purification of the remaining compounds was easily achieved by 
radial chromatography. Structure elucidation of compounds 100 and 300 was achieved by 
analysis of the 1-D and 2-D NMR spectroscopic data (Figures 2.73 and 2.74), which showed 
characteristic signals for all expected protons; of particular importance was the presence of 
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new methine and hydroxylic signals corresponding to the C-2 secondary alcohol moiety, 
confirming that the reduction of 72 had occurred. 
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Scheme 2.39: Synthesis of phenyl 2-exo-hydroxybornane-10-sulfonate 100, phenyl 2-endo-
hydroxybornane-10-sulfonate 300 and 10-isobornyl sultone 87. 
 
 
Table 2.22: Data for the reduction of phenyl camphor-10-sulfonate. 
Compound Reaction Conditions
 1 eq. NaBH4, 
EtOH, 
0 ºC, 12 h 
1 eq. NaBH4,
Isopropanol, 
0 ºC, 12 h 
10 eq. NaBH4, 
EtOH/ H2O (2:1),
-8 ºC, 8 h 
10 eq. NaBH4,
abs. EtOH, 
25 ºC, 12 h 
 Yield (%) Yield (%) Yield (%) Yield (%) 
100 11.2 10.7 81 0 
300 1.3 1.0 12 0 
87 23.1 22.3 4 94 
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Figure 2.73: 400 MHz 1H NMR spectrum of phenyl 2-exo-hydroxybornane-10-sulfonate 
100 in CDCl3.  
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Figure 2.74: 400 MHz 1H NMR spectrum of phenyl 2-endo-hydroxybornane-10-sulfonate 
300 in CDCl3. 
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Assignment of the stereochemistry was based on the analysis of the C-2 proton signals and 
their correlation with protons at C-5, C-6, C-8 and C-10. As is characteristic of camphor 
structures similar to the 2-exo-hydroxy compound 100, where 2-H is endo-orientated, 
shielding between 2-Hendo and all endo protons results in the 2-H signal (4.11 ppm) and all the 
endo proton signals being shifted upfield relative to the corresponding signals in the isomeric 
ester 300. The 2-hydroxylic group, being exo-orientated, causes deshielding of the 8-methyl 
group, and the 8- and 9-methyl signals are thus significantly separated (1.07 and 0.85 ppm, 
respectively), whereas in the 2-endo-hydroxy analogue 300, where the 2-H is exo-orientated, 
the 2-OHendo deshields the endo-orientated protons, the 2-Hexo proton experiences less 
shielding (4.30 ppm) and the 8- and 9-methyl signals resonate closer together (0.92 and 0.93 
ppm) as the methyl groups are in a similar chemical environment.  
 
Finally, the 10-CH2 nuclei of 100 resonate as two doublets (3.15 and 3.73 ppm) and 
experience geminal coupling (13.7 Hz) characteristic of magnetically non-equivalent nuclei; 
the 10-CH2 nuclei of 300, however, resonate as a singlet (3.34 ppm) indicating chemical shift 
equivalence. Computational analysis, performed with Gaussian-03,223 afforded stable 
hydrogen-bonded conformers (Figures 2.75 and 2.76), the structures of which provide a 
possible explanation. The hydroxylic oxygen in 100 is relatively close to H-10a (3.63 Å) but 
distant to H-10b (4.16 Å), whilst the corresponding 10-CH2 nuclei in 300 are both distant from 
the hydroxylic oxygen. Thus H-10a in 100 is deshielded relative to the other 10-CH2 nuclei 
and resonates further downfield at δ 3.72 ppm .  
  
Figure 2.75: Computer-modelled representation of a stable conformation of phenyl 2-exo-
hydroxybornane-10-sulfonate 100, showing distances between the 10-CH2 
nuclei and the hydroxylic oxygen.  
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Figure 2.76: Computer-modelled representation of a stable conformation of phenyl 2-endo-
hydroxybornane-10-sulfonate 300 showing distances between the 10-CH2 
nuclei and the hydroxylic oxygen. 
 
Consideration of the mechanism of the reaction (Scheme 2.40) was necessary to account for 
the observed products. As indicated earlier the carbonyl group at C-2 of the substrate 72, is 
sterically hindered on the exo-face by the bulky 8-methyl group. Thus, nucleophilic attack is 
expected to be favoured at the endo-face, generating the exo-hydroxy compound 100 as the 
dominant ester product. The major reaction product, however, was the 10-isobornyl sultone 
87, formed by intramolecular nucleophilic attack on the sulfonate ester by the highly reactive 
alkoxide species, 224 (the liberated phenoxide is neutralized on work-up to give phenol). 
Limited attack at the exo-face by the metal hydride accounts for the minor ester product, the 
endo-hydroxy isomer 300. It is interesting to note that no trace of an analogous endo-cyclized 
sultone was observed, presumably due to unfavourable orientation of the reactive centres.  
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Scheme 2.40: Mechanistic pathways for the reduction of phenyl camphor-10-sulfonate 72. 
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Analysis of the reaction mechanism suggested that if the concentration and reactivity of the 
alkoxide intermediate 303 could be reduced, cyclization might be minimized. This was 
achieved by reducing the temperature, and by adding H2O to permit early protonation of the 
alkoxide species 303. The amount of water was carefully monitored, as was the overall 
progress of the reaction, and the quantity of NaBH4 was increased to account for any that 
might be rendered inactive by hydrolysis. A vigorous reaction was observed during final acid 
quenching of the reaction, signifying that active NaBH4 was still present. Fine tuning of the 
reaction conditions [NaBH4 (10 eq.), EtOH/H2O (2:1), -8 ºC, 8 h], followed by purification on 
the chromatotron or by HPLC, led to a huge improvement in the yield of phenyl 2-exo-
hydroxybornane-10-sulfonate 100 (81 %) and phenyl 2-endo-hydroxybornane-10-sulfonate 
300 (12 %), and a concomitant decrease in the production of 10-isobornyl sultone 87 (4 %) 
(Scheme 2.39; Table 2.22; p. 165). A further variation in reaction conditions [NaBH4 (10 
eq.), absolute EtOH, room temperature, 12 h], however, afforded the sultone 87 in excellent 
yield (94 %) with no trace of either hydroxy compound! This is a somewhat different 
synthetic method for the production of the sultone 87 than those reported in the 
literature,44,45,47,212,220 primarily as phenoxide is a better leaving group than the alkoxides 
involved in the reported methods; the reaction conditions are thus far milder, the product 
cleaner and the yield generally equivalent or higher. Cleavage of 8746,219,222 and the 
subsequent synthesis of the Morita-Baylis-Hillman auxiliary 306 may be attempted in the 
future (Scheme 2.41). 
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Scheme 2.41:  Proposed route to the Morita-Baylis-Hillman auxiliary 2-acryloyloxy-10-
phenylsulfonylbornane 306. 
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2.3.5.3 Acylation of the 2-Hydroxybornane-10-sulfonates 
 
Acylation of 2,3-dihydroxybornane 284 had been facilitated by the use of NaH or BuLi to 
deprotonate the alcohol substrate, forming an alkoxide, which reacts readily with the acryloyl 
chloride.136 The generation of an alkoxide (e.g. 307) from the alcohols 100 or 300, however, 
caused concern, due to the potential for cyclization to the sultone 87. In the reduction of 
phenyl camphor-10-sulfonate 72, this only occurred significantly at temperatures above -10 
ºC and, consequently, it was expected that the production of sultones would not occur at -78 
ºC. Acylation of the exo-hydroxy compound 100 was attempted by adding BuLi over 20 min 
at -78 ºC, followed by acryloyl chloride at < -10 ºC (Scheme 2.42).  
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Scheme 2.42:  Expected synthesis of phenyl 2-exo-acryloyloxybornane-10-sulfonate 296. 
 
Purification of the resulting reaction mixture proved difficult but was satisfactorily achieved 
by semi-preparative HPLC, which yielded a number of fractions that were identified by NMR 
spectroscopy. Unfortunately, only a small amount (≤ 5 %) of the desired acrylate 296 was 
obtained together with the sultone 87 (79 %) and the phenyl acrylate 309 (76 %), the latter 
being produced by acylation of the released phenoxide (Scheme 2.43, p.179). Under the same 
conditions, however, acylation of the 2-endo-hydroxy analogue 300, afforded 2-endo-
acryloyloxybornane-10-sulfonate 310 in good yield (77 %) The 1H NMR spectrum of the 
product contained characteristic signals for the phenyl bornane-10-sulfonate moiety as well as 
several new downfield signals corresponding to the acrylate protons; however, noticeably 
absent was the 2-hydroxylic proton. The 13C NMR spectrum showed three new downfield 
signals, corresponding to the acrylate carbons. The HSQC spectrum (Figure 2.77) confirmed 
the correlations between the acrylate protons and the carbon signals, while the COSY 
spectrum confirmed the absence of correlations between these signals and signals from the 
rest of the molecule. The significant deshielding of the 2-H nucleus (5.26 ppm) is attributed to 
its proximity to the acrylate and sulfonate moieties and their magnetic anisotropic effects. 
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Figure 2.77:  400 MHz HSQC spectrum of phenyl 2-endo-acryloyloxybornane-10-sulfonate 
310 in CDCl3. 
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Computational analysis of the conformation of the 2-endo-acrylate 310 (Figure 2.78) 
suggests that the phenyl and acrylate groups could favour alignment parallel to one another at 
a distance of between 5 and 6 Å, supporting the idea that the phenyl ring might block access 
to one face (approach “a”) of the acrylate moiety in a Morita-Baylis-Hillman reaction. Similar 
analysis of the 2-exo-acrylate 296 (Figure 2.79) suggests that the phenyl group is disposed 
some distance from the acrylate moiety. While this might raise concern about the 
stereodirecting potential of the phenyl group, internal rotation about the C(1)–C(10) and 
C(10)–S bonds could still provide effective shielding of one face of the acrylate group 
(approach “a”). Perhaps of more significance is the relative orientation of the acrylate groups 
of the isomeric esters 310 and 296, which clearly shows the acrylate carbonyl groups pointing 
in opposite directions, thus exposing different faces to attack by an electrophile and raising 
the possibility of generating enantiomeric products by choosing one isomeric substrate or the 
other. 
 
 
 
 
Figure 2.78:  Computer-modelled representation of a stable conformation of phenyl 2-endo-
acryloyloxybornane-10-sulfonate 310. 
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Figure 2.79:  Computer-modelled representation of a stable conformation of phenyl 2-exo-
acryloyloxybornane-10-sulfonate 296. 
 
The successful synthesis of the endo-acrylate 310 coupled with the tendency of the exo-
isomer to form the sultone 87 added weight to the earlier suspicion that cyclization of the 
endo-alkoxide is sterically unfavourable. Further attempts to produce the 2-exo-acrylate ester 
296 necessitated a search for other possible methods. The problem of cyclization arises from 
the reactivity of the alkoxide species and a possible solution lay in by-passing alkoxide 
formation entirely. While most methods appear to proceed via the alkoxide, a notable 
exception involved the use of tertiary amines to catalyze the reaction.122,225,226 The presence of 
these catalysts is known to increase the rate of acylation of alcohols by a factor of up to 104,227 
and to result in high yielding reactions.227,228 4-(Dimethylamino)pyridine (DMAP)229 
functions as a nucleophilic catalyst enhancing the electrophilicity of the acyl carbon, as a 
neutral leaving group during acyl substitution and, as a base, neutralising the HCl generated in 
the process (although Et3N can be used for this purpose). Unfortunately, treatment of the 2-
exo-alcohol 100 with DMAP, Et3N and acryloyl chloride in dichloromethane failed to produce 
the required ester 296. 
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Attention was turned to the literature230-233 in an attempt to find more suitable reaction 
conditions for the required acylation and two particularly interesting methods were identified. 
The first method involved the highly efficient direct condensation of carboxylic acids with 
alcohols in the presence of Hf(IV) or Zr(IV) salts.232 Unfortunately, the unavailability of the 
catalysts and concerns about the possibility of generating an alkoxide intermediate eventually 
ruled this method out. The second and more recent method,233 however, seemed remarkably 
straightforward and is reported to give excellent yields (90 - 100 %). Yadev and co-workers233 
described the simple and effective acylation of alcohols and amines through the use of 
acylating reagents on an aluminium oxide (Al2O3) solid support. The acylation of alcohols 
was found to occur most readily with acid chlorides and primary alcohols, less readily with 
secondary alcohols and not at all with tertiary alcohols.  
 
The acylation of both alcohols, 100 and 300, was therefore attempted under identical 
conditions. In each reaction the alcohol, Al2O3 and acryloyl chloride were mixed together 
without solvent and left to stand overnight (Scheme 2.43, p. 179). 1H NMR analysis of a 
sample of the reaction mixture showed the decrease of the alcohol signals and the appearance 
of acrylate ester signals. However, the reaction had not yet gone to completion and the 
mixture was left to stand for a total of 72 h. 1H NMR data for the crude reaction mixture 
showed almost complete disappearance of signals for the starting material (100 or 300) and an 
anomalous “doubling” of practically all product signals. The preliminary thought was that 
hindered rotation might afford rotamers.136 However, before any conclusions could be drawn 
it was necessary to purify the crude reaction mixture. This was initially attempted by radial 
chromatography, but separation was exceedingly poor and final purification was achieved by 
semi-preparative HPLC. Several fractions were isolated and subjected to 1H NMR analysis. 
Surprisingly, two products were evident from each of the starting materials 100 and 300, and 
full 1-D and 2-D NMR data sets were obtained. HSQC spectra of the products 296 and 308 
are presented in Figures 2.81 and 2.82. The first product was identified as the exo-acrylate 
296. Comparison with the spectrum of the endo-acrylate 310 (Figure 2.77) revealed that the 
2-Hendo signal is shifted upfield, relative to the 2-Hexo signal in the spectrum of the endo-
acrylate 310. 
 
The HSQC spectrum of the second product 308 (Figure 2.82) isolated from the acylation of 
the 2-exo-alcohol 100 showed many similarities to the spectrum of the acrylate ester 296 
(Figure 2.81). However, no characteristic acrylate peaks were visible and this, together with 
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the presence of two new methylene signals (2.58 and 3.60 ppm), suggested loss of the π-bond 
between C-2’ and C-3’ to form a saturated alkyl chain. The spectra, however, gave very little 
indication as to exactly what was present on the end of the alkyl chain. The IR spectrum 
suggested the presence of a halogen. Confirmation of the molecular composition was 
provided by the HRCI mass spectrum which revealed a peak at m/z 400.10598 which 
corresponds to the molecular formula C19H25O5SCl (calculated m/z 400.11112) and which 
permitted identification of the second product as the 2-exo-(3-chloropropanoyloxy) derivative 
308. 
 
An X-ray diffraction analysis supported the presence of chlorine, and confirmed the 
stereochemical orientation of the 3-chloropropanoyloxy moiety as exo- and thus the complete 
structure of 308 (Figure 2.80). 
 
Figure 2.80: X-ray crystallographic structure of phenyl 2-exo-(3-chloropropanoyloxy)-
bornane-10-sulfonate 308, showing the crystallographic numbering. 
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9-Me 
 
8-Me 
 
 
 
Figure 2.81:  400 MHz HSQC spectrum of phenyl 2-exo-acryloyloxybornane-10-sulfonate 
296 in CDCl3.  
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Figure 2.82: 400 MHz HSQC spectrum of phenyl 2-exo-(3-chloropropanoyloxy)bornane-
10-sulfonate 308 in CDCl3.  
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Scheme 2.43: Acylation reactions of phenyl 2-exo-hydroxybornane-10-sulfonate 100 and 
  phenyl 2-endo-hydroxybornane-10-sulfonate 300. 
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The Al2O3-catalysed reaction of the 2-endo-alcohol 300 also afforded two products, the 
expected 2-endo-acrylate ester 310 (57 %) and the 2-endo-(3-chloropropanoyloxy) derivative 
311 (39 %) (Scheme 2.43). The formation of the chlorinated products 308 and 311 under 
these conditions is attributed to addition of the liberated HCl to the acrylate double bond. 
 
Although the synthesis of the phenyl sulfonate acrylates 310 and 296 was successfully 
achieved, their use in the Morita-Baylis-Hillman reaction was not attempted. The difficulty 
associated with their synthesis and, more importantly, the difficulty in separating the final 
products led to the decision to explore an analogous route employing an adamantyl blocking 
group. 
 
  
2.3.6 Acrylate Esters of N-(1-adamantyl)-2-hydroxybornane-10-sulfonamide 
 
Oppolzer and co-workers studied the potential of the camphor-10-sulfonamide 312 as a chiral 
substrate in the synthesis of β-substituted carboxylic acids 314.219 Yields were good to 
excellent, as were the enantiomeric excesses of the final products (Scheme 2.44). 
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Scheme 2.44:  The synthesis of β-substituted carboxylic acids.219 
 
Sulfonamides tend to be more stable than their sulfonate ester equivalents,136 and a range of 
these compounds has been investigated. In addition, adamantane and its derivatives have 
attracted considerable interest in the recent past,227,234-236 and the potential for the bulky 
adamantyl group 235 to effectively block electrophilic attack at one face of an acrylate system 
312 
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was attractive. The expected mode of attack by aldehydes on the Morita-Baylis-Hillman 
intermediate 315 is illustrated in Figure 2.83.237,238 
 
 
Figure 2.83: Expected direction of electrophilic attack on the reactive species 315 
undergoing a Morita-Baylis-Hillman reaction. 
 
It was anticipated that, as a result of the effective delocalisation of the nitrogen lone-pair 
electrons (Figure 2.84), the adamantylsulfonamide linkage should be considerably more 
stable than the phenyl sulfonate link had been found to be and, consequently, that formation 
of the sultone 87 (via an intermediate alkoxide) would be less likely.136 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.84:  Comparison of alkoxide intermediates of the phenyl sulfonate 303 and the N-
adamantylsulfonamide 316. 
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2.3.6.1 Preparation of N-(1-adamantyl)camphor-10-sulfonamide 
 
Alkyl amines are known to be excellent nucleophiles in SN2 reactions,183 and acylation of 
adamantylamine to form the corresponding sulfonamide 318 (Scheme 2.45, p. 194) was 
expected to occur easily; however, the addition of a catalytic amount of the tertiary amine, 
DMAP, was determined to be useful for its rate enhancing ability.231  
 
A concern was that adamantylamine, as a primary amine, had the potential to be diacylated, 
but this was suspected to be unlikely due to the bulk of the camphorsulfonyl chloride. In an 
analogous acylation of benzylamine, Ramon et al.239-241 obtained only the corresponding 
monoacylated product. Nevertheless, the sulfonyl chloride 298 was used as a limiting reagent 
as a pre-emptive measure. Thus, sulfonyl chloride 298 (1 eq.), adamantylamine 317 (2 eq.) 
and DMAP (0.2 eq.) in acetonitrile were allowed to react at 0 ºC for one hour before 
quenching by the successive addition of H2O and 10 % HCl. Separation and purification of 
the reaction mixture was readily achieved by sequential acid and base extractions to obtain the 
sulfonamide 318 in excellent yield (92 %). Analysis of 1-D and 2-D NMR spectra, 
particularly the HSQC spectrum (Figure 2.85), as well as HRCI mass spectrum analysis 
(Figure 2.87), permitted unambiguous characterization of the sulfonamide 318. Examination 
of the 13C and DEPT 135 spectra suggested that compound 318 contained a total of 20 carbon 
nuclei with 3 intense signals (43.2, 36.0 and 29.7 ppm) each representing 3 magnetically 
equivalent carbon nuclei (one methine and two methylene signals) and the characteristic 
bornane signals evidenced previously. The 1H NMR spectrum contained several signals 
expected for the bornane skeleton; however, several new, broad resonances were evident. 
Attention was focused on the HSQC spectrum (Figure 2.85), and the two intense methylene 
signals (43.2 and 36.0 ppm) in the 13C spectrum were found to correlate directly with two of 
the broad signals in the 1H spectrum (1.66 and 2.99 ppm), which integrated for 6 protons each 
and which were assigned to the adamantyl methylene groups. The final intense signal (29.7 
ppm) correlated with another broad signal (2.09 ppm) in the 1H spectrum, which integrated 
for 3 protons and was identified as the adamantyl methine resonance. The 4-H signal at 2.08 
ppm, almost obscured by the adamantyl methine signal, may be assigned by its correlation to 
C-4 (42.8 ppm) in the HSQC spectrum. The broad singlet in the 1H spectrum at 4.95 ppm was 
noted to have no correlations in the 13C spectrum and was assigned to the amide proton. A 
computer-modelled structure of a stable conformation of the sulfonamide 318 is illustrated in 
Figure 2.86.  
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Figure 2.85:  400 MHz HSQC spectrum of N-(1-adamantyl)-2-oxo-bornane-10-sulfonamide 
318 in CDCl3.  
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Figure 2.86:  Computer-modelled representation of a stable conformation of N-(1-
adamantyl)-2-oxo-bornane-10-sulfonamide 318. 
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Figure 2.87:  HRCI mass spectrum, with selected fragments, of N-(1-adamantyl)-2-oxo-
bornane-10-sulfonamide 318.  
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The HRCI mass spectrum of 318 (Figure 2.87) reveals a peak at m/z 365.20387, the odd mass 
being characteristic of a compound containing an odd number of nitrogen atoms; this 
corresponds to the expected molecular formula C20H31NO3S (calculated m/z 365.20247).  
 
Complete characterization of N-(1-adamantyl)-2-oxo-bornane-10-sulfonamide 318 was thus 
completed, and the excellent yield and easy separation of product were most encouraging. 
 
2.3.6.2 Reduction of N-(1-adamantyl)camphor-10-sulfonamide 
 
The reduction of N-(1-adamantyl)-2-oxo-bornane-10-sulfonamide 318 was expected to occur 
in much the same way as phenyl camphor-10-sulfonate 72, but without the problem of sultone 
formation. Endo attack was again expected to favour production of the exo-alcohol. 
 
The stereoselective reduction of analogous phenyl sulfonamides by Ramon et al.241 was 
conducted in EtOH under various conditions. At 0 ºC, an exo: endo ratio of 86:12 was 
observed, while the use of bulky reducing agents, such as N- or L-selectride, improved the 
ratio marginally (88 % exo: 10 % endo). The reduction of the adamantyl analogue 318 was 
carried out with NaBH4 in EtOH/H2O (5:1) at room temperature overnight. Purification by 
radial chromatography afforded the isomeric exo- and endo-alcohols (319 and 328) in 
excellent yield (99 %) with a higher diastereomeric ratio (94 % exo: 6 % endo) than Ramon et 
al.241 had achieved with the phenyl sulfonamides. No trace of any side products was evident, 
confirming that cyclization was unfeasible under these conditions. 
 
Structure elucidation of  the isomeric alcohols 319 and 328 was achieved through detailed 
analysis of the 1H, 13C, DEPT 135 and HSQC NMR data (Figures 2.88 - 2.91) and by 
comparison with data for similar systems, in particular the ketone precursor 318 and the 
phenyl sulfonates 100 and 300. 
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Figure 2.88:  400 MHz HSQC spectrum of N-(1-adamantyl)-2-exo-hydroxybornane-10-
sulfonamide 319 in CDCl3.  
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Figure 2.89:  400 MHz HSQC spectrum of N-(1-adamantyl)-2-endo-hydroxybornane-10-
sulfonamide 328 in CDCl3. 
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Figure 2.90:  400 MHz 1H NMR spectrum, with an expansion showing 2-Hendo and N-H, of 
N-(1-adamantyl)-2-exo-hydroxybornane-10-sulfonamide 319. 
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Figure 2.91:  400 MHz 1H NMR spectrum, with an expansion showing 2-Hexo and N-H, of 
N-(1-adamantyl)-2-endo-hydroxybornane-10-sulfonamide 328.  
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The HSQC spectra (Figures 2.88 and 2.89) show proton-carbon correlations for 319 and 328 
that allow the identification of nuclei whose signals are obscured in the 1H spectra. Both 
compounds show the presence of new hydroxyl signals and the associated 2-H signals. The 
deshielding effect of the hydroxyl group on nearby nuclei facilitated the assignment of 
stereochemistry. The exo-hydroxylic group of 319 causes deshielding of the nearby 8-Me 
group (1.06 ppm) relative to the 9-Me group (0.82 ppm); hence the signals are widely 
separated. The endo-hydroxylic group of the isomeric system 328 exerts minimal effect on the 
8- and 9-Me nuclei and the signals are close together (Figures 2.90 and 2.91).  
 
The complexity of the 1H NMR signals for the 2-Hendo nucleus of 319 and the 2-Hexo nucleus 
of 328 makes detailed coupling analysis impossible (Figures 2.90 and 2.91); however, the 2-
Hendo nucleus (4.06 ppm) is in a more shielded environment than the 2-Hexo nucleus (4.33 
ppm) and, consequentially the signal for the former is found further upfield. The 3-Hendo (1.79 
ppm), 5-Hendo (1.72 ppm) and 6-Hendo (1.69 ppm) signals for the exo-alcohol 319 are found 
further upfield than in the isomeric sulfonamide system 328, in which the 2-endo-hydroxyl 
group causes deshielding of the endo protons, 3-Hendo (2.33 ppm), 5-Hendo (1.82 ppm) and 6-
Hendo (2.41 ppm). The 10-CH2 nuclei of 319 resonate at widely separated shifts (2.92 and 3.49 
ppm) compared to the corresponding signals in the endo-alcohol 328 - a phenomenon 
attributed to the relative proximity of the 2-exo-hydroxyl group in the former isomer (as 
illustrated in Figures 2.92 and 2.93). Computer-modelling also illustrates the close proximity 
of the 2-OHexo proton to the sulfonyl oxygen of the exo-hydroxy-alcohol 319, suggesting the 
possibility of hydrogen bonding, whereas the significant distance between the corresponding 
groups in the endo-hydroxy epimer 328 would suggest the absence of such hydrogen bonding. 
It is, of course, likely that other conformers contribute to the conformational equilibrium.  
 
The HRCI mass spectrum of the 2-exo-alcohol 319 revealed a peak at m/z 367.21993 
corresponding to a compound containing an odd number of nitrogen atoms and to the 
expected molecular formula C20H33NO3S (calculated m/z 367.21812). Similarly the HRCIMS 
analysis of the endo-isomer 328 revealed a peak at m/z 367.21706, which corresponds to the 
same expected molecular formula. 
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Figure 2.92: Computer-modelled representation of a stable conformation of N-(1-
adamantyl)-2-exo-hydroxybornane-10-sulfonamide 319.  
 
 
 
 
 
 
 
 
Figure 2.93: Computer-modelled representation of a stable conformation of N-(1-
adamantyl)-2-endo-hydroxybornane-10-sulfonamide 328.  
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2.3.6.3 Acylation of the N-(1-adamantyl)-2-hydroxybornane-10-sulfonamides  
 
The problems encountered with the acylation of the exo-hydroxy sulfonate 100 were in a large 
part due to the reactive alkoxide and the availability of the phenyl sulfonate moiety to undergo 
nucleophilic substitution. In the case of the acylation of the endo-hydroxy sulfonate 300, the 
endo-orientation of the hydroxyl group prevented the alkoxide from attacking the sulfonate. 
The relative stability of the adamantyl sulfonamides 319 and 328 suggested that the use of a 
strong base, such as NaH or BuLi, would be appropriate. The acylation was attempted by the 
addition of BuLi at -78 ºC and the addition of acryloyl chloride at -10 ºC. The reaction 
mixture was allowed to warm to room temperature overnight, but 1H NMR analysis showed 
no sign of any acrylate signals. This was very surprising considering the strength of the base 
and the fact that the vigorous reaction on quenching meant that the BuLi was indeed very 
active. Attention was then turned to the use of Al2O3 as a catalyst.233 The epimeric alcohols 
319 and 328 were reacted under identical conditions, viz., addition of the alcohol to neutral 
Al2O3 (1.5 eq.) followed by the addition of acryloyl chloride (2 eq.) and stirring at room 
temperature for 96 h. Purification of the crude reaction mixtures proved difficult, but use of 
semi-preparative HPLC permitted the isolation of four novel compounds, 321 and 320 
(Figures 2.94 and 2.95) and 330 and 329 (Figures 2.96 and 2.97). Assignment of the 
stereochemistry was achieved in a similar manner to that used for the acrylate esters 310 and 
296 and the chloroalkyl derivatives 311 and 308. Confirmation of the molecular composition 
of the acrylate esters 321 and 330 was provided by the HRCIMS analysis which revealed 
peaks at m/z 421.22844 and 421.22485, respectively, which correspond to the expected 
molecular formula, C23H35O4NS (calculated m/z 421.22868). Confirmation of the molecular 
composition of the chloroalkyl derivatives 320 and 329 was also provided by the HRCIMS 
data which revealed peaks at m/z 457.21058 and 457.21295, respectively, which correspond 
to the expected molecular formula C23H36O4NS35Cl (calculated m/z 457.20536). The complete 
pathway to the acrylate esters is illustrated in Scheme 2.45 (p. 194). 
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Figure 2.94: 400 MHz 1H NMR spectrum for 2-exo-acryloyloxy-N-(1-adamantyl)bornane-
10-sulfonamide 321 in CDCl3.  
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Figure 2.95: 400 MHz 1H NMR spectrum for N-(1-adamantyl)-2-exo-(3-chloro-
propanoyloxy)bornane-10-sulfonamide 320 in CDCl3. 
 
8-Me       9-Me 
10-CH2  
Ada-CH2 
Ada-CH 
2-Hendo  
N-H 4-H  3’-HZ  3’-HE  
2’-H  
3-CH2 
5-CH2 
6-CH2 
8-Me        9-Me 
10-CH2  
Ada-CH2 
Ada-CH 320  
N-H 
4-H  
3’-CH2  
3-CH2 
5-CH2 
6-CH2 
2’-CH2  
321 
2-Hendo  
ppm 
ppm 
5
6 1
2
34
79
8
10
O
HN 11
16
15
20
1817
19
12 14
13HS
O
O
1'
2'
3'
O
5
6 1
2
34
79
8
10
O
HN 11
16
15
20
1817
19
12 14
13H
S
O
O
1'
2'
3'
O Cl
δ ppm
δ pm      6.00              5.50              5.00              4.50             4.00              3.50             3.00              2.50              2.00              1.50             1.00               
Discussion 
- 193 - 
 
ppm (t1) 1.001.502.002.503.003.504.004.505.005.506.006.50
43 H
 
Figure 2.96: 400 MHz 1H NMR spectrum for 2-endo-acryloyloxy-N-(1-adamantyl)bornane-
10-sulfonamide 330 in CDCl3.  
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Figure 2.97: 400 MHz 1H NMR spectrum for N-(1-adamantyl)-2-endo-(3-chloro-
propanoyloxy)bornane-10-sulfonamide 329 in CDCl3. 
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Scheme 2.45:  Synthetic routes to the chiral Morita-Baylis-Hillman substrates 321 and 330 
and the products 322 - 327. 
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2.3.6.4  Use of the 2-Exo-acryloyloxy-N-(1-adamantyl)bornane-10-sulfonamide 
auxiliary in the Morita-Baylis-Hillman reaction 
 
Computer-modelling was used to visualize possible intramolecular interactions in the 2-exo- 
and 2-endo-acrylate esters 321 and 330, respectively (Figures 2.98 and 2.99). Potential 
approaches of the aldehyde in a Morita-Baylis-Hillman reaction are labelled “a” and “b”. In 
both instances approach “b” seems to be the more likely direction of attack as the large 
adamantyl moiety may be expected to block approach “a” to some degree. In the Morita-
Baylis-Hillman reaction, tertiary amine-catalyzed addition of a zwitterionic enolate 
intermediate to an aldehyde results in the formation of a carbon-carbon bond at the α-position 
of the enolate.102 Following the successful synthesis and encouraging computer-modelling 
analysis of the acrylates 321 and 330, ample motivation was provided for their use in this 
reaction. As the endo-acrylate 330 is by far the minor product, it was necessary to use the exo-
acrylate 321 for subsequent reactions. A range of six structurally varied aldehydes and the 
tertiary amine catalyst DABCO were chosen to effect this transformation with the exo-
acrylate 321 (Scheme 2.46).  
 
 
 
 
 
Figure 2.98: Computer-modelled representation of a stable conformation of 2-exo-
acryloyloxy-N-(1-adamantyl)bornane-10-sulfonamide 321.  
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Figure 2.99: Computer-modelled representation of a stable conformation of 2-endo-
acryloyloxy-N-(1-adamantyl)bornane-10-sulfonamide 330.  
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Scheme 2.46: Morita-Baylis-Hillman reactions of 2-exo-acryloyloxy-N-(1-adamantyl)-
bornane-10-sulfonamide 321. 
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The reactions were conducted in NMR tubes and progress was monitored by 1H NMR 
spectroscopy. The disappearance of the 2’-H and 3’-CH2 vinylic signals of the acrylate 321 
was accompanied by the appearance of the 3’-H, 3’-OH and vinylic methylene signals of the 
new Morita-Baylis-Hillman products 322 - 327. Structure elucidation was achieved through 
the use of 1-D and 2D-NMR analysis and the HSQC spectrum for the product 325 is 
illustrated in Figure 2.100. The remaining products in the series were characterized similarly. 
 
The 13C and DEPT spectra of 325 showed the presence of 30 carbons including: - three 
methyl signals at 20.0, 20.4 and 27.1 ppm (C-8, C-9 and C-9’); three intense signals at 29.5, 
35.8 and 43.2 ppm (adamantyl); four downfield quaternary signals at 143.2, 156.6, 157.9 and 
165.1 ppm (C-1’, C-2’, C-4’ and C-8’); characteristic pyridine signals at 118.6, 122.1 and 
137.4 ppm (C-5’, C-6’ and C-7’); and a methylene signal at 125.4 ppm (C-10’). The HSQC 
spectrum indicated the correlations detailed in Figure 2.100. Crucial observations from the 
spectroscopic data include the absence of the 2’-H and 3’-CH2 acrylate precursor signals and 
the presence of the 3’-H methine signal (5.68 ppm) and the broad 3’-OH signal (5.49 ppm). 
The corresponding acrylate precursor carbon signals (129.0, 130.0 and 164.6 ppm) are absent 
and new product signals are evident at 70.2 ppm (C-3’), 125.4 (C-10’), 143.2 ppm (C-2’) and 
165.1 (C-1’). The stereoselectivity exhibited in these reactions was determined by comparing 
the 10-CH2, 2-Hendo, 3’-H, 8- and/or 9-Me signal integrals of the purified diastereomeric 
mixture (e.g. Figure 2.101) (The signals in the 1H NMR spectra of the crude reaction mixture 
are, in most instances, broad and overlap considerably, thus precluding their use). 
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Figure 2.100: 400 MHz HSQC spectrum of the Morita-Baylis-Hillman product 325 in CDCl3.  
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Figure 2.101: Diastereoselectivity determination of the Morita-Baylis-Hillman product 322. 
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the relative integrals of product and reactant signals in the 1H NMR spectra of the crude 
reaction mixtures after work-up. The overall results are summarized in Table 2.23. 
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Table 2.23: Stereoselectivity data for the Morita-Baylis-Hillman reaction of the chiral 
acrylate ester 321 with selected aldehydes (Scheme 2.46). 
 
Entry Aldehyde Structure Product Yielda  
(%) 
 % d.e.b 
1 
 
4-Pyridinecarbaldehyde 
 N
O
 
322 93 38 
2 
 
2-Pyridinecarbaldehyde 
 
N
O
 
323 99 22 
3 
 
3-Pyridinecarbaldehyde 
 
N
O
 
324 98 60 
4 
6-Methyl-2-
pyridinecarbaldehyde 
 
N
O
 
325 95 95 
5 
 
2-Nitrobenzaldehyde 
 
O
NO2  
326 89 52 
6 
 
Pivaldehyde 
 
O
 
327 0 --- 
 
aYields determined from 1H NMR spectroscopic data of crude reaction mixtures. 
bDiastereomeric excesses determined from the purified reaction mixtures. 
 
Based on the experimental data, the following conclusions can be drawn: 
 
i) Stereoselectivity varies widely (22 – 95 % d.e.). 
ii) 6-Methyl-2-pyridinecarbaldehyde afforded the corresponding product in good yield 
and with significantly higher diastereomeric excess. 
iii) All the reactions proceeded relatively quickly (90 h) for typical Morita-Baylis-
Hillman reactions. 
iv) In general, very good yields were obtained (89 – 99 %) with the exception of 
pivaldehyde, where no reaction was observed. The carbonyl moiety of this aldehyde 
may be too sterically hindered to allow approach of the Morita-Baylis-Hillman 
zwitterion. 
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2.4 CONCLUSIONS 
 
This project has involved an integrated approach to:- the synthesis of a range of camphor-
derived scaffolds for use in asymmetric synthesis; an investigation of their configurational 
and conformational features; and NMR-based kinetic-mechanistic and computational studies 
of an unexpected intramolecular transesterification. 
 
More specifically, spectroscopic (1- and 2-D NMR) methods have been used to establish, 
unambiguously, the structures of two camphor ketols, and their reduction to mono- and 
dihydroxy derivatives has been explored. “Dimer I” has been shown to afford a 3’-exo-
hydroxy derivative, a 2-exo-3’-endo-dihydroxy derivative and a 2-exo-3’-exo-dihydroxy 
derivative, while “dimer II” gave a 3-exo-2’-endo-dihydroxy derivative as the major product, 
together with a small amount of a 3-exo-2’-exo-dihydroxy derivative. Not unexpectedly, the 
reduction of both dimers involved preferential hydride delivery from the less sterically-
hindered endo-face – an observation attributed to substantial blocking of the endo-face of the 
endo-orientated monomeric units.  
 
In contrast to earlier results,122 alkylation of a specially prepared camphor-derived 
iminolactone was found to afford monoalkylated rather than dialkylated products. Alkylation 
yields of 52 – 65 % were obtained with diastereoselectivities of up to 85 % d.e – results 
consistent with those reported by Xu et al.172,173 and with our original expectation123 that the 
iminolactone scaffold could be used to construct chiral α-amino acids.  
 
The search for novel substrates for use in the chiral Morita-Baylis-Hillman reaction led to the 
identification of a monoacylated camphor-derived molecule with potential for participating in 
hydrogen bonding in the transition state complex. Synthesis afforded the 2-exo- and 3-exo-
acrylate esters together with the diacrylate ester. The observation of an unexpected 
transesterification equilibrium between the monoacrylate esters led to a detailed 1H NMR 
kinetic study of the reaction in various media and at different temperatures. The results 
indicated that first-order forward and reverse reactions were occurring concurrently and, in all 
instances, the rate constant of the forward reaction, (k+1), was found to be ca. 10 % faster than 
that for the reverse reaction (k-1). Acid-catalysis was found to be of great significance, if not 
imperative, in catalysing the process. The catalysed and uncatalysed reactions were further 
Discussion 
- 202 - 
explored in detail through calculations at the DFT level, and a thorough potential energy 
surface scan confirmed the probability of both reactions occurring, although the catalysed 
pathway is favoured.  
 
Continued design and synthesis of suitable substrates for use in the chiral Morita-Baylis-
Hillman reaction, led to several potential candidates with bulky moieties at the C-10 position. 
Several synthetic steps afforded phenyl 2-exo-acryloyloxybornane-10-sulfonate and the endo-
isomer, each step giving excellent yields of 92 – 98 %. These compounds were then acylated 
to give acryloyloxy derivatives together with the related chlorinated competition products in 
excellent yields of up to 97 %. However, the route was plagued by problems related to the 
ready cyclization to afford Oppolzer’s sultone. An alternative approach to a bulky C-10 
moiety involved the use of adamantylamine. Yields of the acrylate esters were again 
excellent, and the use of 2-exo-acryloyloxy-N-(1-adamantyl)bornane-10-sulfonamide as a 
Morita-Baylis-Hillman substrate was explored. Analysis of the results showed that yields 
were high (89 – 99 %) and that stereoselectivity varied widely (22 – 95 % d.e.) with 6-methyl-
2-pyridinecarbaldehyde affording the corresponding product in good yield and with the 
highest diastereomeric excess. Furthermore, all the reactions proceeded relatively quickly (90 
h) for typical Morita-Baylis-Hillman reactions.  
 
Future research is expected to focus on: 
 
i) The use of the dimeric camphor-derived ethers in the construction of chiral reagents, 
such as chirally modified lithium aluminium hydride. 
ii) Fission of Oppolzer’s sultone to afford the phenyl sulfonyl ester, and use of this and 
the phenyl sulfonate esters in the Morita-Baylis-Hillman reaction. 
iii) Exploration of the stereoselectivity afforded by the endo-adamantylamine 
sulfonamide in the Morita-Baylis-Hillman reaction.
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3. EXPERIMENTAL 
 
3.1.  GENERAL 
 
3.1.1 Analysis 
 
All melting points were determined using a Kofler hot-stage apparatus and are uncorrected. 
NMR spectra were obtained on a Bruker AMX400 spectrometer at 303 K in CDCl3 unless 
otherwise stated. Spectra were calibrated using the residual protonated solvent signals in 
CDCl3 (7.25 ppm for 1H and 77.0 for 13C) or in DMSO-d6 (2.5 ppm for 1H and 39.7 ppm for 
13C). Coupling constants are given in hertz (Hz). Infra-red spectra were obtained for samples 
analysed as KBr discs on a Perkin Elmer FT-IR Spectrum 2000 spectrophotometer. Low-
resolution mass spectrometry was carried out on a Finnigan GCQ mass spectrometer using the 
electron impact (EI) mode, whilst HRCI mass spectra were obtained on a double focusing 
Kratos MS 80RF mass spectrometer (Cape Technikon Mass Spectrometry Unit). Optical 
rotations were measured on a Perkin Elmer 141 polarimeter using a 1 dm cell, with 
concentrations cited in g / 100 mL. Optically pure compounds were derived from 
commercially available, homochiral, (1R)-(+)-camphor.  
 
The atom numbering used in quoting NMR data generally follows systematic nomenclature. 
However, given the complexity of certain systems, trivial names are sometimes used to 
facilitate recognition and the numbering follows accordingly. Where necessary, the 
numbering is illustrated by appropriate examples. 
 
3.1.2 Chromatography 
 
Semi-preparative HPLC separations were achieved on a Whatman Partisil 10 Magnum 6 
normal phase column using a Spectra-Physics P100 isocratic pump and a Waters RI410 
differential refractometer detector. Flash chromatography was conducted using Merck silica 
gel 60 PF254. Chromatotron plates were prepared using silica gel 60 PF254 containing CaSO4. 
Routine thin layer chromatography (TLC) was carried out on pre-coated Merck silica gel 
PF254 plates, which were visualised using UV light (254 nm) or I2 vapour. 
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3.1.3 Solvents 
 
Solvents were dried using conventional methods as described by Perrin and Armarego.242 
Thus: - THF was pre-dried over CaH2 and then distilled from Na wire and benzophenone 
under dry N2. Et2O was pre-washed with aq. ferrous sulfate and with water, to remove 
peroxides, and then pre-dried over CaH2; this was followed by distillation from Na wire and 
benzophenone under dry N2. EtOH was dried by reaction with Mg turnings and iodine and 
then distilled from the resulting Mg(OEt)2 under dry N2. DMF was refluxed over 4Å 
molecular sieves, distilled under reduced pressure and stored over 4Å molecular sieves, all 
under dry N2. Acetonitrile was stored for several hours over 4Å molecular sieves. All 
reactions requiring anhydrous conditions were conducted in heat-gun or flame-dried 
glassware under an inert atmosphere of dried spectroscopic grade nitrogen or argon. NaH was 
washed free of oil prior to use, with dry hexane (3 aliquots) and then with the dry solvent to 
be used in the subsequent reaction.  
 
3.1.4 Computational Methods 
 
3.1.4.1 Molecular mechanics calculations 
 
The Accelrys Cerius2 software package,243 and running on an SGI O2 unix-based platform, 
was used exclusively to perform molecular mechanics calculations. The Universal Force Field 
was used as the default setting, as it is a general-purpose force-field, parameterised and 
validated for the complete periodic table. Structures ware drawn, cleaned and minimized 
before running isothermal molecular dynamics routines in order to locate the lowest energy 
conformers. 
 
3.1.4.2 Density functional theory calculations 
 
All calculations for the determination of thermodynamic parameters were performed on 
Pentium 4 PCs at the density functional theory (DFT) level, using the Gaussian-03223 
computational package and the Becke-three-parameter, Lee-Yang-Parr (B3LYP) method, 
with a middle-high basis set. The preferred level of theory for calculations involving general 
structures being B3LYP/6-311++G(d,p) but, where extended mechanistic calculations were 
Experimental 
- 205 - 
necessary, the B3LYP/6-31+G(d) method was used throughout (a requirement for accurate 
comparison of data).  
Mechanistic studies required geometry optimization of ground state and putative intermediate 
molecules, followed by potential energy scans to determine transition state structures. All the 
structures identified as stationary points were subjected to frequency analysis to confirm their 
identities as either equilibrium geometries (zero imaginary frequencies) or as transition states 
(one imaginary frequency) and, additionally, to obtain thermodynamic parameters for the 
structures. The energies of the structures are reported as Gibbs free energies at 298.15 K. 
Intrinsic reaction coordfinate (IRC) calculations were performed to verify that a given 
transition structure actually connects the starting material and product structures, and the 
activation energies were calculated by comparison of zero-point corrected energies of the 
reactants and transition states. 
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3.2 SYNTHETIC PROCEDURES 
 
3.2.1 Dibornyl Ethers 
  
Camphorquinone 22 
Selenium dioxide (100.89 g, 909 mmol) was added to a stirred solution of (1R)-(+)-camphor 
16 (81.25 g, 534 mmol) in acetic anhydride (80 mL). The resulting suspension was boiled 
under reflux for 5 h and thereafter stirred vigorously at 30 ºC overnight. The black selenium 
powder was filtered off and washed with a minimal volume of glacial acetic acid to remove 
the yellow crystals. The filtrate was then neutralized with 10 % aqueous NaOH at 0 ºC, and 
the resulting yellow precipitate was filtered off and washed with a minimum amount of water 
and suction-dried. The yellow solid was then dissolved in petroleum ether (80 – 100 ºC) and 
the residual aqueous layer removed. The organic layer was concentrated in vacuo until 
crystallization began, and then heated to boiling to redissolve the crystals. Initial slow 
crystallization occurred on cooling to room temperature and further crystallization was 
induced by storing overnight at 10 ºC. Filtration afforded bright yellow crystals of: 
camphorquinone 22 (74.59 g, 84.1 %); mp. 189-194 ºC (lit.,244 198 – 201 ºC); νmax / cm-1 
(CHCl3) 1770 and 1750 (C=O); δH (400 MHz; CDCl3) 0.92, 1.05 and 1.09 (9H, 3 × s, 8-, 9- 
and 10-Me), 1.58 - 2.21 (4H, complex of multiplets, 5- and 6-CH2) and 2.61 (1H, d, J 5.2 Hz, 
4-H); δC (100 MHz; CDCl3) 8.8, 17.4 and 21.1 (C-8, C-9 and C-10), 22.3 and 29.9 (5-C and 
6-C), 42.6 and 58.0(C-1 and C-7), 58.7 (C-4) and 202.8 and 204.7 (C-2 and C-3). 
 
3,3-(Ethylenedioxy)-2-exo-hydroxybornane 210 
Method 1 
A solution of 3,3-(ethylenedioxy)-2-bornanone 232 (2.01 g, 9.6 mmol) in dry Et2O (50 mL) 
was added under N2 to a stirred slurry of LiAlH4 (0.52 g, 14 mmol) in dry Et2O at 0 ºC. The 
mixture was allowed to warm to room temperature and then boiled under reflux for 3 h. The 
reaction was then quenched with moist ether and the resulting precipitate removed by 
filtration. The organic layer was subsequently dried over anhydrous MgSO4 and concentrated 
in vacuo to give an oil, which was chromatographed [using silica gel on a chromatotron, 4 
mm plate; elution with hexane-EtOAc (9:1)]  to afford: 
3,3-(ethylenedioxy)-2-exo-hydroxybornane 210 as an oil (1.42 g, 69.9 %) (Found: M+, 
212.14216. C12H29O3 requires M, 212.14124); νmax / cm-1 (CHCl3) 3020 (OH); δH (400 MHz; 
CDCl3) 0.82, 0.89 and 1.08 (9H, 3 × s, 8-, 9- and 10-Me), 1.47 - 1.75 (5H, complex of 
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multiplets, 4-CH, 5- and 6-CH2), 2.35 (1H, br s, OH), 3.27 (1H, s, 2-H) and 3.80 - 4.03 (4H, 
complex of multiplets, OCH2CH2O); δC (100 MHz; CDCl3) 10.9, 20.8 and 21.1 (C-8, C-9 and 
C-10), 21.4 (C-5), 33.5 (C-6), 47.6 and 49.7 (C-1 and C-7), 52.8 (C-4), 63.6 and 65.7 
(OCH2CH2O), 85.6 (C-2) and 115.3 (C-3); m/z 212 (M+, 15.65 %) and 127 (100). 
Method 2 
A suspension of LiAlH4 (0.86 g, 23 mmol) in dry Et2O (100 mL) was boiled under reflux in 
an atmosphere of dry N2 for 1 h. A solution of 3,3-(ethylenedioxy)-2-bornanone 232 (4.52 g, 
21.5 mmol) in Et2O was added drop-wise, and the resulting mixture boiled under reflux for 3 
h and then stirred overnight. The reaction was quenched by the sequential addition of 3M 
NaOH (3 mL) and H2O (3 mL). The resulting white precipitate was filtered off and washed by 
boiling in EtOAc for 1 h. The combined filtrates were then extracted with EtOAc (3 × 20 
mL), and the combined extracts dried over anhydrous MgSO4 and concentrated in vacuo. The 
crude residue was chromatographed [flash chromatography on silica gel; elution with hexane-
EtOAc (19:1)] to afford: 
3,3-(ethylenedioxy)-2-exo-hydroxybornane 210 (3.41 g, 74.7 %).  
 
2,2-(Ethylenedioxy)-3-exo-hydroxybornane 211 
The experimental procedure (Method 2) described for the synthesis of 3,3-(ethylenedioxy)-2-
exo-hydroxybornane 210 was followed, using 2,2-(ethylenedioxy)-3-bornanone 235 (2.02 g, 
9.6 mmol) and LiAlH4 (0.14 g, 3.7 mmol). Work-up and flash chromatography [elution with 
hexane-ethyl acetate (9:1)] afforded, as white crystals: 
2,2-(ethylenedioxy)-3-exo-hydroxybornane 211 (1.78 g, 87.3 %) (Found: M+, 212.14206. 
C12H29O3 requires M, 212.14124); [α]23D = -26.1º; νmax / cm-1 (CHCl3) 3045 (OH); δH (400 
MHz; CDCl3) 0.80, 0.81 and 1.07 (9H, 3 × s, 8-, 9- and 10-Me), 1.06 - 1.83 (5H, series of 
multiplets, 4-CH, 5- and 6-CH2), 2.54 (1H, br s, OH), 3.43 (1H, s, 3-H) and 3.72 - 4.07 (4H, 
m, OCH2CH2O); δC (100 MHz; CDCl3) 9.3, 21.2 and 21.7 (C-8, C-9 and C-10), 24.6 (C-5), 
29.1 (C-6), 47.8 and 51.8 (C-1 and C-7), 51.6 (C-4), 63.9 and 66.6 (OCH2CH2O), 83.0 (C-3) 
and 116.9 (C-2); m/z 212 (25 %) and 162 (100). 
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2’-endo-3-exo-dibornyl ether 214 (“dimer I”) and 2-endo-3’-exo-dibornyl ether 215 (“dimer 
II”) 
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A solution of 3-exo-hydroxybornan-2-one 231 (0.53 g, 3.2 mmol) and p-toluenesulfonic acid 
(0.04 g, 0.2 mmol) in dry benzene (12 mL) was boiled under reflux for 14 h using a Dean-
Stark trap to remove water. The reaction mixture was then cooled and quenched with water (5 
mL). The resulting mixture was extracted with EtOAc (4 × 5 mL) and the organic layers were 
combined and dried over anhydrous MgSO4. The solvent was removed in vacuo to give an 
oil, which was chromatographed [flash chromatography on silica gel; elution with hexane-
EtOAc (9:1)] to afford two colourless crystalline products: 
2’-endo-3-exo-dibornyl ether 214 (“dimer I”) (0.22 g, 44.4 %); m.p. 106 - 108 ºC (lit.,123 104 
ºC) (Found: M+, 318.22067. C20H30O3 requires M, 318. 21950); νmax / cm-1 (CHCl3) 1730 
(C=O); δH (400 MHz; CDCl3) 0.87 (1H, s, 10Me), 0.89 (1H, s, 8’-Me), 0.90 (1H, s, 9-Me), 
0.92 (1H, s, 9’-Me), 0.94 (1H, s, 8-Me), 1.01 (1H, s, 10’-Me), 1.28 - 1.44, 1.546 - 1.65 and 
1.86 - 1.99 (8H, complex of multiplets, 5-, 5’-, 6- and 6’CH2), 2.14 (1H, d, J 4.4 Hz, 4’-H), 
2.16 (1H, d, J 4.8 Hz, 4H), 3.93 (1H, s, 3-H) and 3.98 (1H, s, 2’-H); δC (100 MHz; CDCl3) 9.0 
(C-10), 13.0 (C-10’), 17.7 (C-8’), 19.4 (C-9’), 19.8 (C-9), 21.2 (C-8), 24.0 (C-5’), 24.9  (C-5), 
25.9 (C-6’), 29.0 (C-6), 42.7 (C-7), 46.3 (C-1’), 49.3 (C-4), 50.3 (C-7’), 57.3 (C-1), 60.0 (C-
4’), 84.2 (C-3), 85.5 (C-2’), 217.3 (C-3’), 218.4 (C-2); m/z 318.1(M+, 18.1 %) and 123 (100); 
and  
2-endo-3’-exo-dibornyl ether 215 (“dimer II”) (0.21 g, 41.3 %); m.p. 98-102 ºC (lit.,123 102 
ºC) (Found: M+, 318.21969. C20H30O3 requires M, 318.21950); νmax / cm-1 (CHCl3) 1730; δH 
(400 MHz; CDCl3) 0.82 (1H, s, 8’-Me), 0.85 (1H, s, 10’Me), 0.86 (1H, s, 8-Me), 0.95 (1H, s, 
9’-Me), 0.96 (1H, s, 10-Me), 0.97 (1H, s, 9-Me), 1.35 - 1.45, 1.57 - 1.70 and 1.76 - 1.91 (8H, 
complex of multiplets, 5-, 5’-, 6- and 6’CH2), 2.05 (1H, d, J 4.3 Hz, 4-H), 2.31 (1H, t, J 4.3 
Hz, 4’H), 3.81 (1H, s, 2-Hendo), 4.25 (1H, s, J 5.0 Hz, 3’-Hexo); δC (100 MHz; CDCl3) 9.3 (C-
10’), 10.5 (C-10), 18.5 (C-8), 18.70 (C-9’), 18.74 (C-6’), 19.9 (C-8’), 20.7 (C-5), 21.4 (C-9), 
 
214 
“Dimer I” 
215 
“Dimer II” 
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31.8 (C-5’), 33.4 (C-6), 42.6 (C-7’), 46.1 (C-7), 48.3 (C-4’), 50.0 (C-1), 58.4 (C-1’), 59.2 (C-
4), 81.6 (C-3’), 85.6 (C-2), 217.9 (C-3) and 218.0 (C-2’); m/z 318 (M+, 35.5 %) and 123 
(100). 
 
2-endo-3’-exo-dibornyl ether 215 (“dimer II”) 
The experimental procedure employed for the synthesis of “dimers I and II”, 214 and 215 was 
followed, using 2-exo-hydroxybornan-3-one 233 (0.80 g, 4.8 mmol) and p-toluenesulfonic 
acid (0.06 g, 0.3 mmol) in dry benzene (7 mL) and refluxing for 23 h to afford the crystalline 
product: 
2-endo-3’-exo-dibornyl ether 215 (“dimer II”) (1.23 g, 81.3 %). 
 
3-Exo-hydroxybornan-2-one 231 
Method 1 
1M-HCl (7 mL) was added to a solution of 2,2-(ethylenedioxy)-3-exo-hydroxybornane 211 
(1.53 g, 7.21 mmol) in THF (4 mL). The resulting mixture was gently boiled under reflux for 
2.5 h. The HCl was then neutralised with 3 M-NaOH (2.5 mL). The organic solvent was 
removed in vacuo and the residue extracted with EtOAc (4 × 5 mL). The organic layers were 
combined and dried with anhydrous MgSO4, then concentrated in vacuo to give an oil, which 
was chromatographed [flash chromatography on silica gel; elution with hexane-ethyl acetate 
(9:1)] to afford, as white crystals: 
3-exo-hydroxybornan-2-one 231 (0.69 g, 57 %); m.p.  164 -166 ºC (lit.,173 166 - 168 ºC); νmax / 
cm-1 (CHCl3) 3560 (OH) and 1340 (C=O); δH (400 MHz; CDCl3) 0.90, 0.92 and 0.97 (9H, 3 × 
s, 8-, 9- and 10-Me), 1.30 - 2.22 (4H, complex of multiplets, 5- and 6-CH2), 2.07 (1H, d, J 4.6 
Hz, 4-H), 2.95 (1H, br s, OH) and 3.72 (1H, s, 3-H); δC (100 MHz; CDCl3) 9.0, 20.1 and 21.0 
(C-8, C-9 and C-10), 25.2 and 28.6 (C-5 and C-6), 48.7 (C-1), 49.3 (C-7),  57.1 (C-4), 77.4 
(C-3) and 220.2 (C-2); m/z 168. 
Method 2 
Activated Raney nickel (3.50 g) was added to a solution of camphorquinone 22 (6.22 g, 37.4 
mmol) in absolute ethanol under N2. H2 was then allowed to flood the system and the solution 
was stirred under H2 (1 atm) overnight. Approximately 1.2 L of H2 was taken up by the 
reaction. Removal of the Raney nickel was achieved by filtering the reaction mixture through 
celite under a blanket of N2. The filtrate was concentrated in vacuo, recrystallised from 
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petroleum ether (80 – 100 ºC) and washed with hexane {or, alternatively, chromatographed 
[flash chromatography on silica gel; elution with hexane-ethyl acetate (7:3)]} to afford: 
3-exo-hydroxybornan-2-one 231 (5.69 g, 90.4 %) 
 
3,3-(Ethylenedioxy)-2-bornanone 232 and 2,2;3,3-bis(ethylenedioxy)bornane 234 
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Ethylene glycol (50 mL, 720 mmol) and p-toluenesulfonic acid (1.56 g, 8.2 mmol) were 
added to a solution of camphorquinone 22 (25.08 g, 150.9 mmol) in dry benzene (120 mL). 
The solution was then refluxed in a flask equipped with a Dean-Stark trap for 24 h. The cool 
reaction mixture was washed with 1M-NaOH (100 mL) and H2O (100 mL). The organic layer 
was separated, dried over anhydrous MgSO4 and concentrated in vacuo. The oil obtained was 
stored for seven days at 10 ºC to allow crystallization to take place. Filtration of the mixture 
gave a solid which was recrystallised from hot EtOH to afford transparent needles of: 
3,3-(ethylenedioxy)-2-bornanone 232 (16.24 g, 51.2 %); m.p. 86 – 88 ºC (lit.,124 88 ºC); νmax / 
cm-1 (CHCl3) 1740 (C=O); δH (400 MHz; CDCl3) 0.89, 0.96 and 1.00 (9H, 3 × s, 8-, 9- and 
10-Me), 1.52 - 2.01 (4H, complex of multiplets, 5- and 6-CH2), 1.94 - 1.95 (1H, m, 4-H) and 
3.93 - 4.30 (4H, complex of multiplets, OCH2CH2O); δC (100 MHz; CDCl3) 9.2 (C-10), 19.0 
(C-9), 21.4 (C-5), 21.5 (C-8), 30.9 (C-6), 43.6 (C-7), 51.5 (C-1), 58.2 (C-4), 64.5 and 66.1 (C-
1’ and C-2’), 106.9 (C-3) and 217.4 (C-2); m/z 210 (M+, 11 %) and 162 (100). 
 
The mother liquor was further concentrated and then chromatographed [flash chromatography 
on silica gel; elution with hexane-ethyl acetate (9:1)] to afford more 232 and, as transparent 
needles: 
2,2;3,3-bis(ethylenedioxy)bornane 234 (16.49 g, 43.0 %); m.p. 58 ºC (lit.,124 59 - 60 ºC) 
(Found: M+, 254.15222. C14H22O4 requires M, 254.15181); νmax / cm-1 (KBr) 1240 (C-O) 
 δH (400 MHz; CDCl3) 0.78, 0.85 and 1.16 (9H, 3 × s, 8-, 9- and 10-Me), 1.29 - 1.97 (4H, m, 
5- and 6-CH2) and 3.72 - 3.96 (8H, complex of multiplets, 2 × OCH2CH2O), 1.67 (1H, d, 4-
H); δC (100 MHz; CDCl3) 9.9 (C-10), 20.7 (C-9), 21.0 (C-5), 21.1 (C-8), 29.3 (C-6), 44.5 (C-
232  234 
Experimental 
- 211 - 
7), 52.7 (C-1), 53.3 (C-4), 64.2, 64.5, 65.0, 65.9 (OCH2CH2O), 113.8 (C3) and 114.7 (C-2); 
m/z 254 (M+, 26.8 %) and 113 (100).  
 
2-Exo-hydroxybornan-3-one 233 
The experimental procedure described for the synthesis of 3-exo-hydroxybornan-2-one 231 
(Method 1) was followed, using 3,3-(ethylenedioxy)-2-exo-hydroxybornane 210 (1.22 g; 5.7 
mmol) and 1-M HCl (5.8 mL). Work-up and flash chromatography [elution with hexane-ethyl 
acetate (9:1)] afforded, as white crystals: 
2-exo-hydroxybornan-3-one 233 (0.43 g, 45.0 %); m.p. 223 - 224 ºC (lit.,134 228 - 230 ºC) 
(Found: M+, 168.1143. C10H16O2 requires M, 168.11503); νmax / cm-1 (CHCl3) 3550 and (OH) 
1750 (C=O); δH (400 MHz; CDCl3) 0.91, 1.00 and 1.02 (9H, 3 × s, 8-, 9- and 10-Me), 1.33 - 
1.95 (4H, complex of multiplets, 5- and 6-CH2), 2.15 (1H, d, 4-H), 2.78 (1H, br s, OH) and 
3.51 (1H, s, 2-H); δC (100 MHz; CDCl3) 10.3 (C-10), 18.9 (C-9), 20.3 (C-5), 21.1 (C-8), 33.9 
(C-6), 46.6 (C-1), 49.2 (C-7), 58.7 (C-4), 79.5 (C-2) and 218.7 (C-3); m/z 168 (M+, 58.5 %) 
and 71 (100). 
 
2,2-(Ethylenedioxy)-3-bornanone 235 
Method 1 
1M-Hydrochloric acid (4 mL) was added to a stirred solution of 2,2;3,3-bis(ethylenedioxy)-
bornane 234 (0.23 g, 0.9 mmol) in THF (15 mL) and the resulting solution was stirred for 40 
h at room temperature. The reaction mixture was concentrated in vacuo, washed with brine (3 
× 3 mL) then extracted into EtOAc (3 × 10 mL). The organic layers were combined, and dried 
over anhydrous MgSO4. The solvent was removed in vacuo to give an oil, which was 
chromatographed [using silica gel on a chromatotron, 1 mm plate; elution with hexane-EtOAc 
(9:1)] yielding: 
2,2-(ethylenedioxy)-3-bornanone 235 as a colourless crystalline solid (0.081 g, 35.8 %); m.p. 
43 - 44 ºC (lit.,124 42 - 44 ºC); νmax / cm-1 (CHCl3) 1756 (C=O); δH (400 MHz; CDCl3) 0.87, 
0.92 and 1.01 (9H, 3 × s, 8-, 9- and 10-Me), 1.49 - 2.06 (4H, complex of multiplets, 5- and 6-
CH2), 2.13 (1H, d, J 5.4 Hz, 4-H) and 3.91 - 4.29 (4H, complex of multiplets, OCH2CH2O); 
δC (100 MHz; CDCl3) 8.7, 18.2 and 21.5 (C-8, C-9 and C-10), 22.7 (C-5), 29.2 (C-6), 43.7 
and 51.3 (C-1 and C-7), 59.2 (C-4), 64.8 and 66.3 (OCH2CH2O), 107.4 (C-2) and 216.6 (C-3); 
m/z 210 (14 %) and 162 (100). 
Method 2 
p-Toluenesulfonic acid (1.80 g, 9.5 mmol) was added to a stirred solution of 2,2;3,3-
Experimental 
- 212 - 
bis(ethylenedioxy)bornane 234 (3.05 g, 12.0 mmol) in aqueous methanol (1:1; 40 mL) and the 
resulting solution was boiled under reflux for 9 h. The reaction mixture was neutralised with 
1M-NaOH (15 mL) and concentrated in vacuo. The residual aqueous layer was extracted with 
EtOAc (3 × 20 mL). The organic layers were combined, washed with brine and dried over 
anhydrous MgSO4. The solvent was removed in vacuo to give, as a colourless crystalline 
solid: 
2,2-(ethylenedioxy)-3-bornanone 235 (2.30 g, 91.4 %). 
 
3’-Exo-hydroxy-2’-endo-(2-oxo-3-exo-bornyl)bornane 254, 3’-exo-hydroxy-2’-endo-(2-exo-
hydroxy-3-exo-bornyl)bornane 259 and 3’-endo-hydroxy-2’-endo-(2-exo-hydroxy-3-exo-
bornyl)bornane 258 
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Sodium borohydride (0.05 g, 1.4 mmol) was slowly added to a stirred solution of, 2’-endo-3-
exo-dibornyl ether 214 (“dimer I”) (0.10 g, 0.3 mmol) in ethanol (2 mL) at -10 ºC. The 
solution was stirred at 0 ºC for 2 h and then at room temperature for a further 14 h. The 
reaction was then quenched by the addition of H2O and the solvent evaporated in vacuo to 
give an oil, which was chromatographed [using silica gel on a chromatotron, 1mm plate; 
elution with hexane-EtOAc (6:1)]  to afford three white crystalline products: 
3’-exo-hydroxy-2’-endo-(2-oxo-3-exo-bornyl)bornane 254 (0.003 g, 3.2 %); m.p. 194-196ºC 
(lit.,122 196 ºC) (Found: M+, 320.2332. C20H32O3 requires M, 320.2351); νmax / cm-1 (CHCl3) 
3320 (OH) and 1680 (C=O); δH (400 MHz; CDCl3) 0.84, 0.86, 0.87, 0.89, 0.90 and 0.98 
(18H, 6 × s, 8-, 8’-, 9-, 9’-, 10- and 10’-Me), 1.24 – 2.08 (8H, complex of multiplets, 5-, 5’-, 
6- and 6’-CH2), 2.12 and 2.23 (2H, 2 × d, 4- and 4’-H), 2.20 (1H, br s, 3’-OH), 2.59 (1H, s, 
3’-H) and 3.91 and 4.11 (2H, 2 × s, 2’-H and 3-H); δC (100 MHz; CDCl3) 8.8, 12.8, 16.7, 
19.3, 20.3 and 22.1, (C-8, C-8’, C-9, C-9’, C-10 and C-10’), 24.1 and 24.6 (C-6 and C-6’), 
25.9 and 28.8 (C-5 and C-5’), 42.4 and 47.5 (C-7 and C-7’), 48.9 and 51.9 (C-1 and C-1’), 
 254 259 258 
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49.2 and 60.1 (C-4 and C-4’), 66.8 (C-3’), 84.9 and 85.6 (C-2’ and C-3) and 210.0 (C-2); m/z 
320 (18 %);  
3’-exo-hydroxy-2’-endo-(2-exo-hydroxy-3-exo-bornyl)bornane 259 (0.041 g, 41.1 %)(Found: 
M+, 322.25012. C20H34O3 requires M, 322.25080); δH (400 MHz; CDCl3) 0.79, 0.82, 0.89, 
0.93, 0.97 and 1.05 (18H, 6 × s, 8-, 8’-, 9-, 9’-, 10- and 10’-Me), 0.81 – 1.75 (8H, complex of 
multiplets, 5-, 5’-, 6- and 6’-CH2), 1.64 (1H, m, 4’-H), 1.70 (1H, m, 3’-OHexo), 1.88 (1H, d, J 
4.9 Hz, 4-H), 3.02 (1H, d, 4.2 Hz, 2-OHexo) and 3.56 – 3.66 (4H, complex of multiplets, 2-
Hendo, 3-Hendo, 2’-Hexo, 3’-Hendo); δC (100 MHz; CDCl3) 13.4, 19.5, 10.9, 20.6, 21.1 and 21.8 
(C-8, C-8’, C-9, C-9’, C-10 and C-10’), 24.1, 25.5, 26.2 and 33.0 (C-5, C-6, C-5’ and C-6’), 
29.7, 46.6, 48.7, 50.3 (C-1, C-7, C-1’ and C-7’), 49.8 and 53.0 (C-4 and C4’) and 79.9, 82.5, 
84.2 and 94.7 (C-2, C-3, C-2’ and C-3’); m/z 322 (M+, 1.2 %) and 95 (100); and  
3’-endo-hydroxy-2’-endo-(2-exo-hydroxy-3-exo-bornyl)bornane 258 (0.045 g, 45.3 %) 
(Found: M+, 322.24999. C20H34O3 requires M, 322.25080); δH (400 MHz; CDCl3)  0.80, 0.85, 
0.86, 0.88, 0.93 and 1.12 (18H, 6 × s, 8-, 8’-, 9-, 9’-, 10- and 10’-Me), 1.12 - 1.75 (8H, 
complex of multiplets, 5-, 5’-, 6- and 6’-CH2), 1.83 (1H, t, J 4.0 Hz, 4’-H), 1.90 (1H, d, J 4.7 
Hz, 4-H), 2.42 (1H, d, J 6.6 Hz, 3’-OHendo), 2.67 (1H, d, J 4.1 Hz, 2-OHexo), 3.56 - 3.64 (3H, 
complex of multiplets, 2’-H, 3-H, 2-H) and 4.20 (1H, s, 3’-H); δC (100 MHz; CDCl3) 10.8, 
14.7, 17.8, 18.3, 19.9 and 21.1, (C-8, C-8’, C-9, C-9’, C-10 and C-10’), 21.5 (C-5), 24.3 (C-
5’), 26.6 (C-6), 32.8 (C-6’), 44.4 and 46.5 (C-1 and C-1’), 49.0, 49.7, 50.4 and 50.5 (C-4, C4’, 
C-7 and C-7’), 67.8 (C-3’), 80.0 (C-2) and 85.9 and 87.6 (C-2’ and C-3); m/z 322 (M+, 2.2 %) 
and 95 (100). 
 
2’-Endo-hydroxy-3’-endo-(3-exo-hydroxy-2-exo-bornyl)bornane 260 and 2’-exo-hydroxy-3’-
endo-(3-exo-hydroxy-2-exo-bornyl)bornane 255 
ARD 14OH2
1
3
2'
3'
1'HH
H2
O
OH
1
3
2'
3'
1'HOH
H2
O
OH
ARD 14iii
H HO
 
The experimental procedure employed for the synthesis of 3-exo-hydroxy-2-endo-(2-oxo-3-
endo-bornyl) 254 was followed, using 2-endo-3’-exo-dibornyl ether 215 (“dimer II”) (0.24 g, 
0.8 mmol), NaBH4 (0.05 g, 1.4 mmol), and ethanol (3 mL). Work-up and purification 
260 255 
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[chromatography on silica gel on a chromatotron, 1 mm plate; elution with hexane-EtOAc 
(9:1)] afforded two white crystalline products: 
2’-endo-hydroxy-3’-endo-(3-exo-hydroxy-2-exo-bornyl)bornane  260 (0.11 g, 46.8 %)(Found: 
M+, 322.48198. C20H34O3 requires M, 322.48216); νmax / cm-1 (CHCl3) 3310 (OH); δH (400 
MHz; CDCl3) 0.78, 0.83, 0.84, 0.87, 1.01 and 1.11 (18H, 6 × s, 8-, 8’-, 9-, 9’-, 10- and 10’-
Me), 1.14 - 1.94 (8H, complex of multiplets (5-, 5’-, 6- and 6’CH2), 2.33 and 2.59 (2H, 2 × s, 
4 and 4’H), 3.50 (1H, d, J 6.8 Hz, 2-H) and 3.76 - 3.96 (3H, 2 × m, 2’H, 3-H and 3’-H); δC 
(100 MHz; CDCl3) 11.7, 14.1, 18.3, 18.8, 19.7 and 21.4. (C-8, C-8’, C-9, C-9’, C-10 and C-
10’), 21.5 and 23.8 (C-6 and C-6’), 25.4 and 33.5 (C-5 and C-5’), 44.2 and 46.5 (C-7 and 
C7’), 49.5 and 49.6 (C-4 and C-4’), 49.1 and 51.7 (C-1 and C-1’), 76.5 and 73.2 (C-3 and C-
2’) and 78.5 and 89.2 (C-2 and C-3’); m/z 322 (M+, 0.74 %) and 41 (100); and  
2’-exo-hydroxy-3’-endo-(3-exo-hydroxy-2-exo-bornyl)bornane 255 (0.01 g, 5.4 %); m.p. 208 
- 210 ºC (lit.,122 212 ºC) (Found: M+, 322.48210. C20H34O3 requires M, 322.48216); νmax / cm-
1 (KBr) 3310 (OH); δH (400 MHz; CDCl3) 0.77, 0.82, 0.85, 0.94, 0.99 and 1.03 (18H, 6 × s, 8-
, 8’-, 9-, 9’-, 10- and 10’-Me), 0.85 -1.77 (8H, complex of multiplets (5-, 5’-, 6- and 6’-CH2), 
1.55 (1H, s, 2’-OH), 1.75 and 1.90 (2H, 2 × m, 4- and 4’-H, 2.86 (1H, d, J 5.8 Hz, 3-OH), 
3.45 (1H, br s, 2’-H), 3.57 (1H, d, J 6.9 Hz, 2-H), 3.80 (1H, t, J 6.3 Hz, 3-H) and 1.90 (1H, t, 
J 4.2 Hz, 3’-H); δC (100 MHz; CDCl3) 11.2, 12.1, 19.9, 20.5, 21.3 and 21.7 (C-8, C-8’, C-9, 
C-9’, C-10 and C-10’), 18.8, 23.9, 33.4 and 34.4 (C-5, C-6, C-5’ and C-6’), 46.5, 46.7, 49.0 
and 49.9 (C-1, C-7, C-1’ and C-7’), 49.1 and 51.6 (C-4 and C-4’), 75.8 (C-2’), 85.6 (C-3), 
86.9 (C-2) and 89.5 (C-3’); m/z 322 (M+, 0.8 %) and 152 (100). 
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3.2.2 Iminolactones 
 
The 2-iminolactone 208 
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10 % Pd on C catalyst (0.07 g, 0.007 g Pd metal) was  added under a blanket of N2 to a stirred 
solution of N-(carbobenzyloxy)glycine 2-oxo-3-exo-bornyl ester 274 (0.50 g, 1.4 mmol) in 
absolute ethanol (4 mL). The catalyst was kept in suspension by vigorous stirring. N2 was 
allowed to flow for a further 5 min, followed by the introduction of a slow stream of H2. 
Escaping gas was bubbled through a saturated solution of aqueous Ba(OH)2. Once the 
evolution of CO2 had ceased (as evidenced by the cessation of BaCO3 formation), the mixture 
was heated to ca. 50 ºC until no further evolution of CO2 was observed. The reaction mixture 
was cooled to room temperature, the flow of H2 halted and the system then flushed with N2. 
The suspension was filtered through celite and the solid was washed with ethanol. The filtrate 
and washings were combined and the solvent removed in vacuo to give a yellow oil, which 
was chromatographed [flash chromatography on silica gel; elution with hexane-EtOAc (1:1)] 
to afford a white crystalline solid: 
The 2-iminolactone 208 (0.16 g, 56.2 %); m.p. 101 – 103 ºC (lit.173 103 - 104 ºC); [α]23D = 
+263.2º; νmax / cm-1 (CHCl3) 1745 (C=O); δH (400 MHz; CDCl3) 0.79, 0.96 and 1.05 (9H, 3 × 
s, 8-, 9- and 10-Me), 1.32 - 2.14 (4H, complex of multiplets, 5- and 6-CH2), 2.25 (1H, d, J 
4.5, 4-H), 3.89 (1H, dd, J 17.8 and 1.6 Hz, 2’-Hendo), 4.49 (1H, d, 1.6 Hz, 3-Hendo) and 4.53 
(1H, d, J 17.9 Hz, 2’-Hexo); δC (100 MHz; CDCl3) 9.9, 19.7 and 20.0 (C-8, C-9 and C-10), 
25.4 and 29.5 (C-5 and C-6), 47.5 (C-4), 49.1 and 52.6 (C-1 and C-7), 52.6 (C-2’), 79.7 (C-3), 
168.9 (C-2) and 183.7 (C -1’); m/z 207 (M+, 3.8 %). 
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N-(Carbobenzyloxy)glycine 2-oxo-3-exo-bornanyl ester 274 
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To a solution of N-(carbobenzyloxy)glycine (1.26 g, 6 mmol) in dry DMF (6 mL) was added 
carbonyldiimidazole (0.98 g, 6 mmol) and the resulting solution was stirred for 30 min. 3-exo-
hydroxybornan-2-one 231 (1.01 g, 6 mmol) was then added and the reaction mixture was 
stirred at room temperature for 16 h. The solvent was removed in vacuo to give an oil, which 
was chromatographed [flash chromatography on silica gel; elution with hexane-EtOAc (1:1)] 
to afford: 
N-(carbobenzyloxy)glycine 2-oxo-3-exo-bornyl ester 274 as a clear oil (1.46 g, 67.2 %) 
(Found: M+, 359.17342. C20H25NO5S requires M, 359.17327); [α]23D  = +45.2º; νmax / cm-1 
(CHCl3) 1750 (C=O); δH (400 MHz; CDCl3) 0.91, 0.93 and 0.94 (9H, 3 × s, 8-, 9- and 10-
Me), 1.40 - 1.80 (4H, series of multiplets, 5- and 6-CH2), 2.10 (1H, d, 4-H), 3.95 - 4.06 (2H, 
series of multiplets, 2’-CH2), 4.82 (1H, s, 3-Hendo), 5.11 (2H, s, 4’-CH2), 5.27 (1H, br s, NH) 
and 7.25 - 7.36 (5H, m, ArH); δC (100 MHz; CDCl3) 9.0 (C-10), 19.6 (C-9), 20.7 (C-8), 24.8 
(C-5), 28.5 (C-6), 42.8 (C-2’), 48.3 (C-1), 57.2 (C-7), 59.8 (C-4), 67.1 (C-4’), 77.5 (C-3), 
128.1, 128.2, 128.5 and 136.2 (ArC), 156.2 (C-1’), 169.3 (C-3’) and 213.7 (C-2); m/z 359 
(M+, 23.85 %) and 91 (100). 
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The α-endo-benzyl 2-iminolactone 279a and α-exo-benzyl 2-iminolactone 279b 
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A solution of the 2-iminolactone 208 (0.05 g, 0.2 mmol) in dry THF (3 mL) was added drop-
wise under N2 to a stirred solution of t-BuOK (0.03 g, 0.2 mmol) in dry THF (3 mL) at -78 ºC 
and the solution stirred for 1 h to ensure complete enolization. Benzyl bromide (0.04 g, 0.2 
mmol) in dry THF (3 mL) was then added slowly to the enolate solution and the resulting 
mixture stirred at -78 ºC for 3 h. The mixture was allowed to warm to room temperature and 
stirring continued overnight. The solvent was removed in vacuo and purification 
[chromatography on silica gel on a chromatotron, 1 mm plate; elution with hexane-EtOAc 
(9:1)] afforded, as light brown oils, two products:† 
 the α-endo-benzyl 2-iminolactone 279a (0.004 g, 4.9 %); νmax / cm-1 (CHCl3) 1745 (C=O); δH 
(400 MHz; CDCl3) 0.88, 0.93 and 1.01 (9H, 3 × s, 8-, 9- and 10-Me), 1.35 - 1.41 (1H, 
complex of multiplets, 4-H), 1.63 - 1.95 (4H, complex of multiplets, 5- and 6-CH2), 2.63 (1H, 
s, 3-Hendo), 3.20 (1H, dd, J 5.1 Hz, J 13.8 Hz, 3’-HA), 3.46 (1H, dd, J 4.7 Hz, J 13.7 Hz, 3’-
HB), 4.89 (1H, t, J 4.7 Hz, 2’-Hexo) and 7.14 - 7.30 (5H, complex of multiplets, Ar-H); δC (100 
MHz; CDCl3) 9.9, 19.6 and 19.9 (C-8, C-9 and C-10), 25.8 and 29.5 (C-5 and C-6), 47.1 (C-
4), 37.9 and 49.1 (C-2’ and C-7), 52.4 (C-1), 62.9 (C-3’), 79.1 (C-3), 127.5, 128.6, 131.4 and 
137.8 (Ar-C), 170.9 (C-2) and 181.7 (C-1’); and  
the α-exo-benzyl 2-iminolactone 279b (0.043 g, 60.2 %); νmax / cm-1 (CHCl3) 1740 (C=O); δH 
(400 MHz; CDCl3) 0.70, 0.94 and 1.03 (9H, 3 × s, 8-, 9- and 10-Me), 1.27 - 1.34, 1.51 - 1.58, 
1.69 - 1.77 and 2.00 - 2.09 (4H, series of multiplets, 5- and 6-CH2), 2.22 (1H, d, J 4.7 Hz, 4-
H), 3.28 (1H, dd, J 7.5 Hz, J 14.1 Hz, 3’-HB), 3.51 (1H, dd, J 5.1 Hz, J 14.1Hz, 3’-HA), 3.94 
(1H, dd, J 4.8 Hz, J 1.2 Hz, 2’-Hendo), 4.42 (1H, d, J 1.2 Hz, 3-Hendo) and 7.18 - 7.41 (5H, 
complex of multiplets, Ar-H); δC (400 MHz; CDCl3) 9.9, 19.6 and 20.0 (C-8, C-9 and C-10), 
25.3 and 29.4 (C-5 and C-6), 37. 4 and 49.1 (2’-C and C-7), 47.4 (C-4), 52.5 (C-1), 62.5(C-
3’), 79.6 (C-3), 126.3, 128.1, 130.0, and 138.8 (Ar-C), 170.7 (C-2) and 182.8 (C-1’). 
 
† 1H NMR analysis of the crude mixture indicated 84.9 % d.e. where the exo-isomer predominated. 
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The α-endo-propyl 2-iminolactone 280a and α-exo-propyl 2-iminolactone 280b 
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The experimental procedure employed for the synthesis of 279 was followed, using the 2-
iminolactone 208 (0.05 g, 0.2 mmol) in THF (3 mL), t-BuOK (0.03g, 0.3 mmol) in THF (3 
mL) and propyl iodide in THF (3 mL).  Work-up and chromatography [using silica gel on a 
chromatotron, 1 mm plate; elution with hexane-EtOAc (9:1)] afforded, as light brown oils, 
two products:† 
the α-endo-propyl 2-iminolactone 280a (0.008 g, 13 %); νmax / cm-1 (CHCl3) 1745 (C=O); δH 
(400 MHz; CDCl3) 0.84, 0.99 and 1.17 (9H, 3 × s, 8-, 9- and 10-Me), 0.93 - 1.03, 1.37 - 1.45, 
1.53-1.61, 1.74-1.90 and 2.06–2.17 (11H, series of multiplets, 3’-, 4’-, 5- and 6-CH2 and 5’-
CH3), 2.25 (1H, d, J 4.8 Hz, 4-H), 4.61 (1H, t, J 7.0 Hz, 2’-H) and 4.66 (1H, s, 3-H); δC (100 
MHz; CDCl3) 10.0, 13.9, 19.5, 19.8 (C-5’-, C-8, C-9 and C-10), 20.1, 25.7, 29.3 and 33.3 (C-
3’, C-4’, C-5 and C-6), 47.9 (C-4), 48.1, 52.6, 62.2 (C-1, C-2’and C-7), 78.6 (C-3), 171.0 (C-
2) and 180.4 (C -1’); and  
the α-exo-propyl 2-iminolactone 280b (0.024 g, 38.88 %); νmax / cm-1 (CHCl3) 1740 (C=O); 
δH (400 MHz; CDCl3) 0.96 - 1.08, 1.31 - 1.39, 1.53 - 1.61, 1.72 - 1.80 and 1.92 - 2.12 (11H, 
series of multiplets, 3’-, 4’-, 5- and 6-CH2 and 5’-CH3), 0.75, 0.95 and 1.04 (9H, 3 × s, 8-, 9- 
and 10-Me), 2.24 (1H, d, J 4.9 Hz, 4-H),  3.69 (1H, dd, J 1.2, J 5.8 Hz, 2’-H) and 4.45 (1H, d, 
J 1.2, 3-H); δC (100 MHz; CDCl3) 10.0 14.0, 19.0, 19.7 (C-5’, C-8, C-9 and C-10), 20.1, 25.3, 
29.6 and 33.3 (C-3’, C-4’, C-5 and C-6), 47.4 (C-4), 49.6, 52.5, 60.7 (C-1, C-2’and C-7), 79.5 
(C-3), 169.0 (C-2) and 181.4 (C -1’). 
 
 
 
 
 
 
† 1H NMR analysis of the crude mixture indicated 49.2 % d.e. where the exo-isomer predominated. 
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The α-endo-methyl 2-iminolactone 281a and α-exo-methyl 2-iminolactone 281b 
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The experimental procedure employed for the synthesis of 279 was followed, using the 2-
iminolactone 208 (0.05 g, 0.3 mmol) in THF (3 mL), t-BuOK (0.03g, 0.3 mmol) in THF (3 
mL) and methyl iodide in THF (3 mL).  Work-up and chromatography [using silica gel on a 
chromatotron, 1 mm plate; elution with hexane-EtOAc (9:1)] afforded, as light brown oils, 
two products:† 
the α-endo-methyl 2-iminolactone 281a (0.012 g, 21 %); νmax / cm-1 (CHCl3) 1740 (C=O); δH 
(400 MHz; CDCl3) 0.80, 0.97 and 1.05 (9H, 3 × s, 8-, 9- and 10-Me), 1.34 - 1.36, 1.60- 1.63, 
1.73 - 1.80 and 2.05 - 2.11 (4H, series of multiplets, 5- and 6-CH2), 1.67 (3H, d, J 7.0 Hz, 2’-
CH3), 2.25 (1H, d, J 4.8 Hz, 4-H), 4.57 (1H, s, 3-H) and 4.58 (1H, q, J 7.3 Hz, 2’-H); δC (100 
MHz; CDCl3) 10.0, 19.5 and 20.1 (8-, 9- and 10-Me), 16.3 (C-2’), 25.8 and 29.1 (C-5 and C-
6), 47.8 (C-4), 48.4 and 52.5 (C-1 and C-7), 57.7 (C-2’), 78.5 (C-3), 172.0 (C-2) and 181.2 
(C-1’), and 
the α-exo-methyl 2-iminolactone 281b (0.018 g, 32.7 %); νmax / cm-1 (CHCl3) 1745 (C=O); δH 
(400 MHz; CDCl3) 0.77, 0.96 and 1.05 (9H, 3 × s, 8-, 9- and 10-Me), 1.32 - 1.43, 1.54 - 1.59, 
1.73 - 1.81 and 2.05 - 2.12 (4H, series of multiplets, 5- and 6-CH2), 1.67 (3H, d, J 7.0 Hz, 2’-
Me), 2.25 (1H, d, J 4.8 Hz, 4-H), 3.97 (1H, qd, J 7.1 Hz, J 1.2 Hz, 2’-H) and 4.49 (1H, d, J 
1.2 Hz 3-H); δC (100 MHz; CDCl3) 10.0, 19.7 and 20.0 (8-, 9- and 10-Me), 17.3 (C-2’), 25.1 
and 29.5 (C-5 and C-6), 47.4 (C-4), 49.0 and 52.4 (C-1 and C-7), 56.7 (C-2’), 79.7 (C-3), 
172.0 (C-2) and 183.7 (C-1’). 
 
 
 
 
 
 
 
† 1H NMR analysis of the crude mixture indicated 23.5 % d.e. where the exo-isomer predominated. 
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The α-endo-butyl 2-iminolactone 282a and  α-exo-butyl 2-iminolactone 282b 
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The experimental procedure employed for the synthesis of 279 was followed, using the 2-
iminolactone 208 (0.05 g, 0.3 mmol) in THF (3 mL), t-BuOK (0.03g, 0.3 mmol) in THF (3 
mL) and butyl iodide in THF (3 mL).  Work-up and chromatography [using silica gel on a 
chromatotron, 1mm plate; elution with hexane-EtOAc (9:1)] afforded, as light brown oils, two 
products:† 
the α-endo-butyl 2-iminolactone 282a (0.010 g, 14 %); νmax / cm-1 (CHCl3) 1745 (C=O); δH 
(400 MHz; CDCl3) 0.75, 0.95 and 1.04 (9H, 3 × s, 8-, 9- and 10-Me), 0.93 - 0.94, 1.33 - 1.44, 
1.46 - 1.53, 1.72 - 1.80, 2.07 - 2.13 and 2.18 - 2.19 (13H, series of multiplets, 3’-, 4’-, 5- and 
6-CH2 and 5’-CH3), 2.25 (1H, m, 4-H), 4.50 (1H, t, J 7.9 Hz, 2’-H) and 4.57 (1H, s, 3-H); δC 
(100 MHz; CDCl3) 10.1, 19.5 and 20.1 (C-8, C-9 and C-10), 13.8 (C-6’), 22.3, 25.8, 28.6, 
29.3 and 31.0 (C-5, C-6, C-3’, C-4’ and C-5’), 47.8 (C-4), 48.3 and 56.6 (C-1 and C-7), 62.5 
(C-2’), 78.6 (C-3), 171.3 (C-2) and 180.9 (C-1’); and  
the α-exo-butyl 2-iminolactone 282b (0.029 g, 42 %); νmax / cm-1 (CHCl3) 1745 (C=O); δH 
(400 MHz; CDCl3) 0.89, 0.97 and 1.03 (9H, 3 × s, 8-, 9- and 10-Me), 0.94 - 2.01 (13H, 
complex of multiplets, 3’-, 4’-, 5- and 6-CH2 and 5’-CH3), 2.34 (1H, d, J 5.3 Hz, 4-H), 3.90 
(1H, d, J 1.2 Hz, 3-H) and 4.11 (1H, q, J 1.2, J 7.1 Hz, 2’-H); δC (100 MHz; CDCl3) 10.0, 
19.0 and 20.0 (C-8, C-9 and C-10), 14.0 (C-6’), 22.4, 26.2, 28.8, 29.3 and 31.3 (C-5, C-6, C-
3’, C-4’ and C-5’), 47.7 (C-4), 49.4 and 56.9 (C-1 and C-7), 61.4 (C-2’), 79.5 (C-3), 169.3 (C-
2) and 180.9 (C-1’). 
 
 
 
 
 
† 1H NMR analysis of the crude mixture indicated 48.4 % d.e. where the exo-isomer predominated. 
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3.2.3 Acrylate Esters of 2,3-Dihydroxybornane 
 
2,3-Dihydroxybornane 284 
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LiAlH4 (5.73 g, 151 mmol) was added to dry THF (100 mL) under N2 and the resulting 
mixture stirred for 2 h at 0 ºC. Camphorquinone 22 (10.00 g, 60 mmol) in dry THF (10 mL) 
was then added drop-wise under N2 and the mixture allowed to warm to room temperature 
overnight. The reaction mixture was then heated to, and maintained at, 60 ºC for 2 h. The 
reaction was then quenched under N2 by the successive addition of 3 M-NaOH (5 mL) and 
water (2.5 mL). The resulting precipitate was filtered off, collected and extracted by boiling 
with Et2O (4 × 50 mL). The filtrate and extracts were subsequently combined, washed with 
saturated aqueous NaHCO3 (3 × 20 mL) and dried over anhydrous MgSO4. Concentration of 
the mixture in vacuo afforded, without need for further purification, as a white crystalline 
solid: 
2,3-dihydroxybornane 284 (9.83 g, 96.1 %); m.p. 253-257 (lit.,174 230-231 ºC) (Found: M+, 
170.13050. C10H18O2 requires M, 170.13068); νmax / cm-1 (CHCl3) 3550 (OH); δH (400 MHz; 
CDCl3) 0.78 (3H, s, 10-CH3), 0.88 - 0.99, 1.38 - 1.48 and 1.58 - 1.70 (4H, series of multiplets, 
5- and 6-CH2) 0.92 and 1.08 (6H, 2 × s, 8- and 9-CH3), 1.75 (1H, d, J 4.7 Hz, 4-H), 2.54 - 
3.09 (2H, br signal, 2 × OH), 3.58 (1H, d, J 7.0 Hz, 2-H) and 3.81 (1H, d, J 7.0 Hz, 3-H); δC 
(100 MHz; CDCl3) 11.1, 21.0 and 21.8 (C-8, C-9 and C-10), 24.0 (C-6), 33.1 (C-5), 46.4 and 
48.7 (C1 and C-7), 51.4 (C-4), 76.1 (C-2) and 79.9 (C-3); m/z 170 (M+, 4.2 %) and 95 (100). 
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2-Exo-3-exo-bornanyl diacrylate 288, 2-exo-hydroxy-3-exo-bornanyl acrylate 285 and 
3-exo-hydroxy-2-exo-bornanyl acrylate 287. 
5
6 1
2
34
79
8
10 OH
O 1'
2'
3'
O
5
6 1
2
3
4
79
8
10
OH
O 1'
2'
3'
O
5
6 1
2
3
4
79
8
10
O 1'
2'
3'
O
O
1" 2"
O 3"
ARD 29 ARD 30 ARD 27  
Method 1 
Bornane-2,3-diol 284 (1.01 g, 5.9 mmol) was dissolved in dichloromethane (20 mL) and 4 Å 
molecular sieves were added. Acryloyl chloride (0.56 g, 6.2 mmol) was introduced and the 
reaction mixture was boiled under reflux overnight. The molecular sieves were filtered off 
and the filtrate was washed with saturated aqueous NaHCO3 (3 × 20 mL) to neutralize any 
acid and then dried over anhydrous MgSO4. Removal of the solvent was achieved under 
reduced pressure and the residue was chromatographed [using silica gel on a chromatotron, 1 
mm plate; elution with hexane-EtOAc (19:1)] to afford three products: 
2-exo-3-exo-bornanyl diacrylate 288, as white crystals, (0.19 g, 12 %) (Found: M+, 
278.15199. C16H22O4 requires M, 278.15181); δH (400 MHz; CDCl3) 0.85, 0.88 and 1.15 (9H, 
3 × s, 8-, 9- and 10-Me), 1.19 - 1.83 (4H, complex of multiplets, 5- and 6-CH2), 1.91 (1H, d, J 
4.9 Hz, 4-H), 4.91 (2H, s, 2-H and 3-H), 5.77 (2H, ddd, J 1.4 Hz, 10.4 and 12.7 Hz, 3’- and 
3”-H), 6.03 (2H, dt, J 10.4 and 17.1 Hz, 3’- and 3”-H) and 6.30 (2H, ddd, J 1.4 and 17.4 Hz, J 
18.9 Hz, 2’ and 2”-H); δC (100 MHz; CDCl3) 10.9, 20.4 and 20.9 (C-8, C-9 and C-10), 23.8 
(C-6), 32.9 (C-5), 47.5 and 48.8 (C-1 and C-7), 49.6 (C-4), 77.1 (C-2), 79.8 (C-3), 128.4 (C-
2’), 128.5 (C-2”), 130.47(C-3’), 130.54 (C-3”), 164.89 (C-1’) and 165.00 (C-1”); m/z 278 
(M+, 0.4 %) and 206 (100);  
2-exo-hydroxy-3-exo-bornanyl acrylate 285, as an oil, (0.10 g, 7 %) (Found: M+, 224.14161. 
C13H20O3 requires M, 224.14124); δH (400 MHz; CDCl3) 0.82 (3H, s, 9-Me), 0.93 (3H, s, 8-
Me), 1.02 - 1.84 (4H, complex of multiplets, 5- and 6-CH2), 1.12 (3H, s, 10-Me), 1.84 (1H, d, 
J 5.0 Hz, 2-OH), 1.88 (1H, d, J 4.9 Hz, 4-H), 3.81 (1H, dd, J 5.2 and 6.2 Hz, 2-Hendo), 4.68 
(1H, d, J 6.8 Hz, 3-Hendo), 5.83 (1H, dd, J 1.4 and 10.4 Hz, 3’-HZ), 6.13 (1H, dd, J 10.4 and 
17.3 Hz, 2’-H) and 6.39 (1H, dd, J 1.4 and 17.3 Hz, 3-HE); δC (100 MHz; CDCl3) 11.0 (C-8), 
20.7 (C-10), 21.1 (C-9), 23.9 (C-5), 33.2 (C-6), 46.9 (C-7), 49.0 (C-1), 49.2 (C-4), 79.6 (C-2), 
80.0 (C-3), 128.4 (C-2’), 130.7 (C-3’) and 166.2 (C-1’); m/z 224 (M+, 0.8 %) and 66 (100); 
and  
288 285 287 
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3-exo-hydroxy-2-exo-bornanyl acrylate 287, as an oil, (0.16 g, 12 %)(Found: M+, 224.14161. 
C13H20O3 requires M, 224.14124   ); δH (400 MHz; CDCl3) 0.82 (3H, s, 9-Me), 0.90 (3H, s, 8-
Me), 1.01 - 1.75 (4H, complex of multiplets, 5- and 6-CH2), 1.15 (3H, s, 10-Me), 1.79 (1H, d, 
J 4.8 Hz, 4-H), 1.87 (1H, d, J 4.1 Hz, 3-OH), 4.02 (1H, dd, J 3.7 Hz, 6.2 Hz, 3-Hendo), 4.54 
(1H, d, J 6.7 Hz, 2-Hendo), 5.84 (1H, dd, J 0.9 and 10.4 Hz, 3’-HZ), 6.15 (1H, dd, J 10.4 and 
17.3 Hz, 2’-H) and 6.40 (1H, dd, J 1.4 and 17.3 Hz, 3-HE); δC (100 MHz; CDCl3) 11.2 (C-8), 
20.6 (C-10), 21.1 (C-9), 24.1 (C-5), 33.1 (C-6), 47.0 (C-7), 48.3 (C-1), 51.6 (C-4), 76.7 (C-3), 
82.9 (C-2), 128.4 (C-3’), 130.7 (C-2’) and 166.4 (C-1’); m/z 224 (M+, 0.8 %) and 66 (100). 
Method 2 
A solution of bornane-2,3-diol 284 (0.50 g, 2.9 mmol) in dry THF (7.5 mL) was added drop-
wise under N2 to a stirred solution of pre-washed NaH (0.14 g, 5.6 mmol) in dry THF (25 
mL). The mixture was stirred for 2 h and then refluxed for approximately 2 h until the orange 
colour of the alkoxide was observed. The reaction mixture was cooled, acryloyl chloride (0.34 
g, 3.8 mmol) was added drop-wise and the mixture stirred for 12 h at room temperature and 
then refluxed for 1 h. The THF was removed in vacuo and the residue was partitioned 
between saturated aqueous NaHCO3 (10 mL) and EtOAc (3 × 10 mL). The organic layers 
were combined, dried over anhydrous MgSO4 and concentrated under reduced pressure to 
give an oil, which was chromatographed [using silica gel on a chromatotron, 2 mm plate; 
elution with hexane-EtOAc (5:1)]  to afford three products;  
2-exo-3-exo-bornanyl diacrylate 288 (0.019 g, 2.3 %);  
2-exo-hydroxy-3-exo-bornanyl acrylate 285 (0.087 g, 11 %); and 
3-exo-hydroxy-2-exo-bornanyl acrylate 287 (0.101 g, 15 %). 
Method 3 
Butyllithium (1.6 M solution in hexane; 9.62 mL, 15.4 mmol) was added drop-wise over 20 
min, under dry N2 to a stirred solution of bornane-2,3-diol 284 (2.02 g, 11.8 mmol) in dry 
THF (25 mL) at -5 ºC. After 1.5 h acryloyl chloride (1.41 g, 15.6 mmol)  was added drop-
wise, the mixture was stirred at 0 ºC for 1 h and then allowed to warm to room temperature 
over 14 h. The THF was removed in vacuo and the residue was treated with saturated aqueous 
NaHCO3 (10 mL), extracted with Et2O (3 × 10 mL) and dried over anhydrous MgSO4. 
Concentration under reduced pressure gave an oil, which was chromatographed [using silica 
gel on a chromatotron, 4 mm plate; elution with hexane-EtOAc (9:1)] to afford three products; 
2-exo-3-exo-bornanyl diacrylate 288 (0.36 g, 11 %);  
2-exo-hydroxy-3-exo-bornanyl acrylate 285 (0.90 g, 34 %); and  
3-exo-hydroxy-2-exo-bornanyl acrylate 287 (1.27 g, 48 %). 
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Attempted synthesis  
Carbonyldiimidazole (0.96 g, 5.9 mmol) was added to a stirred solution of acrylic acid (0.42 
g, 5.9 mmol) in dry DMF (2 mL) at room temperature. After stirring for 30 minutes, this 
solution was then added drop-wise to a solution of 2,3-dihydroxybornane 284 (1.00 g, 5.9 
mmol) in dry DMF (2.5 mL). The reaction mixture was stirred for 14 h. Removal of the DMF 
was achieved under reduced pressure and the residue was washed with saturated aqueous 
NaHCO3 and then dried with anhydrous MgSO4. 1H NMR spectroscopy showed no sign of 
the expected acrylate ester. 
 
3.2.4 Acrylate Esters of Phenyl 2-Hydroxybornane-10-sulfonate 
 
Phenyl (+)-camphor-10-sulfonate 72 
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Camphor-10-sulfonyl chloride 298 (10.07 g, 40.2 mmol) was added to a stirred solution of 
phenol (3.78 g, 40.2 mmol) in pyridine (13 mL) at 0 ºC over 20 min. The solution was stirred 
at this temperature for a further 2.5 h and then at room temperature for 1 h. The reaction was 
quenched by diluting with water and the resulting mixture was shaken with 10 % aqueous 
HCl (20 mL) to remove pyridine as the hydrochloride salt. Extraction was achieved with Et2O 
(4 × 50 mL) and the combined organic layers were washed sequentially with H2O (50 mL), 10 
% aqueous HCl (20 mL) and H2O (50 mL). The ether was then washed sequentially with 10 
% aqueous NaOH (10 mL), brine (10 mL), 10 % aqueous NaOH (5 mL) and brine (10 mL) to 
remove excess phenol by generating the water soluble sodium phenoxide salt.  The organic 
layer was then dried over anhydrous MgSO4. The solvent was removed in vacuo  to give a 
colourless oil: 
phenyl (+)-camphor-10-sulfonate 72 (9.63 g, 77.7 %)(Found: M+, 308.10846. C16H20O4S 
requires M, 308.10822); νmax / cm-1 (CHCl3) 1640 (C=O), 1490, 1380 and 1100 (SO2-OPh); 
δH (400 MHz; CDCl3) 0.90 and 1.16 (6H, 2 × s, 8- and 9-Me), 1.45, 1.71, 2.08 and 2.56 (4H, 
72 
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4 × m, 5-CH2 and 6-CH2), 1.96 (1H, d, Jgem 18.5 Hz, 3-Hendo), 2.13 (1H, m, 4-H), 2.41 (1H, m, 
3-Hexo), 3.18 and 3.81 (1H, 2 × d, J 15.0 Hz, 10-CH2) and 7.25 - 7.43 (5H, complex of 
multiplets, Ar-H); δC (400 MHz; CDCl3) 19.7 and 20.0 (C-8 and C-9), 25.1 and 26.9 (C-5 and 
C-6), 42.5 (C-3), 42.9 (C-4), 47.6 and 58.2 (C1 and C-7), 47.9 (C-10), 120.7, 127.2, 129.9 and 
149.3 (Ar-C) and 214.1 (C-2); m/z 308 (M+, 1 %) and 215 (100). 
 
10-Isobornyl sultone 87 
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A solution of phenyl (+)-camphor-10-sulfonate 72 (0.50 g, 1.6 mmol) in ethanol (2 mL) was 
added drop-wise to a stirred solution of NaBH4 (0.10 g, 2.7 mmol) in ethanol (4 mL) at 0 ºC 
over 20 min. The solution was allowed to warm to room temperature and stirred for 8 h.  The 
reaction was quenched by the drop-wise addition of 5 % HCl. The resulting mixture was 
extracted with Et2O (3 × 2 mL) and the combined organic layers were washed with brine (3 × 
1 mL). The Et2O solution was then washed sequentially with 10 % aqueous NaOH (1ml), 
brine (1 mL), 10 % aqueous NaOH (1 mL) and brine (1 mL) to remove phenol and then dried 
over anhydrous MgSO4. The solvent was removed in vacuo to give white crystals of: 
10-isobornyl sultone 87 (0.33 g, 93.7 %); m.p. 109-112 ºC (lit.46 114-116 ºC) (Found: M+, 
216.08158. C10H16O3S requires M, 216.08202); νmax / cm-1 (CHCl3) 1175 (SO2); δH (400 
MHz; CDCl3) 0.94 and 1.11 (6H, 2 × s, 8- and 9-Me), 1.25, 1.40 and 1.88 - 1.96 (6H, series of 
multiplets, 3-, 5- and 6-CH2), 2.22 - 2.32 (1H, m, 4-H), 3.22 (2H, 2 × d, J 13.7 and 10-CH2) 
and 4.37 (1H, dd, J 3.5 and 7.9 Hz, 2-H); δC (100 MHz; CDCl3) 19.7 and 19.8 (C-8 and C-9), 
26.6 and 28.9 (C-5 and C-6), 35.7 (C-3), 44.2 (C-4), 47.3 and 55.4 (C-1 and C-7), 48.9 (C-10) 
and 87.8 (C-2); m/z 216 (M+, 1.5 %) and 93 (100). 
 
 
 
 
 
87 
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Phenyl (+)-2-exo-hydroxybornane-10-sulfonate 100, phenyl (+)-2-endo-hydroxybornane-10-
sulfonate 300 and 10-isobornyl sultone 87. 
5
6 1 2
34
79
8
10
H
S
O
O O
OH
5
6
1 2
3
4
79
8
10
OH
S
O
O O
H
ARD 32 ARD 33  
A solution of phenyl (+)-camphor-10-sulfonate 72 (2.37 g, 7.7 mmol) in ethanol (5 mL) was 
added to a stirred solution of NaBH4 (0.10 g, 2.7 mmol) in EtOH-H2O (10 mL: 5 mL) at -15 
ºC over 20 min. The solution was stirred vigorously for 16 h at -8 ºC.  5 % aq. HCl was added 
drop-wise to quench excess NaBH4. Solvent was removed under reduced pressure, and the 
residue was dissolved in Et2O (8 mL), washed with brine (3 × 3 mL) and then dried over 
anhydrous MgSO4. The solvent was removed in vacuo to give an oil, which was purified 
[flash chromatography on silica gel; hexane-EtOAc (8:2)] to afford three products: 
phenyl (+)-2-exo-hydroxybornane-10-sulfonate 100, as an oil (1.94 g, 81.0 %) (Found: M+, 
310.12333. C16H22O4S requires M, 310.12388); [α]20D  = -35.16º (c 4.42, CHCl3); δH (400 
MHz; CDCl3) 0.85 (3H, s, 9-Me), 1.07 (3H, s, 8-Me), 1.12 - 1.87 (7H, complex of multiplets, 
4-H and 3-, 5- and 6-CH2), 2.82 (1H, d, J 4.4 Hz, 2-OH), 3.15 and 3.73 (2H, 2 × d, J 13.67 
Hz, 10-CH2), 4.11 (1H, m, 2-CH) and 7.25 - 7.44 (5H, complex of multiplets, Ar-H); δC (100 
MHz; CDCl3) 19.8 (C-8), 20.5 (C-9), 27.3 (C-5), 30.2 (C-6), 39.2 (C-3), 44.4 (C-4), 49.0 (C-
7), 50.0 (C-1), 50.3 (C-10), 76.1 (C-2) and 122.0, 127.3, 130.0 and 149.0 (Ar-C); m/z 310 
(M+, 0.3 %) and 94 (100);  
phenyl (+)-2-endo-hydroxybornane-10-sulfonate 300, as an oil (0.28 g, 11.5 %) (Found: M+, 
310.12645. C16H22O4S requires M, 310.12388); [α]20D  = +17.95° (c 0.44, CHCl3); δH (400 
MHz; CDCl3) 0.92 (3H, s, 9-Me), 0.93 (3H, s, 8-Me), 1.14, 1.43, 1.57, 1.83, 2.34 and 2.53 
(6H, complex of multiplets, 3-,5- and 6-CH2), 1.68 (1H, t, J 4.5 Hz, 4-CH), 3.14 (1H, d, J 2.2 
Hz, 2-OHendo), 3.34 (2H, s, 10-CH2), 4.39 (1H, dd, J 2.5 and 10.0H z, 2-Hexo) and 7.28, 7.32, 
7.42 (5H, complex of multiplets, Ar-H); δC (100 MHz; CDCl3) 18.9 (C-8), 20.5 (C-9), 23.8 
(C-6), 28.1 (C-5), 38.2 (C-3), 44.0 (C-4), 51.0 (C-7), 51.9 (C-1), 54.3 (C-10), 75.1 (C-2) and 
122.0, 127.4, 130.0 and 148.7 (Ar-C); m/z 310 (M+, 0.5 %) and 94 (100); and 
10-isobornyl sultone 87 (0.058 g, 3.5 %). 
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Phenyl 2-exo-acryloyloxybornane-10-sulfonate 296 and phenyl 2-exo-(3-
chloropropanoyloxy)bornane-10-sulfonate 308 
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Method 1 
Neutral Al2O3 (0.32 g, 3.1 mmol) was added to the alcohol 100 (0.61 g, 2.0 mmol) and 
acryloyl chloride (0.39 g, 4.3 mmol) was then added. The resulting dispersion was sealed and 
kept unstirred at 25 ºC for 72 h. The residue was taken up in EtOAc (3 × 1 mL), filtered and 
dried over anhydrous MgSO4. Solvent was removed in vacuo to give an oil, which was 
chromatographed [HPLC; elution with hexane-EtOAc (8:2)] to afford two products, as 
transparent crystals: 
phenyl 2-exo-acryloyloxybornane-10-sulfonate 296 (0.40 g, 55 %) (Found: M+, 364.13395. 
C19H24O5S requires M, 364.13445); [α]20D  = -30.52° (c 2.90, CHCl3); δH (400 MHz; CDCl3) 
0.91 and 1.02 (6H, 2 × s, 8- and 9-Me), 1.22, 1.79, 1.64, 179, 1.97 and 1.98 (6H, series of 
multiplets, 3-,5- and 6-CH2), 1.81 (1H, m ,4-H), 3.14 and 3.67 (2H, 2 × d, J 13.9Hz and 10-
CH2), 5.01 (1H, dd, J 3.1 and 7.9 Hz, 2-CH), 5.68 (1H, dd, J 1.4 and 10.4 Hz, 3’-HZ), 5.92 
(1H, dd, J 10.4 and 17.3 Hz, 2’-H), 6.19 (1H, dd, J 1.4 and 17.3 Hz, 3’-HE) and 7.18 – 7.41 
(5H, complex of multiplets, Ar-H); δC (100 MHz; CDCl3) 19.9 and 20.3 (C-8 and C-9), 26.9, 
29.9 and 39.3 (C-3, C-5 and C-6), 44.5 (C-4), 48.8 and 49.5 (C-1 and C-7), 49.3 (C-10), 77.5 
(C-2), 121.9, 127.0, 129.8 and 149.0 (Ar-C), 128.5 (C-2’), 130.3 (C-3’) and 164.6 (C-1’); m/z 
364 (M+, 0.8 %) and 55 (100); and 
phenyl 2-exo-(3-chloropropanoyloxy)bornane-10-sulfonate 308 (0.33 g, 42 %) (Found: M+, 
400.10707. C19H25O5SCl requires M, 400.11112); [α]20D  = -70.51° (c 2.14, CHCl3); δH (400 
MHz; CDCl3) 0.92 and 1.03 (6H, 2 × s, 8- and 9-Me), 1.24, 1.67, 1.78, 1.82 and 1.99 (6H, 
series of multiplets, 3-,5- and 6-CH2), 1.83 (1H, m, 4-CH), 2.58 (2H, m, 2’-CH2), 3.17 and 
3.69 (2H, 2 × d, J 13.9 Hz, 10-CH2), 3.60 (2H, m, 3’-CH2), 4.99 (1H, dd, J 3.2 and 8.0 Hz, 2-
CH) and 7.21 – 7.44 (5H, complex of multiplets, Ar-H); δC (100 MHz; CDCl3) 19.9 and 20.3 
(C-8 and C-9), 26.9, 30.1 and 39.3 (C-3, C-5 and C-6), 37.6 (C - 2’), 38.9 (C- 3’), 44.6 (C- 4), 
308 296 
Experimental 
- 228 - 
48.8 and 49.6 (C-1 and C-7), 49.4 (C-10), 78.1 (C-2), 122.1, 127.2, 129.9 and 149.1 (Ar-C) 
and 168.7 (C-1’); m/z 400 (M+, 2.0 %) and 94 (100). 
Method 2 
Butyllithium (1.6 M solution in hexane; 0.28 mL, 0.5 mmol) was added drop-wise over 20 
min, under dry N2, to a stirred solution of phenyl (+)-2-exo-hydroxybornane-10-sulfonate 100 
(0.13 g, 0.4 mmol) in dry THF (2 mL) at -78 ºC. After 1 h, acryloyl chloride (0.04 g, 0.5 
mmol)  was added drop-wise, the mixture was stirred at -10 ºC for 1 h and then allowed to 
warm to room temperature over 12 h. The THF was removed in vacuo and the residue was 
quenched with saturated aqueous NaHCO3 (1 mL), extracted with Et2O (3 × 1 mL) and dried 
over anhydrous MgSO4. Concentration under reduced pressure gave an oil, which was 
chromatographed [HPLC; elution with hexane-EtOAc (9:1)] to afford three products: 
phenyl 2-exo-acryloyloxybornane-10-sulfonate 296 (0.15 g, 5 %)  
10-isobornyl sultone 87 (0.09 g, 79 %); and  
phenyl acrylate 309 (0.05 g, 82 %) 
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Camphorsulfonic acid 71 (50.17 g, 0.216 mol) was mixed with phosphorus pentachloride 
(44.85 g, 0.215 mol) in a flask connected to an HCl trap at 0 ºC. Once the violently 
exothermic reaction had subsided, the solution was allowed to warm to room temperature and 
stirred for an additional 4 h. The solution was then poured over crushed ice (50 g) and the 
resulting mixture immediately poured over more ice (50 g) and mixed until the reaction had 
been quenched. The reaction mixture was filtered under vacuum and the residue washed with 
cold water before freeze-drying and recrystallisation from petroleum ether (30 – 60 ºC) to 
yield white crystals of: 
10-camphorsulfonyl chloride 298 (32.17 g, 59.4 %). δH (400 MHz; CDCl3) 0.92 and 1.14 (6H, 
2 × s, 8- and 9-Me), 1.45, 1.48, 1.77, 2.09 and 2.44 (6H, series of multiplets, 3-, 5- and 6-
298 
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CH2), 1.98 (1H, d, J 18.6 Hz, 4-H) and 3.72 and 4.30 (2H, 2 × d, J 14.6 Hz, 10-CH2); m/z 266 
(M+, 12.3 %). 
 
Phenyl 2-endo-acryloyloxybornane-10-sulfonate 310 and phenyl 2-endo-(3-
chloropropanoyloxy)bornane-10-sulfonate 311  
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Method 1 
The experimental procedure employed for the synthesis of phenyl 2-exo-acryloyloxybornane-
10-sulfonate 296 and phenyl 2-exo-(3-chloropropanoyloxy)bornane-10-sulfonate 308 
(Method 1) 
was followed, using neutral Al2O3 (0.14 g, 1.4 mmol), phenyl (+)-2-endo-hydroxybornane-
10-sulfonate 300 (0.27 g, 0.9 mmol) and acryloyl chloride (0.18 g, 2.0 mmol). Work-up and 
chromatography [using silica gel on a chromatotron, 1mm plate; elution with hexane-EtOAc 
(8:2)] afforded two products as transparent crystals: 
phenyl 2-endo-acryloyloxybornane-10-sulfonate 310 (0.18 g, 57 %) (Found: M+, 364.13465. 
C19H24O5S requires M, 364.13445); [α]20D  = -61.03° (c 2.04, CHCl3); δH (400 MHz; CDCl3) 
0.96 and 1.00 (6H, 2 × s, 8- and 9-Me), 1.09- 1.13 and 2.47- 2.55 (2H, 2 × m , 3-CH2 ), 1.37 - 
1.43, 1.70 - 1.73, 1.84 - 1.93,  2.58 - 2.651 (4H, series of multiplets, 5- and 6-CH2 ), 1.77 (1H, 
t, J 4.6 Hz, 4-H), 3.26 and 3.35 (2H, 2 × d, J 14.1 Hz, 10-CH2 ), 5.26 (1H, dt, J 2.6 and 9.8 
Hz, 2-H), 5.80 (1H, dd, J 1.3 and 10.5 Hz, 3’-H Z), 6.11 (1H, dd, J 10.5 and 17.4 Hz, 2’-H), 
6.43 (1H, dd, J 1.3 and 17.4 Hz, 3’-H E), 7.22 - 7.39 (5H, complex of multiplets, Ar-H); δC 
(400 MHz; CDCl3) 19.1 and 19.9 (C-8 and C-9), 25.3, 27.9 and 37.4 (C-3, C-5 and C-6), 44.2 
(C-4), 49.7 and 50.8 (C-1 and C-7), 53.3 (C-10), 76.8 (C-2), 122.0 (C-13 and C-15), 127.0 (C-
14), 128.6 (C-2’), 129.9 (C-12 and C-16), 130.8 (C-3’), 149.3 (C-2) and 166.0 (C-1’); m/z 364 
(M+, 0.1 %) and 55 (100); and  
310 311 
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phenyl 2-endo-(3-chloropropanoyloxy)bornane -10-sulfonate 311 (0.14 g, 39 %) (Found: M+, 
400.10875. C19H25O5SCl requires M, 400.11112); δH (400 MHz; CDCl3) 0.96 and 0.99 (6H, 2 
× s, 8- and9-Me), 1.12, 1.40, 1.68, 1.89, 2.49 and 2.57 (6H, series of multiplets, 3-, 5- and 6-
CH2), 1.79 (1H, m, 4-H), 2.81 (2H, t, J 6.9 Hz, 2’-CH2), 3.26 and 3.32 (2H, 2 × d, J 13.9 Hz, 
10-CH2), 3.76 (2H, dt, J 1.1 and 7.0 Hz, 3’-CH2), 5.26 (1H, dd, J 9.8 Hz, 2-CH), 7.21 – 7.44 
(5H, complex of multiplets, Ar-H); δC (100 MHz; CDCl3) 19.1 and 19.8 (C-8 and C-9), 25.3, 
27.9 and 37.3 (C-3, C-5 and C-6), 37.7 (C-2’), 39.1 (C-3’), 44.1 (C-4), 49.6 and 50.9 (C-1 and 
C-7), 53.3 (C-10), 77.1 (C-2), 122.0, 127.1, 129.9, 149.2 (Ar-C) and 170.1 (C-1’); m/z 400 
(M+, 0.3 %) and 135 (100). 
Method 2 
The experimental procedure employed for the synthesis of phenyl 2-exo-acryloyloxybornane-
10-sulfonate 296 (Method 2) was followed, using butyllithium (1.6 M solution in hexane; 
0.28 mL, 0.5 mmol), phenyl (+)-2-endo-hydroxybornane-10-sulfonate 300 (0.10 g, 0.3 mmol) 
and acryloyl chloride (0.033 g, 0.4 mmol) in dry THF (2 mL). Work-up and chromatography 
[using silica gel on a chromatotron, 1mm plate; elution with hexane-EtOAc (8:2)] afforded 
transparent crystals of: 
phenyl 2-endo-acryloyloxybornane-10-sulfonate 310 (0.09 g, 76.5 %)  
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3.2.5 Acrylate Esters of N-(1-adamantyl)-2-hydroxybornane-10-sulfonamide 
 
N-(1-Adamantyl)-2-oxo-bornane-10-sulfonamide 318 
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A solution of 10-camphor sulfonyl chloride 298 (2.52 g, 10.0 mmol) in acetonitrile (20 mL) 
was added drop-wise under N2 to a stirred solution of adamantylamine 317 (3.22 g, 21.3 
mmol) and dimethylaminopyridine (0.26 g, 2.1 mmol) in acetonitrile (10 mL) at 0 ºC, and the 
solution was stirred for 1 h. The reaction mixture was then hydrolysed with water (10 mL) 
followed by 10 % aqueous HCl (2 mL) and the resulting mixture was extracted into EtOAc (3 
× 25 mL). The organic layers were combined, washed with 5 % aqueous NaOH (5 mL) and 
dried over anhydrous MgSO4. The solvent was removed in vacuo affording: 
N-(1-adamantyl)-2-oxo-bornane-10-sulfonamide 318 as white crystals (3.51 g, 92.2 %) 
(Found: M+, 365.20387. C20H31NO3S requires M, 365.20247); δH (400 MHz; CDCl3) 0.90 
(3H, s, 9-Me), 1.04 (3H, s, 8-Me), 1.41, 1.86, 2.02 and 2.32 (4H, series of multiplets, 5- and 
6-CH2), 1.66 (6H, m, 14-,19- and 20-CH2), 1.92 and 2.38 (2H, 2 × m,  3-CH2), 2.00 (6H, m, 
12-, 16- and 17-CH2), 2.09 (3H, m, 13-,15- and 18-CH), 2.10 (1H, m, 4-H), 2.99 and 3.49 
(2H, 2 × d, J 15.0 Hz, 10-CH2) and 4.953 (1H, s, NH); δC (100 MHz; CDCl3) 19.7 (C-8), 19.9 
(C-9), 26.3 and 27.0 (C-5 and C-6), 29.7 (C-13, C-15 and C-18), 36.0 (C-14, C-19 and C-20), 
42.8 (C-4), 42.9 (C-3), 43.2 (12-C, 16-C and 17-C), 48.5 and 55.4 (C-1 and C-7), 54.5 (C-10), 
59.4 (C-11) and 216.7 (C-2); m/z 365 (M+, 30.0 %) and 135 (100). 
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N-(1-Adamantyl)-2-exo-hydroxybornane-10-sulfonamide 319 and N-(1-adamantyl)-2-endo-
hydroxybornane-10-sulfonamide 328 
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A solution of N-(1-adamantyl)-2-oxo-bornane-10-sulfonamide 318 (3.07 g, 8.4 mmol) in 
THF-H2O (2 mL: 1 mL) was added drop-wise to a stirred solution of NaBH4 (3.27 g, 86.3 
mmol) in a solution of THF-H2O (2 mL: 1 mL) at -15 ºC over 20 min. The solution was 
stirred vigorously and allowed to warm to room temperature overnight. The reaction was then 
quenched with 5 % HCl (2 mL) and the resulting mixture extracted into EtOAc (3 × 1 mL). 
The organic layers were combined, washed with 5 % brine (3 mL) and dried over anhydrous 
MgSO4. Solvent was removed in vacuo to give an oil, which was chromatographed [using 
silica gel on a chromatotron, 1mm plate; elution with hexane-EtOAc (8:2)] to afford two 
products:  
N-(1-adamantyl)-2-exo-hydroxybornane-10-sulfonamide 319, as transparent crystals (2.87 g, 
92.8 %) (Found: M+, 367.21993. C20H33NO3S requires M, 367.21812); [α]20D  = -40.98° (c 
2.45, CHCl3); δH (400 MHz; CDCl3) 0.82 and 1.06 (6H, 2 × s, 8- and 9-Me), 1.12, 1.49, 1.68, 
1,71 and 1.76 (6H, series of multiplets, 3-, 5- and 6-CH2), 1.66 and 1.96 (12H, 2 × m, 12-,14-
,16-,17-,19- and 20-CH2), 1.72 (1H, m 4-H), 2.11 (3H, m, 13-,15- and 18-CH), 2.92 and 3.49 
(2H, 2 × d, J 13.8 Hz, 10-CH2), 3.32 (1H, d, J 2.1 Hz, 2-OH), 4.06 (1H, m, 2-H) and 4.20 
(1H, br s, NH); δC (400 MHz; CDCl3) 19.9 and 20.6 (C-8 and C-9), 27.4, 30.7 and 38.9 (C-3, 
C-5 and C-6), 29.6 (C-13, C-15 and C-18), 35.9 and 43.3 (C-12, C-14, C-16,  C-17, C-19 and 
C-20), 44.4 (C-4), 48.6 and 50.8 (C-1 and C-7), 55.3 (C-11), 57.0 (C-10) and 76.4 (C-2); m/z 
367 (M+, 0.6 %) and 151 (100); and  
N-(1-adamantyl)-2-endo-hydroxybornane-10-sulfonamide 328, as transparent crystals (0.17 g, 
5.6 %) (Found: M+, 367.21706. C20H33NO3S requires M, 367.21812); [α]20D  = +4.64° (c 0.56, 
CHCl3); δH (400 MHz; CDCl3) 0.89 and 0.90 (6H, 2 × s, 8- and 9-Me), 1.08, 1.38, 1.54, 1.79, 
2.30 and 2.40 (6H, series of multiplets, 3-, 5- and 6-CH2), 1.63 (1H, t, 4.5 Hz, 4-H), 1.66 and 
319 328 
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1.95 (12H, 2 × m, 12-,14-,16-,17-,19- and 20-CH2), 2.10 (3H, m, 13-,15- and 18-CH), 3.09 
and 3.15 (2H, 2 × d, , J 14.1 Hz, 10-CH2), 3.48 (1H, d, J 2.5 Hz, 2-OH), 4.23 (1H, br s, NH) 
and 4.33 (1H, ddd, J 2.6, 5.2 and 10.0 Hz, 2-H); δC (100 MHz; CDCl3) 18.9 and 20.5 (C-8 and 
C-9), 23.9, 28.3 and 38.3 (C-3, C-5 and C-6), 29.6 (C-13, C-15 and C-18), 35.9 and 43.3 (C-
12, C-14, C-16,  C-17, C-19 and C-20), 43.9 (C-4), 51.3 and 51.5 (C-1 and C-7), 55.5 (C-11), 
60.6 (C-10) and 75.2 (C-2); m/z 367 (M+, 0.5 %) and 151 (100). 
 
N-(1-Adamantyl)-2-exo-acryloyloxybornane-10-sulfonamide 321 and N-(1-adamantyl)-2-exo-
(3-chloropropanoyloxy)bornane-10-sulfonamide 320 
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Method 1: 
The experimental procedure employed for the synthesis of phenyl 2-exo-acryloyloxybornane-
10-sulfonate 296 and phenyl 2-exo-(3-chloropropanoyloxy)bornane-10-sulfonate 308 
(Method 1) was followed, using neutral Al2O3 (0.47 g, 4.6 mmol), N-(1-adamantyl)-2-exo-
hydroxybornane-10-sulfonamide 319 (1.10 g, 3.0 mmol) and acryloyl chloride (0.56 g, 6.2 
mmol). Work-up and purification [HPLC; elution with hexane-EtOAc (8:2)] afforded two 
products:  
N-(1-adamantyl)-2-exo-acryloyloxybornane-10-sulfonamide 321, as transparent crystals, 
(0.80 g, 63.2 %) (Found: M+, 421.22844. C23H35NO4S requires M, 421.22868); [α]20D  = -
51.26° (c 4.06, CHCl3); δH (400 MHz; CDCl3) 0.89 and 1.02 (6H, 2 × s, 8- and 9-Me), 1.18, 
1.59, 1.75, 1.99 (6H, series of multiplets, 3-, 5- and 6-CH2), 1.61 and 1.90 (12H, 2 × m, 12-
,14-, 16-, 17-, 19- and 20-CH2), 1.77 (1H, m, 4-H), 2.05 (3H, m,13-, 15- and 18-CH), 2.90 
and 3.54 (2H, 2 × d, J 13.9 Hz, 10-CH2), 4.11 (1H, s, NH), 5.03 (1H, m, 2-CH), 5.77 (1H, dd, 
J 1.0 and 10.4 Hz, 3’-HZ), 6.08 (1H, dd, J 10.4 and 17.3 Hz, 2’-H) and 6.33 (1H, dd, J 1.0 and 
17.3 Hz, 3’-HE); δC (100 MHz; CDCl3) 20.0 and 20.4 (C-8 and C-9), 27.0, 29.9 and 39.5 (C-3, 
C-5 and C-6), 29.6 (C-13, C-15 and C-18), 35.9 (C-14, C-19 and C-20), 43.2 (C-12, C-16 and 
C-17), 44.4 (C-4), 49.3 and 49.5 (C-1 and C-7), 55.1 (C-11), 55.3 (C-10), 78.0 (C-2), 129.0 
321 320 
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(C-2’), 130.0 (C-3’) and 164.6 (C-1’); m/z 421 (M+, 2.8 %) and 135 (100); and 
 N-(1-adamantyl)-2-exo-(3-chloropropanoyloxy)bornane-10-sulfonamide 320, as transparent 
crystals, (0.48 g, 35.0 %) (Found: M+, 457.21058. C23H36NO4SCl requires M, 457.20536); 
[α]20D  = -13.64° (c 0.22, CHCl3); δH (400 MHz; CDCl3) 0.89 and 1.01 (6H, 2 × s, 8- and 9-
Me), 1.16 -2.02 (6H, series of multiplets, 3-,5- and 6-CH2), 1.66 and 1.94 (12H, 2 × m, 12-, 
14-, 16-, 17-, 19- and 20-CH2), 1.78 (1H, m, 4-H), 2.10 (3H, m, 13-, 15- and 18-CH), 2.77 
(2H, t, J 6.8 Hz, 2’-CH2), 3.21 (2H, 2 × d, J 13.9 Hz, 10-CH2), 3.74 (2H, m, J 6.9 and 16.5 
Hz, 3’-CH2), 4.00 (1H, s, NH) and 4.99 (1H, dd, J 2.4 and 7.8 Hz, 2-CH); δC (100 MHz; 
CDCl3) 20.0 and 20.4(C-8 and C-9), 27.1, 30.1 and 39.5 (C-3, C-5 and C-6), 29.6 (C-13, C-15 
and C-18), 35.9 and 43.4 (C-12, C-14, C-16, C-17, C-19 and C-20), 37.9 (C-2’), 39.2 (C-3’), 
44.4 (C-4), 49.3 and 49.4 (C-1 and C-7), 55.1 (C-11), 55.5 (C-10), 78.7(C-2) and 168.8 (C-
1’); m/z 457 (M+, 3.3 %) and 135 (100). 
Method 2: 
Triethylamine (0.32 g, 3.1 mmol) was added to a mixture of N-(1-adamantyl)-2-exo-
acryloyloxybornane-10-sulfonamide 321 and N -(1-adamantyl)-2-exo-(3-
chloropropanoyloxy)bornane-10-sulfonamide 320 [1.68 g (0.80 g, 1.7 mmol of 320)]. The 
reaction mixture was stored under N2 and stirred at 25 ºC for 1 h and then taken up in EtOAc 
(5 mL), washed with brine and dried over anhydrous MgSO4. Solvent was removed in vacuo 
to give transparent crystals of: 
N-(1-adamantyl)-2-exo-acryloyloxybornane-10-sulfonamide 321 (0.67 g, 92.1 %). 
 
Attempted Synthesis: 
The experimental procedure employed for the synthesis of phenyl 2-exo-acryloyloxybornane-
10-sulfonate 296 (Method 2) was followed, using N-(1-adamantyl)-2-exo-hydroxybornane-
10-sulfonamide 319 (0.21 g, 0.6 mmol) in dry THF (8 mL) at -78 ºC, butyllithium (1.6 M 
solution in hexane; 0.43 mL, 0.7 mmol) and acryloyl chloride (0.11 g,  1.2 mmol). Work-up 
was followed by 1H NMR analysis which failed to show any change in the starting material. 
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N –(1-Adamantyl)-2-endo-acryloyloxybornane-10-sulfonamide 330 and N-(1-adamantyl)-2-
endo-(3-chloropropanoyloxy)bornane-10-sulfonamide 329 
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Method 1: 
The experimental procedure employed for the synthesis of phenyl 2-exo-acryloyloxybornane-
10-sulfonate 296 and phenyl 2-exo-(3-chloropropanoyloxy)bornane-10-sulfonate 308 
(Method 1) was followed, using neutral Al2O3 (0.08 g, 0.8 mmol), N-(1-adamantyl)-2-endo-
hydroxybornane-10-sulfonamide 328 (0.19 g, 0.5 mmol) and acryloyl chloride (0.16 g, 1.8 
mmol). Work-up and purification [HPLC; elution with hexane-EtOAc (8:2)] afforded two 
products, as white crystals:  
N-(1-adamantyl)-2-endo-acryloyloxybornane-10-sulfonamide 330 (0.15 g, 67.1 %) (Found: 
M+, 421.22485. C23H35NO4S requires M, 421.22868); [α]20D  = -32.50° (c 1.24, CHCl3); δH 
(400 MHz; CDCl3) 0.93 and 0.97 (6H, 2 × s, 8- and 9-Me), 1.08, 1.36, 1.68, 1.84, 2.49 and 
2.57 (6H, series of multiplets, 3-,5- and 6-CH2), 1.63 and 1.90 (12H, 2 × m, 12-, 14-, 16-,17-, 
19- and 20-CH2), 1.72 (1H, m, 4-H), 2.07 (3H, m,13-, 15- and 18-CH), 3.10 and 3.14 (2H, 2 × 
d, J 14.3 Hz, 10-CH2), 3.97 (1H, s, NH), 5.23 (1H, d, J 9.6 Hz, 2-H), 5.85 (1H, dd, J 1.0 and 
10.4 Hz, 3’-HZ), 6.14 (1H, dd, J 10.5 and 17.4 Hz, 2’-H) and 6.46 (1H, dd, J 1.0 and 17.3 Hz, 
3’-HE); δC (100 MHz; CDCl3) 19.2 and 19.9 (C-8 and C-9), 25.6, 28.0 and 37.7 (C-3, C-5 and 
C-6), 29.6 (C-13, C-15 and C-18), 35.9 (C-14, C-19 and C-20),  43.3 (C-12, C-16 and C-17), 
44.0 (C-4), 50.2 and 50.6 (C-1 and C-7), 55.0 (C-11), 59.6 (C-10), 77.3 (C-2), 128.9 (C-2’), 
130.9 (C-3’) and 165.9 (C-1’); m/z 421 (M+, 4.2 %) and 135 (100); and 
N-(1-adamantyl)-2-endo-(3-chloropropanoyloxy)bornane-10-sulfonamide 329 (0.07 g, 
30.7%) (Found: M+, 457.21295. C23H36NO4SCl requires M, 457.20536); [α]20D  = +24.52° (c 
0.42, CHCl3); δH (400 MHz; CDCl3) 0.92 and 0.95 (6H, 2 × s, 8- and 9-Me), 1.08, 1.36, 1.65, 
1.85, 2.45 and 2.49 (6H, series of multiplets, 3-, 5- and 6-CH2), 1.65 and 1.92 (12H, 2 × m, 
330 329 
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12-, 14-, 16-, 17-, 19- and 20-CH2), 1.73 (1H, m, 4-H), 2.10 (3H, m, 13-, 15- and 18-CH), 
2.84 (2H, dd, J 6.8 and 12.3 Hz, 2’-CH2), 3.06 and 3.14 (2H, 2 × d, J 14.0 Hz, 10-CH2), 3.79 
(2H, t, J 6.9 Hz, 3’-CH2), 4.07 (1H, s, NH) and 5.26 (1H, d, J 9.7 Hz, 2-CH); δC (100 MHz; 
CDCl3) 19.2 and 19.9 (C-8 and C-9), 25.5, 28.0 and 37.5 (C-3, C-5 and C-6), 29.6 (C-13, C-
15 and C-18), 35.9 and 43.3  (C-12, C-14, C-16, C-17, C-19 and C-20), 37.9 (C-2’), 39.3 (C-
3’), 43.9 (C-4), 50.3 and 50.7 (C-1 and C-7), 55.0 (C-11), 59.9 (C-10), 77.2 (C-2) and 170.2 
(C-1’); m/z 457 (M+, 3.68 %) and 135 (100). 
Method 2: 
The experimental procedure employed for the synthesis of N-(1-adamantyl)-2-exo-
acryloyloxybornane-10-sulfonamide 321 (Method 2) was followed, using triethylamine (0.01 
g, 0.1 mmol) and a mixture of N-(1-adamantyl)-2-endo-acryloyloxybornane-10-sulfonamide 
330 and N-(1-adamantyl)-2-endo-(3-chloropropanoyloxy)bornane-10-sulfonamide 329 [0.50 
g (0.04g, 0.08 mmol of 329)]. Workup afforded N-(1-adamantyl)-2-endo-
acryloyloxybornane-10-sulfonamide 330 (0.03 g, 79.7 %). 
 
Attempted Synthesis: 
The experimental procedure employed for the synthesis of phenyl 2-exo-acryloyloxybornane-
10-sulfonate 296 (Method 2) was followed, using N-(1-adamantyl)-2-endo-hydroxybornane-
10-sulfonamide 328 (0.15 g, 0.4 mmol) in dry THF (6 mL) at -78 ºC, butyllithium (1.6 M 
solution in hexane; 0.30 mL, 0.5 mmol) and acryloyl chloride (0.07 g,  0.8 mmol). Work-up 
was followed by 1H NMR analysis which failed to show any change in the starting material. 
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3.2.6 Morita-Baylis-Hillman Products from N-(1-adamantyl)-2-exo-
acryloyloxybornane-10-sulfonamide 
 
The reactions in this series were essentially complete; thus, the crude yield as determined 
from NMR analysis was considered an adequate assessment of the chemical transformation in 
each reaction. The diastereomeric excess (% d.e.) was determined from the integral ratios of 
several signals (typically 3’-H, 9’-CH2 and 8- and 9-Me) for the diastereomeric components. 
Separation of diastereomeric products was not attempted thus NMR data for both isomers are 
reported together. 
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5
6 1 2
34
79
8
10
O
NH
11 12
13
19
20
16
14
15
H
S
O
O
1' 2'
O
9'
3' 4'
OH
8'
7'
N
6'
5'
18
17
H H
BH 1
 
To a solution of N-(1-adamantyl)-2-exo-acryloyloxybornane-10-sulfonamide 321 (0.10 g, 
0.24 mmol) in CDCl3 (0.40 mL) was added pyridine-4-carbaldehyde (0.03 g, 0.27 mmol), and 
DABCO (0.003 g, 0.02 mmol). The solution was stirred at room temperature for 90 h then 
concentrated in vacuo. The residue was purified by washing with a minimal amount of cold 
Et2O to afford a mixture of the diastereomeric compounds: 
Morita-Baylis-Hillman products 322A and 322B (93 %, 38 % d.e.); δH (400 MHz; CDCl3) 
0.80/0.88 and 0.84/0.97 (6H, 2 × s, 8- and 9-Me), 1.14 – 1.232 and 1.68 – 1.79 (2H, complex 
of multiplets, 5-CH2), 1.52 – 1.65 and 1.92 – 1.99 (2H, complex of multiplets, 6-CH2), 1.57 – 
1.67 (6H, complex of multiplets, 14-, 19- and 20-CH2), 1.62 – 1.69 and 1.93 – 1.99 (2H, 
complexes of multiplets, 3-CH2), 1.73 – 1.78 (1H, m, 4-H), 1.86 – 1.94 (6H, complexes of 
multiplets, 12-, 16- and 17-CH2), 2.05 (3H, br m, 13-, 15- and 18-H), 2.87 and 3,35/2.92 and 
3.46 (2H, 2 × d, J 13.9 Hz, 10-CH2), 4.27 (1H, s, NH), 5.01/5.05 (1H, dd, J 3.2 and 7.9 Hz, 2-
H), 5.02 (1H, br s, 3’-OH), 5.52/5.57 (1H, s, 3’-H), 5.93/5.99 (2H, 2 × s, 9’-CH2), 7.33 (2H, t, 
322 
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J 6.3 Hz, 5’- and 8’-H), 8.54/8.55 (2H, s, 6’- and 7’-H); δC (100 MHz; CDCl3) 19.6/19.9 and 
20.2/20.3 (C-8 and C-9), 27.1/27.0 (C-5), 29.57/29.58 (C-13, C-15 and C-18), 30.2/30.8 (C-
6), 35.88/35.90  (C-14, C-19 and 20), 39.4/39.6 (C-3), 43.3/43.4 (C-12, C-16 and C-17), 
44.3/44.9 (C-4), 49.2/49.3 and 49.6/49.7 (C-1 and C-7), 55.2/55.7 (C-10), 55.7 /55.7 (C-11), 
71.6/72.4 (C-3’), 79.07/79.19 (C-2), 121.33/121.55 (C-5’ and C-8’), 127.14/127.42 (C-9’), 
141.70/142.19 (C-2’), 149.69/149.70(C-6’ and C-7’), 150.35/150.67 (C-4’) and 
164.78/164.81 (C-1’); 
 
Morita-Baylis-Hillman products 323A and 323B 
5
6 1 2
34
79
8
10
O
NH
11 12
13
19
20
16
14
15
H
S
O
O
1' 2'
O
9'
3' 4'
OH
8'
7'
6'
N
5'
18
17
H H
BH 2
 
The experimental procedure employed for the synthesis of the Morita-Baylis-Hillman 
products 322A and 322B was followed, using N-(1-adamantyl)-2-exo-acryloyloxybornane-10-
sulfonamide 321 (0.10 g, 0.24 mmol) in CDCl3 (0.40 mL), pyridine-2-carbaldehyde (0.03 g, 
0.26 mmol), and DABCO (0.003 g, 0.02 mmol). Work-up afforded the diastereomeric 
compounds: 
Morita-Baylis-Hillman products 323A and 323B (99 %; 22 % d.e.); δH (400 MHz; CDCl3) 
0.66/0.88 and 0.82/1.01 (6H, 2 × s, 8- and 9-Me), 1.13 – 1.26 and 1.40 – 2.12 (22H, 
complexes of multiplets, 3-, 5-, 6-, 13-, 14-, 15-, 18-, 19- and 20-CH2, 4-, 12-, 16- and 17-
CH), 1.59 (1H, m, 4-H), 2.82/2.85 and 3.46/3.49 (2H, 2 × d, J 14.1/13.8 Hz, 10-CH2), 
4.44/4.13 (1H, s, NH), 4.98/5.07 (1H, br s, 3’-OH), 5.02/ 5.10 (1H, dd, J 3.5/2.9 and 7.9/7.9 
Hz, 2-H), 5.54/5.71 (1H, s, 3’-H), 5.90 and 6.36/5.80 and 6.23 (2H, 2 × s, 9’-CH2), 7.17 - 7.23 
(1H, m, 7’-H), 7.41 /7.47 (1H, d, J 7.8/8.0 Hz, 5’-H), 7.65 - 7.70 (1H, complex of multiplets, 
6’-H), 8.55 /8.50 (1H, d, J 4.7 Hz, 8’H); δC (100 MHz; CDCl3) 19.5/20.0 and 20.4/20.3 (C-8 
and C-9), 27.0/27.1 (C-5), 29.5/29.7 (C-13, C-15 and C-18), 35.7/35.8 (C-6), 35.8/36.0 (C-14, 
C-19 and C-20), 39.3/39.41 (C-3), 43.3/43.4 (C-12, C-16 and C-17), 44.3/44.5 (C-4), 
323 
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49.2/49.5 and 49.3/49.6 (C-1 and C-7), 55.0/55.3 (C-10), 55.1/55.3 (C-11), 70.9/73.0 (C-3’), 
79.0/78.7 (C-2), 120.9/121.7 (C-5’), 122.65/122.68 (C-7’), 125.6/128.0 (C-9’), 137.0/137.1 
(C-6’), 142.9/143.1 (C-2’), 147.8/148.2 (C-8’), 151.8/152.0 (C-4’), 169.3/169.9 (C-1’);  
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The experimental procedure employed for the synthesis of the Morita-Baylis-Hillman 
products 322A and 322B was followed, using N-(1-adamantyl)-2-exo-acryloyloxybornane-10-
sulfonamide 321 (0.10 g, 0.24 mmol) in CDCl3 (0.40 mL), pyridine-3-carbaldehyde (0.03 g, 
0.26 mmol), and DABCO (0.003 g, 0.03 mmol). Work-up afforded the diastereomeric 
compounds: 
Morita-Baylis-Hillman products 324A and 324B (93 %, 60 % d.e.); δH (400 MHz; CDCl3) 
0.86/0.88 and 0.89/0.96 (6H, 2 × s, 8- and 9-Me), 1.14 – 1.25 and 1.70 – 1.78 (2H, complex 
of multiplets, 5-CH2), 1.56 -1.64 and 1.90 – 1.97 (2H, complex of multiplets, 6-CH2), 1.64 
(6H, br s, 14-, 19- and 20 CH2), 1.67 – 1.75 (2H, complex of multiplets, 3-CH2), 1.75/1.77 
(1H, d, J 3.3/3.9 Hz, 4-H), 1.91/1.92 (6H, br s, 13-, 15- and 18-CH2), 2.06 (3H, br s, 12- 16- 
and 17-CH), 2.85/2.90 and 3.30/3.41 (2H, 2 × d, J 13.8/13.8 Hz, 10-CH2), 4.31/4.45 (1H, s, 
NH), 5.04 - 5.08 (1H, m, 2-H), 5.05 (br s, 3’-OH), 5.57/5.63 (1H, s, 3’-H), 5.75/5.63 and 
6.27/6.27 (2H, 2 × s, 9’-CH2), 7.27/7.29 (1H, d, J 4.8/4.8 Hz, 6’-CH), 7.73 - 7.77 (1H, m, 5’-
CH), 8.50 - 8.53 (1H, m, 7’-CH), 8.59/ 8.58 (1H, d, J 2.1/1.9 Hz, 8’-CH); δC (100 MHz; 
CDCl3) 19.9/20.0 and 20.3/20.3 (C-8 and C-9), 26.99/27.03 (C-5), 29.6 (C-14, C-19 and C-
20), 30.1/30.2 (C-6), 35.9 (C-13, C-15 and C-18), 39.36/39.42 (C-3), 43.4 (C-12, C-16 and C-
17), 44.3/44.4 (C-4), 49.25/49.32 and 49.6/49.7 (C-1 and C-7), 54.87/54.89 (C-11),55.2/55.7 
(C-10), 71.0/71.7 (C-3’), 78.9/79.0 (C-2), 123.38/123.42 (C-6’), 126.3/126.4 (C-9’), 
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134.3/134.5 (C-5’), 142.9/142.5 (C-2’), 148.3/148.5 (C-8’), 148.9/149.1 (C-7’), 1.49.2/150.0 
(C-4’) and 164.8/164.9 (C-1’);  
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The experimental procedure employed for the synthesis of the Morita-Baylis-Hillman 
products 322A and 322B was followed, using N-(1-adamantyl)-2-exo-acryloyloxybornane-10-
sulfonamide 321 (0.10 g, 0.25 mmol) in CDCl3 (0.40 mL), 6-methylpyridine-2-carbaldehyde 
(0.03 g, 0.27 mmol), and DABCO (0.004 g, 0.03 mmol). Work-up afforded the 
diastereomeric compounds: 
Morita-Baylis-Hillman products 325A and 325B (98 %, 95 % d.e.); δH (400 MHz; CDCl3) 
0.88 and 1.01 (6H, 2 × s, 8- and 9-Me), 1.20 - 1.24 and 1.72 – 1.80 (2H, multiplet of 
multiplets, 5-CH2), 1.41 and 1.53 (6H, 2 × d, J 12.1 Hz, 14-, 19- and 20-CH2), 1.58 – 1.66 and 
1.95 -2.01 (2H, multiplet of multiplets, 6-CH2), 1.76 – 1.92 and 1.97 – 2.05 (2H, complex of 
multiplets, 3-CH2), 1.79 (1H, m, 4-H), 1.80 (6H, br s, 12-, 16- and 17-CH2), 1.92 (3H, br s, 
13-, 15- 18-CH), 2.52 (3H, s, 9’-Me), 2.84 and 3.50 (2H, 2 × d, J 13.9 Hz, 10-CH2), 4.17 (1H, 
s, NH), 5.11 (1H, dd, J 3.0 Hz, J 7.9 Hz, 2-H), 5.49 (1H, br s, OH), 5.68 (1H, s, 3’-H), 5.79 
and 6.22 (2H, 2 × s, 10’-CH2), 7.03 (1H, d, J 7.6 Hz, 7’-H), 7.22 (1H, d, J 7.8 Hz, 5’-H) and 
7.55 (1H, t, J 7.7 Hz, 6’-H); δC (100 MHz; CDCl3) 20.0 and 20.4 (C-8 and C-9), 24.2 (C-9’), 
27.1 (C-5), 29.5 (C-13, C-15 and C-18), 30.0 (C-6), 35.8 (C-14, C-19 and C-20), 39.4 (C-3), 
43.2 (C-12, C-16 and C-17), 44.4 (C-4), 49.3 and 49.6 (C-1 and C-7), 55.0 (C-11), 55.2 (C-
10), 70.2 (C-3’), 78.7 (C-2), 118.6 (C-7’), 122.1 (C-5’), 125.4 (C-10’), 137.4 (C-6’), 143.2 
(C-2’), 156.6 (C-4’), 157.9 (C-8’) and 165.1 (C-1’); 
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Morita-Baylis-Hillman products 326A and 326B 
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The experimental procedure employed for the synthesis of the Morita-Baylis-Hillman 
products 322A and 322B was followed, using N-(1-adamantyl)-2-exo-acryloyloxybornane-10-
sulfonamide 321 (0.10 g, 0.24 mmol) in CDCl3 (0.40 mL), 2-nitrobenzaldehyde (0.04 g, 0.27 
mmol), and DABCO (0.003 g, 0.03 mmol). Work-up afforded the diastereomeric compounds: 
Morita-Baylis-Hillman products 326A and 326B; (89 %, 52 % d.e.); δH (400 MHz; CDCl3) 
0.87/0.88 and 0.91/1.00 (6H, 2 × s, 8- and 9-Me), 1.14 – 1.28 and 1.55 – 2.12 (6H, complex 
of multiplets, 3-, 5- and 6-CH2), 1.65/1.64 (6H, br s, 14-, 19- and 20-CH2), 1.91/1.92 (1H, m, 
4-H), 1.96/1.95 (6H, br s, 12-, 16- and 17-CH2), 2.09 (3H, br s, 13-, 15- and 18-CH), 
2.94/2.86 and 3.36/3.47 (2H, 2 × d, J 13.9/13.9 Hz, 10-CH2), 4.31/4.20 (1H, s, NH), 4.99 - 
5.04/5.09 – 5.13 (1H, m, 2-H), 5.05 (1H, br s, 3’-OH), 5.47/5.48 and 6.28/6.22 (2H, 2 × s, 
10’-CH2), 6.22/6.19 (1H, s, 3’-H), 7.43 – 7.49 (1H, m, 7’-H), 7.63 -7.69 (1H, m, 9’-H), 7.72 - 
7.96 (1H, m, 8’-H) and 8.00/8.11 (1H, dd, J 1.2/1.4 Hz, J 8.2/7.9 Hz, 6’-H); δC (100 MHz; 
CDCl3) 19.7/19.9 and 20.29/20.31 (C-8 and C-9), 27.04/26.97 (C-6), 29.64/29.61 (C-13, C-15 
and C-18), 30.3/30.0 (C-5), 35.9 (C-14, C-19 and C-20), 39.4/39.3 (C-3), 43.33/43.25 (C-12, 
C-16 and C-17), 44.37/44.41 (C-4), 49.29/49.19 and 49.31/49.78 (C-1 and C-7), 55.27/56.13 
(C-10), 55.27/56.08 (C-11), 67.7/68.5 (C-3’), 79.1/78.7 (C-2), 124.9/126.0 (C-6’), 
128.7/128.6 (C-10’), 129.0/128.9 (C-9’), 133.8/133.6 (C-7’), 134.0/134.1 (C-8’), 136.5/136.3 
(C-4’), 142.0/141.5 (C-2’), 164.7/164.4 (C-5’) and 171.5/171.6 (C-1’); 
 
Attempted Synthesis of Morita-Baylis-Hillman products 327A and 327B 
The experimental procedure employed for the synthesis of the Morita-Baylis-Hillman 
products 322A and 322B was followed, using N-(1-adamantyl)-2-exo-acryloyloxybornane-10-
sulfonamide 321 (0.10 g, 0.24 mmol) in CDCl3 (0.40 mL), pivaldehyde (0.02 g, 0.26 mmol), 
and DABCO (0.003 g, 0.03 mmol). Work-up afforded the starting material 321. 
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3.3  NMR KINETIC STUDY  
 
This study focused on the transesterification of the hydroxybornanyl acrylates 285 and 287 in 
various media and under different reaction conditions. Complete data sets, together with 
graphical charts, can be found in Appendix II on CD. In the following section, the 
experimental details, plots of the integral ratios and the natural logarithm of the integral ratios 
as a function of time are presented for each of the reactions A1 – G4. 
 
3.3.1. General Purification, Spectroscopic Techniques and Calculations 
 
A mixture (ca. 1g) of the hydroxybornanyl acrylates, 2-exo-hydroxy-3-exo-bornanyl acrylate 
285 and 3-exo-hydroxy-2-exo-bornanyl acrylate 287 was subjected to HPLC separation 
[staggered multiple injections at 10 min intervals, each injection consisting of ca. 30 mg 
sample in 200 μL of solvent; elution with hexane-EtOAc (7:3); approximate retention times: 
285: 12.5 min and 287: 16.5 min]. The solutions of the pure compounds were immediately 
stored at -78 ºC (dry ice-acetone mixture) to minimize the possibility of transesterification. 
The solvent was removed from each fraction under reduced pressure and the pure compounds 
were stored under N2 at -78 ºC. Aliquots (0.5 mL) of solutions of 285 or 287 in deuterated 
solvent were used for NMR spectroscopic analysis. Each aliquot was injected into a clean, 
dry, N2-flushed NMR tube. The NMR tube was inserted into the NMR spectrometer, its 
temperature was allowed to warm to that of the probe (ca. 5 min) and the instrument was then 
shimmed. Data acquisition was achieved using an automated programme to obtain individual 
spectra at regular time intervals. After a suitable number of data sets had been collected, the 
kinetic run was terminated and the data analyzed. Reactions were monitored over a range of 
temperatures in order to obtain data for the calculation of kinetic and thermodynamic 
parameters. The precision and accuracy of the spectrometer temperature setting was judged to 
be ± 0.5 K. In order to obtain the final equilibrium concentrations, the samples, in sealed 
NMR tubes, were placed in constant temperature (± 0.5 K) water baths for periods of seven to 
thirty days, and monitored by NMR spectroscopy at random time intervals until the product 
ratios were constant. Ratios of the hydroxybornanyl acrylates were obtained by comparing the 
integrals of selected signals. For convenience and accuracy, the 2-Hendo and 3-Hendo signals of 
both compounds were chosen for comparison, as they are characteristic for each isomer and 
are completely unobscured by other proton signals (Tables 3.1, 3.2 and 3.3).  
 
Experimental 
- 243 - 
Table 3.1: 400 MHz 1H NMR data for comparison of the isomeric esters, 2-exo-hydroxy-
3-exo-bornanyl acrylate 285 and 3-exo-hydroxy-2-exo-bornanyl acrylate 287, 
in unpurified CDCl3 at 303 K. 
 
 285 287 
Proton assignment 2-Hendo 3-Hendo 3-Hendo 2-Hendo 
Chemical shift, δH (ppm) 3.76 4.64 4.02 4.58 
Multiplicity d d d d 
Coupling Constants, J (Hz) 6.8 6.8 6.7 6.7 
 
Table 3.2: 400 MHz 1H NMR data for comparison of the isomeric esters, 2-exo-hydroxy-
3-exo-bornanyl acrylate 285 and 3-exo-hydroxy-2-exo-bornanyl acrylate 287, 
in purified CDCl3 at 303 K. 
 
 285 287 
Proton assignment 2-Hendo 3-Hendo 3-Hendo 2-Hendo 
Chemical shift, δH (ppm) 3.81 4.68 4.02 4.54 
Multiplicity dd d dd d 
Coupling Constants, J (Hz) 5.2; 6.2 6.8 3.7; 6.2 6.7 
. 
Table 3.3: 400 MHz 1H NMR data for comparison of the isomeric esters, 2-exo-hydroxy-
3-exo-bornanyl acrylate 285 and 3-exo-hydroxy-2-exo-bornanyl acrylate 287, 
in purified DMSO-d6 at 303 K. 
 
 285 287 
Proton assignment 2-Hendo 3-Hendo 2-OH 3-Hendo 2-Hendo 3-OH 
Chemical shift, δH (ppm) 3.59 4.65 4.97 3.79 4.53 4.87 
Multiplicity dd d d dd d d 
Coupling Constants, J (Hz) 2.2; 6.4 6.8 6.0 5.1; 6.6 6.7 5.0 
 
Following the automated processing of the integrals of the 2-Hendo and 3-Hendo signals for both 
compounds, the data were used to determine the relative concentrations. In each set of 
experiments, the mathematical relationships described in detail in the Discussion (Section 
2.3.2.1) were used to calculate kinetic and thermodynamic parameters for both forward and 
reverse reactions.  
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3.3.2 Reactions in Unpurified CDCl3  
 
The acrylate ester, 3-exo-hydroxy-2-exo-bornanyl acrylate 287 (0.1316 g, 0.59 mmol) was 
transferred to a dry 5 mL volumetric flask. Unpurified CDCl3 was added and the volume 
made up to 5 mL to give a concentration of 0.117 mol L-1. Aliquots of 0.50 mL were removed 
from the flask and immediately used for NMR spectroscopic analyses at temperatures ranging 
from 301 to 323 K. A solution of the isomeric ester, 2-exo-hydroxy-3-exo-bornanyl acrylate 
285 (0.0153 g, 0.068 mmol) in 0.50 mL of unpurified CDCl3 was used similarly.  
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Kinetics in CDCl3 @ 301 K 
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Experiment A1: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in unpurified 
CDCl3 at 301 K. 
 
T/K Mass/g Conc. /mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
301 0.0132 0.117 0.465 0.535 1.15 5.68E-06 2.64E-06 3.04E-06
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Experiment A2: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in unpurified 
CDCl3 at 307 K. 
 
T/K Mass/g Conc. /mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
307 0.0132 0.117 0.482 0.518 1.08 9.96E-06 4.80E-06 5.16E-06
 
Kinetics in CDCl3 @ 307 K 
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Experiment A3: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in unpurified 
CDCl3 at 313 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
313 0.0132 0.117 0.491 0.509 1.04 1.41E-05 6.92E-06 7.18E-06 
 
Kinetics in CDCl3 @ 313 K 
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Experiment A4: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in unpurified 
CDCl3 at 315 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
315 0.0132 0.117 0.481 0.519 1.08 2.27E-05 1.09E-05 1.18E-05 
 
Kinetic in CDCl3 @ 315 K 
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Experiment A5: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in unpurified 
CDCl3 at 317 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
317 0.0132 0.117 0.474 0.526 1.11 2.18E-05 1.03E-05 1.15E-05 
 
Kinetics in CDCl3 @ 317 K
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Experiment A6: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in unpurified 
CDCl3 at 319 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
319 0.0132 0.117 0.487 0.513 1.05 3.75E-05 1.83E-05 1.92E-05 
 
Kinetics in CDCl3 @ 319 K 
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Experiment A7: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in unpurified 
CDCl3 at 321 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
321 0.0132 0.117 0.478 0.522 1.09 2.72E-05 1.30E-05 1.42E-05 
 
Kinetics in CDCl3 @ 321 K 
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Experiment A8: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in unpurified 
CDCl3 at 323 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
323 0.0132 0.117 0.475 0.525 1.11 5.00E-05 2.37E-05 2.63E-05 
 
Kinetics in CDCl3 @ 323 K 
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Experiment A9: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in unpurified 
CDCl3 at 323 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
323 0.0153 0.136 0.475 0.525 0.90 4.91E-05 2.33E-05 2.58E-05 
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3.3.3 Reactions in Purified CDCl3 under N2 
 
The acrylate ester 2-exo-hydroxy-3-exo-bornanyl acrylate 285 (0.010 – 0.021g) was 
accurately weighed into dry NMR tubes, which had been pre-filled with N2. CDCl3 (0.5 mL) 
was then purified, under a stream of N2, by passage through neutral alumina and crushed 4Å 
molecular sieves in a dry Pasteur pipette directly into the NMR tubes, which were then 
flushed with N2 before sealing. The samples were used immediately for NMR spectroscopic 
analysis and experiments were conducted at various temperatures (301 to 315 K) following 
the method described previously (Section 3.3.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Experimental 
- 255 - 
Kinetics in Purified CDCl3 & N2 @ 301K 
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Experiment B1: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
CDCl3 under N2 at 301 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
301 0.0104 0.093 0.465 0.535 0.87 2.77E-07 1.29E-07 1.48E-07 
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R2 = 0.5541
y = -3E-12x2 + 2E-07x + 0.0146
R2 = 0.5541
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
0 2 4 6 8 10 12 14 16
time / sec x 103
In
te
ns
ity
 R
at
io
ARD 30
ARD 29
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
time / sec × 103 
time / sec × 103 
In
te
gr
al
 ra
to
 
ln
([2
85
]-[
28
5]
eq
m
) 
    287 
    285 
    285 
Experimental 
- 256 - 
Experiment B2: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
CDCl3 under N2 at 305 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
305 0.0101 0.090 0.472 0.528 0.89 1.73E-06 8.17E-07 9.14E-07 
 
Kinetics in Purified CDCl3 & N2 @ 305K
y = 3E-10x2 + 1E-08x + 0.0325
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Experiment B3: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
CDCl3 under N2 at 307 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
307 0.0095 0.085 0.482 0.518 0.93 9.07E-07 4.37E-07 4.70E-07 
 
Kinetics in Purified CDCl3 & N2 @ 307K
y = 1E-12x2 - 5E-07x + 0.9872
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Experiment B4: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
CDCl3 under N2 at 315 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
315 0.0210 0.187 0.481 0.519 0.93 1.07E-05 4.80E-06 5.56E-06 
 
Kinetics in Purified CDCl3 & N2 @ 315K
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3.3.4 Temperature Effect on Acrylate data in CDCl3 under N2  
 
Purified CDCl3 (0.5 mL) was added to 3-exo-hydroxy-2-exo-bornanyl acrylate 287 (0.014 g) 
in a dry NMR tube. The tube was flushed with nitrogen prior to sealing. Spectra were 
recorded over 1 h at temperatures in the range 305 to 323 K. 1H NMR Spectra were obtained 
at various temperatures and their line-shape was compared at each temperature and again on 
cooling. The spectra are presented in Section 2.3.2.2.2. 
 
Experiment C1:  Data for the thermal stability study of purified CDCl3 with 3-exo-hydroxy-
2-exo-bornanyl acrylate 287 
 
T/K Mass/g Conc./mol L-1 
305 - 323 0.0140 0.125 
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3.3.5 Thermal Stability Study of Purified CDCl3 in Air 
 
Purified CDCl3 (0.5 mL) was added to the acrylate esters 2-exo-hydroxy-3-exo-bornanyl 
acrylate 285 (0.010 g) or 3-exo-hydroxy-2-exo-bornanyl acrylate 287 (0.014 g) in dry NMR 
tubes. The tubes were not flushed with N2 before sealing and the samples were used 
immediately for NMR spectroscopic analysis. Experiments were conducted at various 
temperatures (313 to 323 K) following the method described previously (Section 3.3.1). 
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Kinetics in purified CDCl3 with atmospheric O2 @ 313 K 
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Experiment D1: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
CDCl3 under air at 313 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
313 0.0101 0.090 0.509 0.491 0.96 3.15E-05 1.55E-05 1.61E-05 
Kinetics in purified CDCl3 with atmospheric O2 @313 K
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Experiment D2: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
CDCl3 under air at 317 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
317 0.0101 0.090 0.474 0.526 0.89 9.15E-05 4.34E-05 4.81E-05 
Kinetics in purified CDCl3 with atmospheric O2 @ 317 K 
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Experiment D3: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
CDCl3 under air at 321 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
321 0.0101 0.090 0.478 0.522 0.92 2.08E-05 9.92E-06 1.08E-05 
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Experiment D4: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
CDCl3 under air at 323 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
323 0.0101 0.093 0.475 0.525 0.90 2.15E-05 1.02E-05 1.13E-05 
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3.3.6 Reactions in Purified DMSO-d6 under N2 
 
Purified DMSO-d6 (0.5 mL) was added to the acrylate esters 2-exo-hydroxy-3-exo-bornanyl 
acrylate 285 (0.083 g) or 3-exo-hydroxy-2-exo-bornanyl acrylate 287 (0.164 g) in dry NMR 
tubes. The tubes were flushed with N2 before sealing and the samples were used immediately 
for NMR spectroscopic analysis. Experiments were conducted at various temperatures (301 to 
329 K) following the method described previously (Section 3.3.1). 
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Experiment E1: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in purified 
DMSO-d6 under N2 at 301 K. 
 
T/K Mass/g Conc./mol L-1 
301 0.0164 0.146 
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Experiment E2: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in purified 
DMSO-d6 under N2 at 305 K. 
 
 
T/K Mass/g Conc./mol L-1 
305 0.0164 0.146 
 
Kinetics in DMSO @ 305K
y = -9E-07x + 0.9891
R2 = 0.5456
y = 9E-07x + 0.0109
R2 = 0.5456
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
0 0.5 1 1.5 2 2.5
time / sec x 103
In
te
ns
ity
 R
at
io
ARD 30
ARD 29
 
Kinetics in DMSO @ 305K
y = -9E-07x - 0.011
R2 = 0.5459
-0.014
-0.013
-0.012
-0.011
-0.010
-0.009
-0.008
0 0.5 1 1.5 2 2.5
time / sec x 103
ln
([A
]-[
A
] eq
m
)
ARD 30
 
 
 
 
time / sec × 103 
time / sec × 103 
 
In
te
gr
al
 ra
to
 
ln
([2
87
]-[
28
7]
eq
m
) 
    287 
    285 
    287 
Experimental 
- 268 - 
Experiment E3: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
DMSO-d6 under N2 at 315 K. 
 
 
T/K Mass/g Conc./mol L-1 
315 0.0083 0.074 
Kinetics in DMSO @ 315 K
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Experiment E4: Equilibration of 3-exo-hydroxy-2-exo-bornanyl acrylate 287 in purified 
DMSO-d6 under N2 at 315 K. 
 
 
T/K Mass/g Conc./mol L-1 
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Experiment E5: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
DMSO-d6 under N2 at 329 K. 
 
 
T/K Mass/g Conc./mol L-1 
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3.3.7 Reactions in Purified DMSO-d6 with H2SO4 under N2 
 
Purified DMSO-d6 (0.5 mL) was added to the acrylate ester 2-exo-hydroxy-3-exo-bornanyl 
acrylate 285 (0.0083 g) in a dry NMR tube. A catalytic amount (1 drop) of H2SO4 was added 
and the tube was flushed with N2 before sealing. The sample was used immediately for NMR 
spectroscopic analysis (301 K) following the method described previously (Section 3.3.1). 
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Kinetics in DMSO & H2SO4 @ 301K (28oC)
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Experiment F1: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
DMSO-d6 with H2SO4 under N2 at 301 K. 
 
 
T/K Mass/g Conc./mol L-1 
301 0.0083 0.093 
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3.3.8 Reactions in Purified DMSO-d6 with p-TsOH under N2 
 
Purified DMSO-d6 (0.5 mL) was added to the acrylate ester 2-exo-hydroxy-3-exo-bornanyl 
acrylate 285 (0.0096 – 0.0135 g) in a dry NMR tube. A catalytic amount of p-TsOH was 
added and the tube was flushed with N2 before sealing. The sample was used immediately for 
NMR spectroscopic analysis (301 – 323 K) following the method described previously 
(Section 3.3.1). 
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Kinetics in DMSO & p-TsOH @ 301 K 
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Experiment G1: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
DMSO-d6 with p-TsOH under N2 at 301 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
301 0.0135 0.120 0.472 0.528 0.89 3.25E-06 1.53E-06 1.71E-06 
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Experiment G2: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
DMSO-d6 with p-TsOH under N2 at 307 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
307 0.0135 0.120 0.471 0.529 0.89 9.22E-06 4.34E-06 4.88E-06 
 
Kinetics in DMSO & p-TsOH @ 307 K 
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Experiment G3: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
DMSO-d6 with p-TsOH under N2 at 315 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
315 0.0135 0.120 0.462 0.538 0.86 4.42E-05 2.04E-05 2.38E-05 
 
Kinetics in DMSO & p-TsOH @ 315 K 
y = -2E-10x2 + 2E-05x + 0.0543
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Kinetics in DMSO & p-TsOH @ 315 K 
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Experiment G4: Equilibration of 2-exo-hydroxy-3-exo-bornanyl acrylate 285 in purified 
DMSO-d6 with p-TsOH under N2 at 323 K. 
 
T/K Mass/g Conc./mol L-1 [287]eqm [285]eqm k-1/k+1 k+1+k-1 k-1 k +1 
323 0.0096 0.086 0.476 0.524 0.91 5.53E-05 2.64E-05 2.90E-05 
 
Kinetics in DMSO & p-TsOH @ 323 K 
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5. APPENDIX I 
 
5.1 CRYSTALLOGRAPHIC DATA FOR PHENYL 2-EXO-(3-CHLORO-
PROPANOYLOXY)BORNANE-10-SULFONATE 308 
 
Empirical Formula C19 H25 Cl O5 S 
Formula Weight 400.92 
Temperature (K) 113 
Wavelength 0.71073 Å 
Crystal System Orthorhombic 
Space group P2(1)2(1)2(1) 
Unit cell dimensions a = 36.0852(7) Å                  α= 90º
 b = 7.0606(2) Å                    β= 90º
 c = 7.5933(2) Å                    γ= 90º
Volume 1934.65(8) Å3 
Z 4 
Density (calculated) 1.377 Mg/m3 
F(000) 848 
Crystal Size 0.15 x  0.15 x  0.25 mm3 
Theta range for data collection 2.3 - 27.9º 
Index ranges -47<=h<=43,-9<=k<=9, -9<=l<=9 
Scan (Type & Range) phi- and omega scans of 0.8-1.0º
Reflections collected 10287 
Independent reflections 4103 [R(int) = 0.068] 
Absorption correction Integration 
Min and Max transmission 0.0879 and 2.827 
Refinement method Full-matrix, least squares on F2 
Data / restraints / parameters 4103 / 0 / 237 
Goodness-of-fit on F2 1.05 
Largest diff. peak and hole -1.04 and 0.56 e.Å-3 
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6. APPENDIX II 
 
6.1 KINETIC DATA FOR THE TRANSESTERIFICATION STUDIES 
 
(See attached CD) 
 
 
